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THESIS ABSTRACT 
Over-expression of the human GPI-linked carcinoembryonic antigen (CEA) family 
members CEA and CEACAM6 is a common feature characteristic of about 70% of human 
cancers inc1uding colon, breast and lung. CEA and CEACAM6 belong to the CEA 
subfamily of cell surface intercellular adhesion molecules within the immunoglobulin 
superfamily. It has previously been demonstrated that its over-expression inhibits cellular 
differentiation, blocks cell polarization, distorts tissue architecture, and inhibits anoikis in 
vitro. Although our laboratory previously demonstrated the role of integrin aS Pl, the main 
receptor for the ECM component fibronectin, in the CEA-mediated inhibition of 
differentiation and anoikis in vitro, the molecular mechanism implicated in these 
inhibitory effects remained unc1ear. In this work, we established a model for CEA 
signaling in which c1ustering of CEA molecules in the cell surface induces membrane 
microdomain aggregation and subsequent co-c1ustering and activation of the integrin aSpl 
and associated integrin-signaling elements such as the PI3-K and MAPKinase cascades. 
Further studies done in a transgenic mice harboring part of the human CEACAM family 
gene locus (CEABAC), with similar protein expression patterns as those found in humans, 
allowed us to extrapolate these in vitro observations to an in vivo system. At low to 
moderate expression levels of CEACAM6, we found transgene copy number-dependent 
increases in CEABAC colonocyte surface levels of integrin aS and Akt activation. An 
increase in colonocyte proliferation, an inhibition of differentiation, and marked inhibition 
of colonocyte anoikis/apoptosis was also observed. At tumor-like expression levels, this 
phenotype was accentuated, CEABAC mice showed massively enlarged colons with 
dysplastic and serrated adenomatous morphology. Subsequent analysis of the molecular 
mechanism involved in the CEA-mediated anoikis inhibition, demonstrated that the CEA-
GPI anchor and self-adhesive extracellular domains were crucial for the CEA inhibitory 
anoikis signal, implicating the intrinsic apoptotic pathway and the PI3-K cascade. In 
summary, the results presented in this thesis establish a potential molecular mechanism 
involved in CEA-mediated tumorigenic effects. 
RESUME DE THESE 
La surexpression de CEA et CEACAM6, membres de la famille des antigènes 
carcinoembryonnaires (CEA) humains liés à un GPI, est une caractéristique commune 
d'environ 70% des cancers humains, dont ceux du côlon, du sein et du poumon. CEA et 
CEACAM6 appartiennent à la sous-famille des molécules de surface cellulaire servant à 
l'adhésion intercellulaire de la super famille des immunoglobulines. Il a déjà été démontré 
in vitro que cette surexpression inhibe la différenciation cellulaire, bloque la polarisation 
des cellules, déforme l'architecture des tissus et inhibe l'anoikis. Notre laboratoire a déjà 
démontré in vitro le rôle de l'intégrine a5~1, récepteur principal d'une composant de la 
matrice extracellulaire (la fibronectine), dans l'inhibition de la différenciation et de 
l'anoikis par l'entremise de CEA. Toutefois, le mécanisme moléculaire impliqué dans ces 
effets inhibiteurs demeure incertain. Dans ce travail, nous avons établi un modèle de 
signalisation de CEA dans lequel l'agglomération de molécules de CEA à la surface des 
cellules induit l'agrégation de microdomaines membranaires et, subséquemment, la 
coagglomération et l'activation de l'intégrine a5~1 et des éléments associés à la 
signalisation d'intégrines, comme la PI3-K et les cascades de MAPKinases. Des études 
additionnelles réalisées sur des souris transgéniques (CEABAC) possédant une portion du 
locus humain de la famille de CEACAM et ayant un mode d'expression de protéines 
similaire à celui des humains, nous ont permis d'extrapoler un système in vivo à partir de 
ces observations in vitro. À des niveaux d'expression de CEAICEACAM6 bas à modéré, 
nous avons constaté une augmentation dépendante du nombre de copies du transgène, du 
niveau intégrine a5 à la surface des colonocytes et de l'activité Akt. Une augmentation de 
la prolifération des colonocytes, une inhibition de la différenciation et une inhibition nette 
de l'anoikis/apoptose des colonocytes ont également été observées. À un niveau 
d'expression semblable à celui d'une tumeur, ce phénotype s'accentue: les souris 
CEABAC développent des côlons beaucoup plus gros et ayant une morphologie 
dysplasique et des structures festonnées. Des analyses ultérieures sur le mécanisme 
moléculaire impliqué dans l'inhibition de l'anoikis par l'entremise de CEA on démontré 
que les CEA ancrés par un GPI et les domaines auto-adhésifs extracellulaires sont cruciaux 
pour le signal d'inhibition de l'anoikis par CEA, impliquant la voie apoptique intrinsèque 
et la cascade de PI3-K. En conclusion, les résultats présentés dans cette thèse établissent 
un mécanisme moléculaire potentiel impliqué dans les effets tumorigènes de CEA. 
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PREFACE 
This thesis includes the text of original research articles formatted in accordance to the 
"Guidelines for Thesis Preparation" from the Faculty of Graduate and Postdoctoral 
Studies. The relevant section of the "Guidelines for Thesis Preparations" states: 
As an alternative to the traditional thesis format, the dissertation can consist of a collection 
of papers that have cohesive, unitary character making them a report of a single program 
of research. The structure for the manuscript-based thesis must conform the following: 
1.- Candidates have the option of including, as part of the thesis, the text of one or more 
papers submitted, or to be submitted, for publication, or the clearly duplicates text (not the 
reprints) of one or more published papers. These texts must conform to the Thesis 
Preparation Guidelines with respect to font size, line spacing and margin sizes and must be 
bound together as an integral part of the thesis. (Reprints of published papers can be 
included in the appendices at the end of the thesis). 
2.- The thesis must be more than a collection of manuscripts. AIl components must be 
integrated into a cohesive unit with a logical progression from one chapter to the next. In 
order to ensure that the thesis has continuity, connecting texts that provide local bridges 
between the different papers are mandatory. 
3.- The thesis must conform to all other requirements of the "Guidelines for Thesis 
Preparations" in addition to the manuscripts. The thesis must inc1ude the following: a table 
of contents, an abstract in English and French; an introduction which c1early states the 
rational and objectives of the research, a comprehensive review of the literature (in 
addition to that covered in the introduction of each paper); a final conclusion and 
summary; and, rather than individual reference lists after each chapter or paper, one 
comprehensive bibliography or reference list, at the end of the thesis, after the conclusion 
and summary. 
4.- As manuscripts for publication are frequently very concise documents, where 
appropriate, additional material must be provided (e.g. in appendices) in sufficient detail to 
allow a clear and precise judgment to be made of the importance and originality of the 
research reported in the thesis. 
5.- In general, when co-authored papers are included in a thesis a candidate must have 
made a substantial contribution to aIl papers included in the thesis. In addition, the 
candidate is required to make an explicit statement in the thesis as to who contributed to 
such work and to what extent. This statement should appear in a single section entitled 
"Contribution to Authors" as a preface to the thesis. The supervisor must attest to the 
accuracy of this statement at the doctoral oral defense. Since the task of the examiners is 
made more difficult in these cases, it is the candidate's interest to clearly specify the 
responsibilities of aIl the authors ofthe co-authored papers. 
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6.- When previously published copyright material is presented in a thesis, the candidate 
must inc1ude signed waivers from the publishers and submit these to the Graduate and 
Postdoctoral Studies Office with the final deposition, if not submitted previously. The 
candidate must also include signed waivers from any co-authors of unpublished 
manuscripts. 
7.- Irrespective of the internaI and external examiners reports, if the oral defense 
committee feels that the thesis has major omissions with regard to the above guidelines, 
the candidate may be required to resubmit an amended version of the thesis. See 
"Guidelines for Doctoral Oral Examinations", which can be obtained from the web 
(http://www.mcgill.ca/fgsr). Graduate Secretaries of departments or from the Graduate and 
Postdoctoral Studies Office, James Administration Building. 
8.- ln no case can a co-author of any component of such thesis serve as an external 
examiner for that thesis. 
Chapter 2 contains the complete text of the following paper: Pilar Camacho-Leal, 
Alexander B. Zhai and Clifford P. Stanners. A co-c1ustering model involving a5~1 
integrin for the biological effects of GPI-anchored human Carcinoembryonic Antigen 
(CEA) Journal of Cel! Physiology. In press (reformatted to conform to the style of this 
thesis). 
Chapter 3 contains the complete text of the following paper: Carlos H.F. Chan*, Pilar 
Camacho-Leal* and Clifford P. Stanners. Colorectal Hyperplasia and Dysplasia due to 
Human Carcinoembryionic (CEA) and CEACAM6 Expression in Transgenic Mice, where 
*denotes co-first authors submitted to Plos Biology (reformatted to conform to the style of 
this thesis). 
Chapter 4 contains the complete text of the following manuscript: Pilar Camacho-Leal and 
Clifford P. Stanners. Human Carcinoembryonic Antigen (CEA)-GPI anchor specifies 
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anoikis inhibition by inactivation of the intrinsic death pathway. Manuscript in 
preparation (refonnatted to confonn to the style ofthis thesis). 
Contribution of Authors 
AlI figures presented in Chapter 2 and Chapter 4 represent my own work. 
In Chapter 2 Co-author Alex Zhai and Luisa De Marte contributed initialIy with the 
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CHAPTERI 
Thesis Introduction 
1.-The Human Carcinoembryonic Gene Family 
1.1 Discovery of CEA and clinicat importance 
CEA is highly glycosylated protein of 180 kDa that was described initially as a 
tumor- associated antigen in human colon cancer tissue extracts (Go Id and Freedman, 
1965). CEA was thought to be an oncofetal antigen, but further studies demonstrated that 
it was also expressed in normal adult tissues (Thomson, 1966). The clinical importance of 
CEA as a tumor marker arose from studies of patients with colorectal and other tumors of 
epithelial origin, where CEA levels were found to be higher than in normal adult colonic 
tissues (Thomson, 1966). Since then, CEA has been used as a tumor marker in a variety 
of cancers (Fuks et al., 1975) and has become a popular target antigen for novel cancer 
therapies: radioimmunotherapy, cellular immunotherapy antibody therapy and cancer 
vaccines (Berinstein, 2002; Goldenberg, 2003; Rance et al., 2005). 
1.2 Gene organization and structure of the human CEA gene family 
In 1987, the CEA cDNA was cloned (Beauchemin et al., 1987; Oikawa et al., 
1987) and the amino acid sequence derived from the cDNA indicated that it was part of 
the immunoglobulin superfamily (Ig) (paxton et al., 1987). Following this important 
finding, about 30 different genes/pseudogenes were identified in the human CEA family, 
clustered on the long arm of human chromosome 19q13.2 (Olsen et al., 1994). CEA-
related genes can be divided into two subgroups based on nucleotide sequence 
comparisons, i.e. the CEA and the PSG (pregnancy-specific glycoprotein) subgroups, 
containing 12 and 11 members respectively (Rammarstrom, 1999; Thompson et al., 
1991). 
Ruman CEA family members are highly glycosylated proteins (Paxton et al., 
1987) consisting of a V-like Ig variable amino-terminal domain followed by up to six 1-
like Ig internaI domains that are either anchored to the cell membrane via a glycosyl-
phosphatidyl inositol moiety (GPI anchor) (CEA, CEACAM6, CEACAM7 and 
CEACAM8) or by a hydrophobic transmembrane domain followed by either long or 
short cytoplasmic domains (CEACAM1, CEACAM3 and CEACAM4) (Rammarstrom, 
2 
1999; Thompson et al., 1991) (Fig. 1). The PSGa subgroup which includes 11 members 
(PSG1-11), are secretory glycoproteins (Hammarstrom, 1999; Thompson et al., 1991). 
In mouse and rat, about 19 and 9 CEA family members have respectively been 
characterized (Zimmermann, 1998). Although the gene classification is similar to that 
established in humans, the rodent secretory members are part of the CEA subgroup and 
often contain more than one N-domain. In addition, no GPI-anchored members for the 
CEA group have been identified (Zimmermann, 1998). The organization of the CEA 
family members in mouse is the following: the CEA sub-group is composed of two 
transmembrane anchored members (CEACAM1 and CEACAM2) and eleven secretory 
members (CEACAM9-11, PSG16-23 and PGS28)(Zimmermann, 1998). 
3 
TIlT TI 
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Figure 1 Structure of CEACAM family glycoproteins. GPI-linked CEACAM family 
members (CEA, CC6, CC7 and CC8), and transmembrane family members [CCI-L (with 
long cytoplasmic tail) and CCI-S (short cytoplasmic tail), CC3 and CC4] are shown. 
(Taken from www.cea.klinikum.uni-muenchen.de/index.php). 
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1.3 Expression patterns of CEA family members 
During early human embryonic development, starting to the 9th week, high levels 
of CEA are present in the gastro-intestinal tract (gastro-oesophageal junction, pyloric 
antrum, upper duodenum, colon and appendix); and to a lesser extent in other endoderm-
derived organs (Benchimol et al., 1989; Nap et al., 1988). This expression is maintained 
throughout life (Nap et al., 1988). CEA expression in normal adult tissues is more limited 
than other CEACAM family members such as CEACAMI and CEACAM6, that have a 
broader tissue distribution (Hammarstrom, 1999). The expression of CEA is restricted 
mainly to columnar epithelial and goblet cells in colon (Baranov et al., 1994; Frangsmyr 
et al., 1999; Jothyet al., 1993; Nap et al., 1988). CEA is also found at 10wer expression 
levels in secretory epithelial cells present in the stomach and small intestine (Kodera et 
al., 1993; Nap et al., 1988), in squamous epithelial cells of the tongue, esophagus and 
cervix (Nap et al., 1988), in epithelial ceUs of the prostate and in transitional epithelial 
cells of the urinary bladder (Nap et al., 1988). CEACAM6 in general, has the same tissue 
distribution as CEA, but is also present in the small intestine, in duct cells of the breast 
and pancreas, in pneumocytes and bronchiole epithelial cells of the lung, and in myeloid 
cells of the bone marrow, spleen and other tissues (Kuijpers et al., 1992; Kuroki et al., 
1992a; Scholzel et al., 2000a). CEACAMI has the broadest distribution of all in normal 
tissues and is expressed in a number of different epithelia: cervix (Prall et al., 1996), 
stomach, duodenum/jejunum/ileum, colon, pancreas, liver, gall bladder, kidney, prostate 
(Frangsmyr et al., 1999; Frangsmyr et al., 1995; Prall et al., 1996), esophagus, 
endometrium, urinary bladder (Prall et al., 1996), sweat and sebaceous-glands (Metze et 
al., 1996), in endothelial cells (Prall et al., 1996), in duct cells of the breast (Huang et al., 
1988; Prall et al., 1996; Riethdorfet al., 1997), in Sertoli cells of the testis (Lauke et al., 
2004), and in myeloid and lymphoid cells (Moller et al., 1996; Prall et al., 1996). Not 
much is known about the distribution of the rest of the CEACAM family members, 
although it has been shown that CEACAM7 expression is similar to that of CEA in 
certain epithelial cells of the colon. It is not expressed in granulocytes (Scholzel et al., 
2000a). CEACAM3, CEACAM4 and CEACAM8 are expressed in granulocytes but not 
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in epithelial cells (Kuijpers et al., 1992; Kuroki et al., 1992b; Nagel et al., 1993). Finally, 
the PSG molecules are mainly produced in the placenta (Zhou et al., 1997), but are also 
found in hematopoietic cells (Wu et al., 1993), fetal liver, salivary gland, testis and 
myeloid cells (Thompson et al., 1991). 
1.4 Importance of membrane anchorage function 
The plasma membrane of polarized epithelial cells is structurally separated into 
two main domains, apical and basolateral, where differential lipid and protein 
compositions are found, reflecting specialized functions (Mostov et al., 2003). One of the 
mechanisms responsible for directing proteins to the cell membrane is via post-
translational modifications with lipids. The attachment of fatty acids to pro teins in the 
cytoplasm, or palmitate and cholesterol in the lumen of the endoplasmic reticulum, 
directs protein localization to the cell membrane (Mayor and Riezman, 2004). 
GPI-linked proteins are targeted to the apical membrane by the addition of a 
glycophosphatidylinositol (GPI) anchor to the C-terminal carboxyl group of a protein on 
the luminal side of the of the ER membrane (Mayor and Riezman, 2004). The typical GPI 
anchor structure includes ethanolamine phosphate, trimannoside, glucosamine and 
inositiol phospholipids (Ikezawa, 2002). Its biosynthetic pathway is mostly conserved 
between organisms (Ikezawa, 2002). GPI anchor properties can be modified by sugar or 
lipid composition; it has been suggested that such modifications can be crucial for the 
physical properties of the GPI -anchored protein in the membrane (Mayor and Riezman, 
2004). 
As mentioned previously, GPI-linked proteins are found mainly in the plasma 
membrane. It has been demonstrated that the membrane-anchorage properties of GPI-
linked proteins determine their association with subdomains of the plasma membrane 
having a particular lipid composition (Brown, 1993; Simons and Ikonen, 1997). These 
membrane microdomains were initially named "membrane rafts" or "detergent-resistant 
microdomains" (DRM) due to their insolubility in non-ionic detergents. DRM were found 
to be important entities for signaling functions (Brown, 1993; Rodgers et al., 1994; 
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Stefanova et al., 1991) (see section 4.5). Thus, membrane raft localization of GPI-
anchored proteins has important implications for their signaling functions (Janes et al., 
1999; Kramer et al., 1999; Leyton et al., 1999). 
2.-Functions of CEA Family members 
2.1 Cell adhesion 
Cell adhesion lS a critical mechanism involved in tissue morphogenesis, 
embryogenesis and organogenesis as weIl as the maintenance of proper tissue 
architecture. Four major categories of proteins mediate cell adhesion through ceIl-ceIl 
interactions i.e. cadherins, members of the immunoglobulin superfamily (Ig CAMs) 
selectins and integrins, the latter also involved in the regulation of cell-matrix interactions 
(Aplin et al., 1998). 
Sorne members of the Ig superfamily play a crucial role in the deve10pment of the 
nervous system. SpecificaIly, they are implicated in axon guidance and in the 
establishment and maintenance of neural connections (Baldwin et al., 1996; Murase and 
Schuman, 1999; Tessier-Lavigne and Goodman, 1996). Neural Ig CAMs act, in general, 
as homotypic receptors (Baldwin et al., 1996; Tessier-Lavigne and Goodman, 1996). 
Another important biological function regulated by Ig-CAMs occurs in the immune 
system, where they are implicated in antigen recognition, cytotoxic T -cell functions, and 
lymphocyte recirculation. These receptors, in contrast to neural Ig CAMs, are often 
involved in heterotypic interactions (Rosales and Juliano, 1995; Springer, 1995). 
In the case of CEACAM family members, in vitro studies have demonstrated that these 
molecules function as intercellular adhesion molecules mediating homotypic and 
heterotypic binding (Benchimol et al., 1989; Jessup et al., 1993; Levin and Griffin, 1991; 
Oikawa et al., 1991; Oikawa et al., 1992; Rojas et al., 1990; Turbide et al., 1991; Zhou et 
al., 1990). The CEACAM1 adhesion function is dependent on temperature and Ca2+ 
concentration (Rojas et al., 1990; Turbide et al., 1991), whereas CEA and CEACAM6 
binding is temperature- and Ca2+ concentration- independent (Rojas et al., 1996; Rojas et 
al., 1990). 
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Cell adhesion elicited by CEA related molecules can occur in two different fashions, by 
parallel interactions, requiring N-N domain binding on the same cell surface (Taheri et 
al., 2003), or antiparallel interactions through double reciprocal bonds from adjacent cells 
between the N-domains of one molecule, with the A3B3 domain of the other and 
viceversa (Zhou et al., 1993a). Heterotypic binding has been also observed through N-N 
domain interactions (Rojas et al., 1996; Rojas et al., 1990; Stanners et al., 1992; Teixeira 
et al., 1994; Watt et al., 1994) or through N-A1B1 domain interactions (Oikawa et al., 
1991; Oikawa et al., 1989; Oikawa et al., 1992; Stanners, 1998; Zhou et al., 1990) 
between CEACAMlICEACAM8 and CEACAM6, and CEACAM6/CEACAM1 with 
CEA. It is important to mention that the mode of cell adhesion is not just a mechanical 
mechanism implicated in bringing cells together, rather both types of interactions would 
have the effect of c1ustering molecules on the cell surface, which represents an important 
event implicated in the activation ofintracellular signaling (see section 2.7). 
2.2 Inhibition of cell differentiation 
An important biological process implicated in CEA biological functions is CEA 
inhibitory effects on cell differentiation. This effect has been observed for GPI-anchored 
CEACAMs, CEA, CEACAM6 and CEACAM7, but not the transmembrane member 
CEACAM1 in a number of different cell types both in vitro and in vivo (Chan et al., 
2007; Eidelman et al., 1993; Ilantzis et al., 2002; Rojas et al., 1996; Screaton et al., 1997; 
Taheri et al., 2003). 
Since CEA and CEACAM6 have been considered as differentiation markers in 
different cell types, based on the observed CEA and CEACAM6 expression in the 
healthy human colon, it has been difficult for the CEA field to consider the inhibitory 
effects ofthis molecule in cell differentiation. However, there is evidence suggesting that 
this is the case. It is know that in the normal adult situation, CEA expression is restricted 
to well-differentiated epithelial cells (Abbasi et al., 1992; Benchimol et al., 1989; 
Hammarstrom and Baranov, 2001), with much lower expression levels in cells with 
proliferative capacity at the bottom of colonic crypts (Ilantzis et al., 1997; Jothy et al., 
1993; Scholzel et al., 2000a). In contrast, during embryogenesis, CEA is expressed at 
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high levels in undifferentiated cells of the developing gut (Benchimol et al., 1989; Nap et 
al., 1988). Interestingly expression of CEA and CEACAM6 in colon cancer cells were 
found to be inversely correlated with the degree of cell differentiation, resembling the 
embryonic situation (Ilantzis et al., 1997). These findings suggested that high expression 
of CEAICEACAM6 could lead to a "fetal-like" situation by maintaining the proliferative 
potential of the cells (Ilantzis et al., 2002). Thus it was established a possible contribution 
of CEAICEACAM6 to colon tumorigenesis by inhibition of cell differentiation. This 
hypothesis is supported by further experiments demonstrating that injection into nude 
mice of L6 myoblasts expressing CEA showed increased tumor formation (Screaton et 
al., 1997). Recently, generation of a transgenic mouse harboring part of the human 
CEACAM family gene c1uster containing the CEA, CEACAM3, CEACAM6 and 
CEACAM7 genes, demonstrated dramatic tumorigenic effects in vivo (Chan et al., 2007). 
2.3 Inhibition of anoikis 
Anoikis is an apoptotic process induced by loss of cell adhesion or inappropriate 
cell adhesion (Frisch and Francis, 1994). Adhesion to the extracellular matrix is 
important to determine whether a cell is in the correct location and to eliminate displaced 
cells by apoptosis. Anoikis thus represents an important mechanism for the maintenance 
oftissue architecture 
In addition to cell differentiation, over-expression of CEA and CEACAM6, but 
not CEACAM1, in L6 rat myoblasts, MDCK epithe1ial cells, human SW1222, Caco-2 
and HT29 colorectal cancer cells (Ordonez et al., 2000), and in human PANC1, capan2 
and MiaPa Ca2 pancreatic cancer cells (Duxbury et al., 2004d; Soeth et al., 2001; Wirth 
et al., 2002), has been shown to have inhibitory effects on anoikis. In summary, these 
findings suggest that these two processes are important mechanisms for the tumorigenic 
effects induced by CEA and CEACAM6 (see section 5). 
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2.4 Immunity 
Intestinal epithelial cells have been shown to play an important regulatory role in 
the immune responses towards luminal antigens, either by adaptative immune responses 
(Mayer and Shlien, 1987; Mizoguchi et al., 2000) or via the innate system (Santos et al., 
1990). Interestingly, regulatory CD8+T cell activation by IECs was found to be regulated 
by a complex expressed on epithelial cells, formed by CEA (gp 180), which is a CD8 
ligand (Campbell et al., 2002); and the non-classical class 1 molecule CDld (aaAllez et 
al., 2004). The recognition of this complex by suppressor CD8+CD28- T cells induced 
their activation, which represents an important event involved in the downregulation of 
inflammatory and immune responses in the GI tract (aaAllez et al., 2004). 
The involvement of CEACAMI in T cell response has been documented by 
various groups (Chen and Shively, 2004; Chen et al., 2004; Kammerer et al., 2001; 
Morales et al., 1999). The role of CEACAM1 in activated T-cells is either inhibitory 
(Boulton and Gray-Owen, 2002; Chen and Shively, 2004; Markel et al., 2002a; Nakajima 
et al., 2002), or activating (Boulton and Gray-Owen, 2002). These contradictory data can 
be explained as the result of the ligation of different CEACAM1 isoforms (Chen et al., 
2004): the long cytoplasmic tail human CEACAMI isoform functions as an inhibitory 
receptor, whereas the short cytoplasmic tail isoform is a costimulatory receptor (Chen et 
al., 2004). CEACAM1 has also been shown to regulate B-cell (Greicius et al., 2003) and 
NK cell activation (Markel et al., 2004; Markel et al., 2002a; Markel et al., 2002b) as 
well as dentritic cell maturation (Kammerer et al., 2001). 
Finally, studies of human CEACAMs have demonstrated their role as cellular 
receptors for several bacteria such as Escherichia coli (Berger et al., 2004; Sauter et al., 
1991) Neisseria gonorrhoeae, Neisseria meningitis (Gray-Owen et al., 1997; Hill et al., 
2005; Vüji et al., 1999; Virji et al., 1996) Haemophilus influenzae (Virji et al., 2000), 
Moraxella catarrhalis (Hill and Virji, 2003), as well as the murine mouse hepatitis virus 
which binds to the murine homologs of CEACAM1 and CEACAM2 in vitro (Dveksler et 
al., 1993; Dveksler et al., 1991; Nedellec et al., 1994; Tan et al., 2002). Interestingly, in 
vivo results showed that a CEACAMl knockout mouse was entirely resistant to infection 
10 
by the most pathogenic strain of this virus MHV A59 (Hemmila et al., 2004). These 
findings suggest that CEACAMs have an important role in the regulation of bacterial 
colonization, probably acting as a defense mechanism during infection (Hammarstrom, 
1999). Recent studies have established for the first time the mechanism by which 
CEACAM1 could counteract microbial infection (Muenzner et al., 2005). 
2.5 Angiogenesis 
Angiogenesis is a cellular process responsible for the formation of the mature 
blood vessels (Folkman and D'Amore, 1996; Hanahan and Folkman, 1996). Implication 
of the transmembrane member CEACAM1 during this process has been demonstrated by 
several groups (Ergun et al., 2000; Kilic et al., 2005; Wagener and Ergun, 2000). Ergun 
et al. showed that CEACAMI purified from granulocytes and endothelial cells, as weIl as 
recombinant CEACAM1 stimulated angiogenesis in vivo and in vitro (Ergun et al., 
2000). In addition, a monoclonal anti-CEACAMI antibody prevented VEGF-induced 
tube formation and vascularization, providing evidence that CEACAMI is as a potent 
angiogenic factor and VEGF effector (Ergun et al., 2000). The role of CEACAMI in 
vascularization is further supported by phenotypes exhibited by genetically-altered mice 
(Horst et al., 2006). Ceacam1 -/- mice show deficient vascular remodeling, whereas 
transgenic mice overexpressing CEACAM1-L in the endothelium exhibit an increase in 
vascular growth (Horst et al., 2006). Recently, it has been shown that CEACAMI-L 
expression on endothelial cells regulated cell morphology during cell adhesion to ECM 
and promoted endothelial cell migration (Muller et al., 2005), suggesting that 
CEACAM1-integrin interactions are implicated during the activation phase of 
angiogenesis (Muller et al., 2005). 
2.6 Regulation of insulin clearance 
Insulin clearance is a key mechanism involved in the regulation of circulating 
insulin levels. The efficacy of this mechanism has important consequences in many liver 
diseases such as T2 diabetes mellitus (T2DM). (Najjar, 2002). 
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Studies done with the transmembrane member CEACAMI showed that it functions as a 
substrate of the insulin receptor tyrosine kinase in rat hepatocytes (IR) (Rees-Jones and 
Taylor, 1985). Subsequent studies, in a transgenic mouse model, demonstrated the role of 
CEACAMI in insulin clearance (poyet al., 2002). Overexpression of a dominant 
negative form of CEACAM1 in the liver induced hyperinsulinemia due to insulin 
clearance impairment. In addition, altered fat metabolism observed in these mi ce 
established the contribution of CEACAMI in the pathogenesis of obesity (Poyet al., 
2002). New evidence implicated CEACAM1 in the regulation oflipid metabolism (Najjar 
et al., 2005). 
2.7 Structural requirements for CEA bioIogicaI effects 
Structural studies of the CEA molecule were previously conducted in order to 
establish which subdomains within the CEA molecule are required for inhibition of cell 
differentiation and anokis (Screaton et al., 2000; Taheri et al., 2003; Taheri et al., 2000). 
Point mutations within three 5 amino acid subdomains of the CEA arnino-
terminal domain are required for the CEA-mediated differentiation block (Taheri et al., 
2003). A large region of the amino terminal domain including these subdomains were 
previously identified as necessary for CEA adhesive properties (Eidelman et al., 1993). 
Experiments done with a CEA mutant lacking the first 75 amine acids of the N-domain 
(~NCEA) lacked the intercellular adhesion properties and the ability to block L6 
myoblast cell differentiation, thus implicating the involvement of self binding of the 
extracellular domains of CEA (Eidelman et al., 1993). Further work provided evidence 
that the intercellular adhesion and differentiation-blocking functions of CEA could be 
independently blocked (Taheri et al., 2003) suggesting that CEA-CEA parallel 
interactions on the same cell were also specifically required to block differentiation, since 
the ~NCEA mutant could inhibit differentiation by cross-linking with specific antibodies 
(Taheri et al., 2003). Further studies showed that the CEA GPI-anchor was aiso required 
for CEA inhibitory effects (Screaton et al., 2000). The expression of chimeric proteins 
consisting of the CEA-GPI anchor fused to the extracellular domain of NCAM or 
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CEACAMI in L6 myoblasts inhibited myogenic differentiation of these cells, whereas 
the CEACAMI transmembrane domain and cytoplasmic long tail fused to the CEA 
extracellular domain did not block cell differentiation. In addition, since the GPI-
anchored variant of NCAM itself failed to block myoblast differentiation, the specifie 
anchor of CEA is required. These results suggested that the mode of anchorage of the 
CEA molecule determines its differentiation-inhibitory property, and further, that the 
specifie GPI anchor of CEA was necessary. It was suggested that the external domains 
are required only to be self-binding so as to cause clustering of CEA molecules including 
their GPI anchors (Screaton et al., 2000). We hypothesize that this clustering causes 
CEA-containing membrane raft aggregation leading to CEA-mediated signaling 
activation (see section 4.5). 
3.-Signal transduction by cell adhesion receptors: the role of cadherins, 
selectins immunoglobulin-cell adhesion molecules and integrins. 
Cell adhesion represents an important process implicated in the generation, 
maintenance and regulation of tissue architecture. Cell-cell and cell-ECM adhesion is 
modulated by several adhesion receptor families such as cadherins, selectins, integrins 
and the immunoglobulin-cell adhesion molecules. In addition to the structural adhesion 
function of these molecules, they have been shown to activate signal transduction 
cascades involved in gene expression, cell cycle, cell survival and differentiation. 
3.1 Cadherins 
The Cadherin family comprises a group of transmembrane proteins with a 
common type of extracellular domain consisting of multiple repeats of a cadherin-
specific motif (Y agi and Takeichi, 2000). The "cl as sic" cadherin subfamily includes the 
E-, N-, P-, R- and B- cadherins. Cadherins are calcium-dependent homotypic cell-cell 
adhesion molecules that are usually found in specialized sites of cell-cell contacts known 
as adherens junctions (Aberle et al., 1996). Cadherins are linked to the cytoskeleton 
through the binding of the intracellular proteins a-catenin and ~-catenin to their 
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cytoplasmic domain (Aberle et al., 1996). This complex mediates cadherin interaction 
with actin (Rimm et al., 1995), a-actinin (Knudsen et al., 1995) and pl20-catenin (Daniel 
and Reynolds, 1995), a protein implicated in signaling to the Rho GTPases (Noren et al., 
2000), that binds directly to the membrane-proximal region of cadherin cytoplasmic tail 
(Daniel and Reynolds, 1995). The association between cadherins and catenin molecules 
represents an important feature for signal transduction, due to the association of a number 
of signaling proteins to the cadherin-catenin complex, such as receptor tyrosine kinases 
and phosphatases, PB-Kinase, and Shc (Yap and Kovacs, 2003). 
3.2 Selectins 
Selectins mediate heterotypic cell-cell interactions through calcium-dependent 
recognition of sialylated glycans. Selectins are mainly involved in inflammatory 
processes mediating leukocyte adherence to endothelial cells and platelets (Springer, 
1994). Selectins comprise a family of lectin-like adhesion receptors that contain an 
amino-terminal domain homologous to calcium-dependent animallectins, followed by an 
epidermal growth factor (EGF)-type domain, various consensus repeat domains (CR) and 
a single transmembrane domain and a short cytoplasmic tail. Besides their adhesive role, 
selectins have been shown to possess signaling functions (Patel et al., 2002). Se1ectin-
mediated signaling activation is initiated either by artificialligation of selectin molecules 
or directly by their ligands (Pate1 et al., 2002). Ligand-mediated signaling stimulates 
superoxide generation (Nagata et al., 1993) and p2-integrin activation (Evangelista et al., 
1996; Kuijpers et al., 1991), whereas antibody-mediated selectin cross-linking activates 
calcium flux (Laudanna et al., 1994; Lorenzon et al., 1998) and tyrosine phosphorylation 
ofvarious effectors such as MAPK (Hu et al., 2001; Waddell et al., 1995). Association of 
selectins with the cytoskeleton can occur by the interaction of L-selectin with a-actinin 
(Pavalko et al., 1995). 
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3.3 Integrins 
Integrins are heterodimeric adhesion receptors and members of cell-surface 
glycoproteins that mediate both cell-cell adhesion and adhesion to the extracellular 
matrix (ECM) components, resulting in cytoskeletal reorganization and intracellular 
signaling (Giancotti and Ruoslahti, 1999; Guo and Giancotti, 2004b; Hynes, 2002). 
Integrins consist of non-covalently associated type-I transmembrane subunits, a 
and p. Each subunit forms a globular head that represents the main ligand-binding region, 
connected to a single membrane-spanning region and, except for the p4 integrin, a short 
cytoplasmic domain (Aplin et al., 1998; Humphries, 2000; Juliano, 2002). In vertebrates, 
integrin a and p-subunits form at least 25 heterodimers with 19 different a-subunits and 
8 p-subunits (Giancotti and Ruoslahti, 1999; Humphries, 2000; Hynes, 2002). AlI 
integrins bind their ligands in a divalent-cation dependent manner, with manganese and 
magnesium generally promoting binding and calcium having the opposite effect (Smith et 
al., 1994). Three regions have been identified as important sites for ligand-binding: 1) a 
series of seven repeats in the N-terminal portion of the a-chain that contain a putative 
Ca2+ binding site, 2) an inserted I-domain present in several a-subunits containing a 
nuc1eotide binding fold and a divalent cation coordination site, and 3) an I-domain-like 
region found in the P-subunit (Shimaoka et al., 2002). 
The transition of integrin molecules from an inactive to an activate state 
(Humphries et al., 2003) represents a crucial event required to bind physiologicalligands 
triggering signal transduction (Hynes, 1992; Hynes, 2002). Integrins can assume various 
affinity states that can be regulated by bidirectional signaling (Hynes, 2002) either by 
"outside in" signaling, induced by extracellular factors, or "inside out" signaling, where 
intracellular events involving the cytoplasmic domain of a and p integrin subunits are 
coupled to extracellular conformational changes (Ginsberg et al., 2005) (Fig. 2). 
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Figure 2 Molecular view of Integrin bidireccional signaling. Integrins exist in low-
(bent conformation) and high- (extended conformation) affinity states. In the low affinity 
state, C-terminal a and p integrin subunits are in a folded configuration with laterally 
associated transmembrane and cytoplasmic domains. Separation of a and p subunits at 
their cytoplasmic, transmembrane and leg domains are implicated in the transition to the 
active state. Disruption of the association between the integrin heads and legs leads to a 
switchblade-like extension (high-affinity ligand binding). Intermediate integrin 
conformational changes can occur (middle panel). Separation of the integrin a and p 
subunits is implicated in the triggering of inside-out conformational signaling [(integrin 
priming) (uppward arrow)]. Ligand occupancy and receptor c1ustering initiate outside-in 
signaling (downward arrow)(Luo and Springer, 2006). 
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Integrin activation is regulated by several mechanisms such as affinity regulation, 
which implicates conformational changes of single integrin molecules (Carman and 
Springer, 2003; Hynes, 2002; Liddington and Ginsberg, 2002; Takagi and Springer, 
2002) Valency or integrin clustering, which implies changes in local density and lateral 
mobility of integrins along the plasma membrane; and avidity regulation, that results 
from changes in affinity of individual-receptor ligand bonds and valency (Bazzoni and 
Hernler, 1998; Dustin and Springer, 1989; Faull et al., 1994; Hato et al., 1998; Loftus et 
al., 1994; Shirnaoka et al., 2002; Stewart and Hogg, 1996; van Kooyk and Figdor, 2000; 
Xiong et al., 2003) (Fig. 3). Although all these rnechanisms are currently extensively 
studied, it is still controversial how affinity, valency, or avidity changes of integrins 
regulate ligand-binding (Bazzoni and Hernler, 1998; Carman and Springer, 2003) (these 
aspects will be discussed in more detail in the next section). 
Activation of integrin-mediated signal transduction implicates the Focal Adhesion 
Kinase (FAK) (Komberg et al., 1992) or the non-receptor tyrosine kinases, i.e., Src 
family kinases (Giancotti and Ruoslahti, 1999), which induce the activity of GTPases of 
the Ras and Rho families and subsequent activation of the rnitogen-activated protein 
kinase (MAPK) pathway (Giancotti, 2000; Schlaepfer et al., 1994). Activation of the 
Phosphoinositide 3-Kinase (PI3-K) cascade can result in downstream Integrin-linked 
Kinase (ILK) and Akt activation (Giancotti and Ruoslahti, 1999) (Fig. 4). Integrin-
mediated signal transduction leads to the regulation of gene expression determining cell 
state: proliferation, differentiation and survival (Giancotti and Ruoslahti, 1999; Hannigan 
et al., 2005; Hynes, 2002). 
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Figure 3 Models for integrin activation. Two main models for integrin activation have 
been established: affinity regulation implicates conformational changes of individual ap 
heterodimers, whereas valency regulation involves changes in cell surface receptor 
diffusivity and local density. Regulation of integrin activation by affinity regulation 
oecurs by transition from a low- to high-affinity conformation. Binding of adaptors to the 
cytoplasmic integrin tails may lead to tail separation and subsequent integrin activation. 
Modes of integrin activation associated with valency regulation can occur in a ligand-
dependent (ligand-induced) (A) and ligand-independent (active) (B) fashion. In (A), an 
example of adhesion strengthening, the main ligand-dependent regulatory event, the 
binding of integrins to extracellular matrix (ECM) components, is shown. Inside-out 
signaIs may release cytoskeletal constraints, increasing receptor diffusivity facilitating 
ligand-dependent accumulation of integrins in the zone of contact with the substrate. In 
B, the recruitment of integrins into lipid raft domains represents a mechanism for ligand-
independent or active valency regulation. A vidity regulation results from the combination 
of both, affinity and valency regulation (overall individual-receptor bonds and the total 
number of bonds formed). 
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Figure 4 Integrin signaling. Major signal transduction pathways activated by integrins 
are represented by main arrows, leading to the regulation of cell survival, cell 
proliferation and cytoskeleton organization. Details of the interactions between these 
signaling pathways are omitted, but key linker proteins are contained within black 
squares. Activation of integrin-associated signaling cascades is mediated by the linkage 
of integrin receptors with membrane-associated signaling elements (represented as the 
pentagon underneath activated integrins). 
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3.4 Immunoglobulin-Superfamily members 
For the past years, extensive studies elucidated the molecular events implicated in 
Ig-CAM functions. Among the immunoglobulin superfamily members, the neural Ig-
CAM, NCAM, is one of the most studied. NCAM is widely expressed in the nervous 
system and it functions as a homotypic, calcium-independent cell-cell adhesion receptor. 
NCAM mediates signal transduction involved in growth cone activation and neurite 
extension (Baldwin et al., 1996; Crossin and Krushel, 2000; Kamiguchi and Lemmon, 
2000; Walmod et al., 2004). One of the tirst signaling events activated upon homotypic 
binding of NCAM molecules at the cell surface is Ca2+ flow. Altered calcium flux 
resulting from NCAM-dependent signaling regulates growth cone guidance by activation 
of calcium channels (Doherty et al., 1991). The lipid metabolite arachidonic acid (AA) is 
suggested to be an upstream activator of the Ca2+ channels in NCAM -mediated signaling 
(Williams et al., 1994a). In addition to AA, Phospholipase C (PLC) (Saffell et al., 1997), 
DAG lipase (Williams et al., 1994b) and G proteins (Saffell et al., 1992) have also been 
described as upstream regulators of NCAM -mediated calcium signaling. These events 
occur upon activation of Fibroblast Growth Factor Receptor (FGFR), placing FGFR as 
the major NCAM-activated tyrosine kinase activated upstream of Ca 2+ channel 
activation (Ronn et al., 2000; Saffell et al., 1997; Williams et al., 1994a). 
Another important signaling event activated by NCAM involves the MAPK cascade. 
Recruitment ofintracellular tyrosine kinases (FAK and p59 Fyn) (Beggs et al., 1997) and 
FGFR leads to Erk/MAPK signaling (Perron and Bixby, 1999). Although the 
involvement of the MAPK in NCAM-mediated neurite outgrowth is still controversial, 
MAPK has been shown to stimulate the neuritogenic response (Perron and Bixby, 1999). 
The CEA family plays an important role in signal transduction processes (Draber 
and Skubitz, 1998). For instance, CEACAM1 carries two different cytoplasmic domains, 
a short 10 amine acid or a long 71-73 (in mou se) aminoacid domain. The cytoplasmic 
domains are the most conserved domains of this family throughout evolution. The 
signaling functions of the transmembrane CEACAM1 were suggested by experiments 
showing in vitro phosphorylation of the long splice variant CEACAM1-L on its tyrosine 
21 
as weIl as its serine and threonine residues (Afar et al., 1992). This was shown in 
hepatocytes, after activation of the insulin and EGF receptor (Abou-Rjaily et al., 2004; 
Najjar et al., 1993), and in neutrophils after antibody binding (Skubitz et al., 1992). The 
short cytoplasmic domain lacks tyrosine residues, but has been shown to be 
phosphorylated by protein kinase C on serine and threonine residues (Edlund et al., 
1998). These phosphorylation events are critical for lumen formation ofMCF10A breast 
tumor cells grown as suspended structures in three dimensional matrices (Kirshner et al., 
2003). Further studies demonstrated the presence of two immunoreceptor tyrosine-based 
inhibitory motifs (ITIM) within the CEACAM1-L long cytoplasmic domain that are 
phosphorylated by Src family kinases (Brummer et al., 1995; Skubitz et al., 1993). 
Binding of Src homology protein-1I2 (SHP-1I2) to CEACAM1 phosphorylated ITIMs 
was responsible for CEACAMI growth inhibitory functions in epithelial cells 
(Beauchemin et al., 1997; Chen and Shively, 2004; Huber et al., 1999). 
Other important CEACAMI interactions were established by CEACAM1 
association with several cytoskeletal proteins. The CEACAM1-L cytoplasmic domain 
binds to paxilin (Ebrahimnejad et al., 2000), talin (Muller et al., 2005) filamin (Klaile et 
al., 2005) and actin. Consequently, it can activate the Rho family of GTPases (Fournes et 
al., 2003; Sadekova et al., 2000). Both CEACAMI isoforms interact with G-actin and 
tropomyosin (Schumann et al., 2001) and with calmodulin (Blikstad et al., 1992; 
Campbell and Ginsberg, 2004) whereas CEACAM1-S binds directly to F-actin 
(Schumann et al., 2001). 
The involvement of CEACAM-1-mediated cell-adhesion with ECM-integrin 
signaIs was demonstrated by the association of integrin receptors with CEACAM1, i.e. 
integrin p3 binds CEACAMI-L (Brummer et al., 2001), whereas integrin pl binds to 
CEACAM-l-S in the MCF-7 breast epithelial cellline (Kirshner et al., 2004; Muenzner 
et al., 2005). 
Although recent evidence has implicated the GPI-linked CEA family members in 
signal transduction, it is still unc1ear how the CEA-mediated signal transduction occurs. 
Antibody-mediated cross-linking of CEACAM6 in pancreatic adenocarcinoma cells 
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induced c-Src activity VIa av~3 integrin (Duxbury et al., 2004a) in a caveolin-l-
dependent manner (Duxbury et al., 2004b). In addition, based on structural studies of the 
CEA molecule previously mentioned (see section 2.4), it was suggested that parallel 
CEA-CEA interactions on the same cell surface are probably required to activate 
signaling by clustering CEA-containing membrane rafts and associated signaling 
molecules (Screaton et al., 2000). Furthermore, the a5~1 integrin receptor has been 
functionally implicated in CEA-mediated inhibition of differentiation and anoikis 
(Ordonez et al., 2007). 
4.-An overview of Integrin function 
4.1 Integrin activation 
After the first X-ray crystal structure of the integrin extracellular domain was 
published in 2001 (Xiong et al., 2001), an important advance in knowledge regarding 
integrin function took place. The crystal structure of the av~3 integrin in the presence of 
Ca2+ revealed a V -shape structure that resembles a "head" piece connected to two "legs" 
bent at the region termed the "genu" or "knee", where the head-pieces of the a and ~­
subunits are placed close to the membrane-proximal portions of the tail (Xiong et al., 
2001). The latter was suggested to represent the integrin inactive conformation, since the 
crystal structure was obtained in the presence of Ca2+ known to stabilize integrins in this 
conformation (Smith et al., 1994). Additional evidence reinforced this idea, where close 
association of juxtamembrane regions was shown to maintain integrins in an inactive 
state (Lu et al., 2001; Takagi et al., 2002) (Fig. 2). 
Further studies established a switchblade-like rearrangement of the receptor after 
activation. Based on functional and structural data, these studies provided a better model 
for integrin activation (Beglova et al., 2002). The nuclear magnetic resonance (NMR) 
solution structure of the epidermal growth factor 2 and 3 bound to the ~2 integrin subunit 
showed an extended structure. Superimposition of the latter onto the previously described 
integrin av~3 crystal structure (Xiong et al., 2001) allowed the visualization of important 
residues that were sterically inaccessible in the bent av~3 integrin structure, suggesting 
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that the bent integrin avp3 confonnation represented the low-affinity state and that a 
switchblade-like rearrangement occurred during activation that allowed the epitopes to 
become accessible for antibody recognition (Beglova et al., 2002). Thus, this data 
demonstrated that in the high affinity confonnation, the integrin receptor is extended and 
the ligand-binding head piece of the integrin heterodimer is situated away from the 
plasma membrane (Takagi et al., 2002). (Fig. 2). Subsequent studies demonstrated that 
the transition to the active state seems to be regulated by the separation of the a and p 
subunits at their cytoplasmic, transmembrane and leg domains (Kim et al., 2003; Luo et 
al., 2004; Shimaoka et al., 2002; Takagi et al., 2002; Xiao et al., 2004). Multiple affinity 
states resulting from intennediate confonnations of the integrin receptor have been 
suggested (Shimaoka et al., 2002; Takagi et al., 2002) (Fig. 2). This represents a 
regulatory mechanism for the overall integrin ligand affinity and ligand-binding 
specificity (Mould et al., 2003; Salas et al., 2004). 
The affinity modulation model implies confonnational changes for the activation 
of single integrin receptor molecules. The concepts of valency (integrin clustering) and 
avidity regulation (both valency and affinity regulation) were introduced to the integrin 
field in the past eight years, creating an important debate regarding how these processes 
act together in order to induce integrin activation (Bazzoni and Hemler, 1998; Carman 
and Springer, 2003; Shimaoka et al., 2002; van Kooyk and Figdor, 2000) (Fig 3). 
To better judge the basis of this debate, it is important to be familiar with the 
CUITent models of integrin signaling. Integrin activation can be regulated by "inside-out" 
integrin signaling or "priming", where stimuli by other cell-surface receptors lead to a 
cellular signal that induces confonnational changes of the integrin cytoplasmic domains. 
This subsequently alters the ligand-binding ability of the integrin extracellular domain 
(Ginsberg et al., 2005; Humphries et al., 2003; Hynes, 2002). The opposite "outside in" 
mechanism activates signaIs from the extracellular integrin region towards the inside of 
the cell (Ginsberg et al., 2005; Humphries et al., 2003; Hynes, 2002). Structural and 
functional studies have shown that separation of the cytoplasmic regions of the integrin a 
and p subunits is required to initiate integrin bidirectional signaling (see section 
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3.3)(Hughes et al., 1995; Kamata et al., 2005; Li et al., 2005; Lu et al., 2001; Luo et al., 
2005; Luo et al., 2004; Partridge et al., 2005; Takagi et al., 2001) (Fig 2). 
What is then the relative contribution of conformational changes and c1ustering in 
the signaling mediated by integrin molecules? The main postulate regarding this 
controversy is whether ligand binding is the cause of integrin conformational changes, or 
whether valency and/or affinity regulation represent the main mechanisms for ligand-
binding changes (Bazzoni and Hemler, 1998; Carrnan and Springer, 2003). The most 
accepted model (ligand-dependent) proposes that subsequent to ligand-binding induced 
by inside-out signaling, integrin molecules undergo c1ustering (valency), leading to 
multivalent ligand binding and subsequent outside-in signaling (Carrnan and Springer, 
2003; Shimaoka et al., 2002). However, other groups have shown that integrin activation 
can occur in a ligand-independent fashion by valency regulation. One of the hypotheses 
for this model is that recruitment of integrin molecules to specifie regions of the plasma 
membrane (membrane rafts) determine valency priming (Hogg et al., 2002; Krauss and 
Altevogt, 1999; Leitinger et al., 2000; Sharnri et al., 2002). However, this hypothesis has 
been questioned due to lack of evidence showing that disruption of lipid raft association 
prevents integrin activation (Fig. 3). 
Another important observation that established a potential mechanism for integrin 
c1ustering was suggested by other groups. These studies showed that homomeric 
associations of integrin transmembrane domains in micelles (Li et al., 2001) and both 
homomeric and heteromeric associations in biological membranes (Li et al., 2004) 
(Schneider and Engelman, 2004) are crucial for integrin activation. In addition, 
mutational studies of a region within the p3 integrin transmembrane domain in CHO 
cells, found previously to be important for homomeric transmembrane interactions 
(Choma et al., 2000), as well as mutations that disrupted integrin oligomerization (Li et 
al., 2005) prevented integrin c1ustering and thus activation (Li et al., 2003). In contrast to 
the previous results, other studies have failed to show homo-multimers of activated 
integrin aIIb and p3 in spite of integrin transmembrane domain separation (Luo et al., 
2004). Furthermore, mutational analysis of this heterodimeric interface was shown to 
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activate ligand binding (Luo et al., 2005). Although these contrary results suggest that 
activation may be a consequence of conformational changes of the integrin extracellular 
domain and increases in affinity for monomeric ligand, they do not exc1ude the 
possibility of homomeric interactions between transmembrane integrin domains once 
ligand-binding-driven microc1ustering has occurred (Kim et al., 2004). 
4.2 Integrins and tumor progression 
Cancer cells are usually characterized by their uncontrolled growth, their ability to 
invade adjacent tissue, migrate and survive within the interstitial stroma, and metastasize 
(Hanahan and Weinberg, 2000). The latter events implicate an alteration of normal cell-
cell and cell-ECM interactions leading to the de-regulation of cell proliferation, 
differentiation, survival and gene expression (Guo and Giancotti, 2004b). Thus the ECM 
represents not only a structural scaffold for cells but also an important modulator of cell 
behavior (Bissell and Radisky, 2001; Boudreau and Bissell, 1998). 
As previously mentioned (section 3.3), ECM effects on cells are mainly mediated 
by integrins (Guo and Giancotti, 2004b). Thus, tumor malignancy has been related with 
integrin function (Guo and Giancotti, 2004b; Juliano, 1994; Juliano et al., 2004; Juliano 
and Varner, 1993; Varner and Cheresh, 1996). Interestingly, restoration of normal 
integrin interactions and integrin-mediated signaling in a three-dimensional context has 
shown to reverse the tumorigenic phenotype (Park et al., 2006; Wang et al., 2002; 
Weaver et al., 1997). 
Studies directed at evaluating integrin expression in transformed and tumor cells 
versus normal cells have shown changes in integrin expression (Guo and Giancotti, 
2004b; Juliano and Varner, 1993). These results suggested that malignant cells modulate 
their integrin expression profiles in order to lose their adhesion to the basement 
membrane, allowing them to survive and migrate during tumor invasion (Guo and 
Giancotti, 2004b). 
Although it has been difficult to establish an integrin expression pattern as well as 
a correlation between the degree of malignancy and integrin levels for tumor cells (Guo 
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and Giancotti, 2004b; Juliano and Vamer, 1993), there is evidence supporting the role of 
integrin a2f31 and a3f31 as tumor suppressors, whereas integrin avf33, avf36 and a6f34 
promote tumorigenesis (Guo and Giancotti, 2004b; Juliano and Vamer, 1993; Lipscomb 
and Mercurio, 2005; Vamer and Cheresh, 1996). 
In the case of a5f31 integrin, there is contrary evidence regarding its role in tumor 
growth (Giancotti and Ruoslahti, 1990; Juliano and Vamer, 1993; Schreiner et al., 1991; 
Tavema et al., 1998; Vamer et al., 1995). Based on previous studies (Tavema et al., 
1998; Vamer et al., 1995) it is possible to propose that opposite effects observed for 
a5f31 on cell growth are due to the nature of integrin-ligand interactions, i.e. elevated 
levels of a5f31 but not the ligand, fibronectin, versus un-ligated integrin, may 
differentially regulate integrin-mediated signaling events (Juliano and Vamer, 1993). 
4.3 Integrins and Apoptosis 
Programmed cell death or apoptosis is a tightly regulated process that plays an 
important role in tissue homeostasis during embryogenesis and in adult tissues (Jacobson 
et al., 1997). De-regulation ofthis process has been implicated in several human diseases 
(Fadeel and Orrenius, 2005). An apoptotic cell is characterized by chromatin 
condensation, nuc1ear fragmentation (pyknosis) and plasma membrane bebbling (Kerr, 
2002). Apoptosis at the cellular level is regulated by various stimuli, death-receptor 
ligands (DR), growth factors, radiation, mechanical stress, etc. 
Anoikis is a type of apoptosis that is specifically triggered by an inadequate or 
inappropriate cell-matrix interaction (Frisch and Francis, 1994; Frisch and Screaton, 
2001). Anoikis was demonstrated for the first time in endothelial and epithelial cell 
(Frisch and Francis, 1994; Meredith et al., 1993), where integrin signaling was directly 
implicated in cell survival (Frisch and Ruoslahti, 1997). Further studies demonstrated the 
role of anoikis in fibroblasts (Tian et al., 2002), neurons (Banks and Noakes, 2002), 
intestinal and epidermal cells (Dufour et al., 2004; Grossmann et al., 2001; Tiberio et al., 
2002) and prostate cells (Bondar and McConkey, 2002). Anoikis resistance has shown to 
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be crucial during carcinogenesis in sorne tissues (Grossmann, 2002; Windham et al., 
2002; Yang et al., 2006; Yawata et al., 1998). 
The molecular regulation of anoikis is mainly controlled by the PB-K, F AK and 
Ras/MAPK cascades (Frisch and Screaton, 2001; Grossmann, 2002). However 
differential activation of signaling among different cell types has been observed, probably 
due to the specific integrin repertoire present in each cell type. For example, the a 
integrin subunits of certain integrins recruit Src family kinases Fyn and Yes through 
caveolin-l which in turn activates the ERK pathway (Wary et al., 1996). Most p-subunits 
recruit FAK (Parsons, 2003) which in tum activates Src, PB-K, paxilin and p130 CAS. 
ILK interacts with the pl and p3 integrin subunits and its activation is linked to cell 
survival (Attwell et al., 2000; Grashoff et al., 2004). In addition, integrin signaling can 
induce the expression of the anti-apoptotic protein Bcl-2 (Zhang et al., 1995). 
Another important event implicated in the regulation of anoikis is the activation of 
the caspase cascade (Reddig and Juliano, 2005). Caspases are cysteine proteases that 
cleave at conserved aspartic acids (Boatright and Salvesen, 2003). In the absence of 
apoptotic stimuli, caspases are present in the cell as latent precursors or "procaspases". 
During apoptosis, caspase activation occurs in two different phases, where the initiator 
caspases (caspase-2, -8, -9, and 10) are first activated which in turn is required to induce 
executioner caspase activity (caspase-3, -6 and -7) (Boatright and Salvesen, 2003). 
Anoikis regulation has been suggested to be controlled via both intrinsic and 
extrinsic pathways (Frisch, 1999; Grossmann, 2002; Grossmann et al., 2001; Marconi et 
al., 2004; Miyazaki et al., 2004; Rytomaa et al., 2000; Rytomaa et al., 1999; Valentijn 
and Gilmore, 2004). Cellular stress (intrinsic death pathway) implicates mitochondrial 
permeabilisation and release of cytochrome c, which leads to apoptosome formation, a 
proteolytic complex formed by caspase-9, cytochrome c and the scaffold protein Apafl 
(Boatright and Salvesen, 2003). Downstream activation of the Ras-PI-3K-Akt cascade is 
involved during this pathway (Frisch and Screaton, 2001; Stupack and Cheresh, 2002). 
Death receptor-initiated cell death (extrinsic pathway) is triggered by ligation of death 
receptors (DR) on the cell surface such as TNFR or Fas (Boatright and Salvesen, 2003). 
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DR signaling implicates the activation of ERK, JNK and NFKB pathways (Strasser et al., 
2000), or by interaction with adaptor proteins such as F ADD which leads to the 
recruitment and activation of caspase-8 and 10 (death-inducing signaling complex) 
(Boatright and Salvesen, 2003). Cross-talk between these pathways, known as extrinsic 
pathway type II, has been observed, where caspase-8 activates the intrinsic pathway by 
cleavage of the bcl-2 protein Bid, which induces cytochrome-c release (Stupack and 
Cheresh,2002). 
Lastly, a distinct apoptotic mechanism known as integrin-mediated death (IMDD) 
which occurs in adherent cells, implicates the activation of caspase-8 but it is independent 
of death receptor activation (Stupack et al., 2001). 
4.4 Integrins and cell differentiation 
Cellular differentiation is mediated through signaIs from the extracellular 
environment, thus any changes in the composition or structure of the ECM has effects on 
the differentiation process (Streuli, 1999). 
Integrin -mediated cell adhesion signaling through MAPK kinase (ERKl/2), 
represents a key pathway in the control of cell growth and differentiation (Giancotti and 
Ruoslahti, 1999). Cross-talk between integrin and growth receptor signaling has been 
shown to be important for the regulation of the balance between cell cycle entry and 
differentiation (Danen and Yamada, 2001; Howe et al., 1998; Lee and Juliano, 2004). 
The intestinal epithe1ium is characterized by constant and active cell renewal, where 
proliferative and differentiated compartments are located in the lower regions of the 
crypts and on the villi or upper parts of the crypt respectively. This property represents a 
fine balance between cell proliferation, differentiation and apoptosis. Thus, cell-cell, cell-
matrix interactions are important processes involved in the regulation of cell growth and 
survival in the colonic crypt. Although the molecular mechanism by which stem cells 
from the crypt commit to differentiation are not fully elucidated. The role of integrins and 
cell matrix interactions during enterocyte differentiation has previously been 
demonstrated (Beaulieu, 1999; Stutzmann et al., 2000). 
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Analysis of integrin expressIOn and distribution along the crypt-villus aXIS 
implicates a number of P 1 and p4 integrins; specifically, integrins a2p 1, al P 1 and aS pl 
expression are found to be coupled with the undifferentiatedlproliferative status of crypt 
cells (Beaulieu, 1999; Lussier et al., 2000). 
4.5 GPI-linked proteins, integrins and membrane rafts 
Several studies have suggested that membrane rafts are functionally involved in 
GPI-anchored protein-mediated signaling (Brown, 1993; Simons and Ikonen, 1997; 
Varma and Mayor, 1998). 
The fluid-mosaic model for the plasma membrane proposed by Singer and 
Nicholson in the early 1970's (Singer and Nicolson, 1972) demonstrated that amphiphilic 
proteins reside within the membrane bilayer. Further modifications of the original Singer-
Nicholson model were inc1uded based on lipid trafficking and signal transduction studies, 
which suggested that lipids and proteins do not distribute randomly in the plasma 
membrane. Later on, a new model proposed a different organization of the plasma 
membrane (Brown, 1998; Simons and Ikonen, 1997; Simons and Toomre, 2000; Simons 
and van Meer, 1988). This hypothesis c1aimed the existence of "rafts", a particular type 
of membrane microdomain enriched in cholesterol and sphingolipids, with specific 
membrane protein composition and with a functional role, such as intracellular lipid 
traffic and cell signaling (Brown, 1998; Simons and Ikonen, 1997; Simons and Toomre, 
2000). 
The composition and properties of lipid rafts were previously described based on 
their isolation by detergent-insolubility. Detergent-resistant lipid rafts (DRLR) can be 
isolated from cells by non-ionic detergent extraction (London and Brown, 2000) after 
sucrose gradient centrifugation (Simons and Ikonen, 1997). This property relies on the 
composition and distribution of sphingolipid and cholesterol in rafts: a liquid order phase 
in lipid rafts surrounded by a liquid-disordered phase, the latter due to the presence of 
sphingolipid molecules in the outer leaflet which are connected to the inner leaflet by 
cholesterol molecules (Brown, 1998; Munro, 2003; Simons and Ikonen, 1997). Several 
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criticisms have questioned if DRLR can be identified as membrane rafts before detergent 
extraction (Lichtenberg et al., 2005; Munro, 2003; Silvius and Nabi, 2006). However, 
sorne studies have shown that detergent-fractionation procedures can recapitulate results 
obtained by other non-perturbing methods such as fluorescent-spectroscopy (Wang et al., 
2001) or confocal microscopy (Silvius, 2005). The functional relevance of the lipid raft 
concept cornes from the proposed plasma membrane organization, so that pro teins can be 
recruited into or exc1uded from membrane rafts based on their physical properties 
(Munro, 2003). Thus, defined protein-protein interactions given in each raft allow the 
activation of specific signaling pathways (Simons and Ikonen, 1997). 
Much evidence has been generated demonstrating that signaling elements such as 
non-receptor tyrosine-kinases are present in the inner leaflet of the lipid rafts (Brown, 
1993; Simons and Toomre, 2000) and serve as signaling mediators of GPI-linked proteins 
(Brown, 1993). Recently GPI-anchored proteins have been shown to activate intracellular 
signaling via integrin receptors as weIl (Aguirre Ghiso et al., 1999; Ahmed et al., 2003; 
Chaurasia et al., 2006; Degryse et al., 2001; Duxbury et al., 2004a; Ossowski and 
Aguirre-Ghiso, 2000; Tarui et al., 2006; Tarui et al., 2003). 
5.-Molecular mechanism of CEA tumorigenic effects 
5.1 Tissue architecture model 
It has been hypothesized that regulation of cell proliferation and apoptosis by the 
extracellular matrix is a crucial event that determines an appropriate tissue architecture 
organization and prevents a dysplastic phenotype (Kenny and BisseIl, 2003; Park et al., 
2006). Appropriate ECM-cell interactions are therefore required in order to preserve 
normal regulation of quality control mechanisms such as cell differentiation and 
apoptosis (Boudreau and Bissell, 1998; Zahir and Weaver, 2004). 
As mentioned in section 4.4, the human intestinal epithelium is characterized by 
its continuous cell renewal and the production of enterocytes in the crypts which 
differentiate and then migrate toward the upper ends of the crypts or the villi where 
anoikis takes place (Grossmann et al., 2002; Vachon et al., 2000). Regulation of cell 
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survival in the colonie crypt has been shown to be differentiation-state specifie (Gauthier 
et al., 2001; Vachon et al., 2002). Fundamental observations in vitro and in vivo 
demonstrated that deregulated CEAICEACAM6 overexpresslOn blocked cell 
polarization, inhibited cell differentiation and anoikis (Chan et al., 2007; Eidelman et al., 
1993; Ilantzis et al., 2002; Ordonez et al., 2000; Rojas et al., 1996; Screaton et al., 1997; 
Taheri et al., 2003). Thus, in a normal situation CEA expression correlates positively 
with colonocyte differentiation, but deregulated CEA expression in cells at the base of 
colonie crypts that have not yet differentiated keep their dividing capacity. 
The proposed model for CEA tumorigenic effects suggested that CEA -CEA 
phenotypic adhesive interactions occur when CEA is overexpressed over the entire cell 
surface of colonic cells which results in a perturbation of normal adhesion molecule 
function giving a mutilayered embryonic-like cell arrangement instead of a mono layer 
architecture characteristic of normal epithelial cells (Benchimol et al., 1989; Ilantzis et 
al., 2002). Inhibition of cell differentiation, loss of cell anchorage and induction of 
anoikis towards the lumen is inhibited leading to an aberrant tissue architecture, 
resembling the embryonic colonic epithelia and early stages of human colorectal 
adenocarcinomas (Benchimol et al., 1989; Ilantzis et al., 1997). The latter phenotype 
results from aberrant ECM-cell matrix interactions most likely due to changes in integrin 
activation, specifically the fibronectin receptor aS p 1 (Ordonez et al., 2007). 
5.2 CEA-mediated extracellular matrix signal 
Aberrant ECM-cell interactions which finally perturb the normal activation of cell 
signaling is a general feature of almost aIl transformed cells (Kenny and BisseIl, 2003). 
Several studies have been directed towards understanding more c10sely how ECM 
molecules and their respective transmembrane receptors integrate cell signaling leading 
to gene expression and malignant transformation (Bissell and Radisky, 2001; Kenny and 
Bissell, 2003; Park et al., 2006). The latter evidence, together with findings in 3D cell 
gland models, where the malignant phenotype can be reversed by exposure of specifie 
inhibitors such as those of PI3-K, the epidermal growth factor receptor (EGFR), or 
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MAPK, indicate that cell adhesion molecules are crucial not only for their role in cell-cell 
or cell-ECM adhesion but for the regulation of intracellular signaling (Liu et al., 2004; 
Wang et al., 2002; Wang et al., 1998; Weaver et al., 1997). 
Our current molecular model for CEA tumorigenic effects suggests a molecular 
mechanism whereby signaling events initiated by CEA may be the result of parallel 
CEA-CEA interactions on the cell surface that lead to CEA c1ustering and subsequent co-
c1ustering of membrane microdomain-CEA associated signaling elements. Integrin a5 pl 
was identified as an important signaling element responsible for CEA inhibitory effects. 
Rowever, the mechanistic nature ofthis activation, subsequent downstream signaling and 
the impact on cell phenotype at the time of initiating the thesis work were important 
questions that still remained unanswered. 
6.-CEA molecular signaling: basic and clinical perspectives 
Due to CEA and CEACAM6 overexpression in more than 70% ofhuman cancers, 
inc1uding colon, breast and lung (Chevinsky, 1991; Rammarstrom, 1999), CEA has been 
used as tumor marker in cancer c1inics (Buccheri and Ferrigno, 2003; Mujagic et al., 
2004) and has gained popularity for cancer therapies such as cancer vaccines, cellular 
immunotherapy, radioimmunotherapy, antibody and gene therapy (Berinstein, 2002; 
Goldenberg, 2003; Goldstein and Mitchell, 2005; Rance et al., 2005; Koch et al., 2001; 
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Sarobe et al., 2004). Although there have been considerable advances in the development 
of novel CEA-based cancer therapies based on the precept of using CEA as tumor cell 
surface molecule for binding cell-killing agents, a potential aspect that could be explored 
is the use of a CEA-based molecular therapeutics to modulate cell behaviour. 
New insights into the mechanisms that regulate cell survival and cell 
differentiation, migration and invasion have placed integrin molecules as interesting 
candidates for cancer treatment (Jin and Vamer, 2004). Currently, a number of integrin 
inhibitors are under development for therapeutic agents in phase l, II and III clinical 
trials, specifically angiogenesis-inhibiting agents such as antibody and peptide inhibitors 
for avp3, avp5 and a5pl integrins (Adjei and Rowinsky, 2003; Jin and Vamer, 2004). 
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In addition, identification of key integrin-mediated signaling cascades implicated in the 
development and control of cancer, have led to the development of novel molecular 
targets for cancer treatment such as components of the PI-3K, AKTIPKB and the 
RafIMEKIErk cascades, as weIl as tyrosine kinases (Adjei and Rowinsky, 2003; Bianco 
et al., 2006; Mazitschek and Giannis, 2004; Melisi et al., 2004; Seymour, 1999). 
7.-Scope ofthis work 
Our CUITent knowledge regarding the molecular events initiated by 
CENCEACAM6 and their involvement in the CENCEACAM6-mediated changes in 
cellular state such as inhibition of cell differentiation and anokis, are still partially 
explained. It was previously demonstrated that the molecular mechanism involved in 
these inhibitory effects was related to the perturbation in the function of the aSpl 
integrin receptor. In the work presented in this thesis, we explored further the nature of 
the mechanism involved in CEA-mediated signaling activation. In Chapter 2, we 
establish a molecular model for CEA tumorigenic effects in vitro, where we propose and 
then show supporting evidence that CEA clustering on the cell surface due to self-binding 
of its external domains, leads to subsequent clustering of CEA-containing microdomains 
and co-clustering ofintegrin aSpl co-Iocalized in the same microdomains. We identified 
the PI3-K and MAPK signaling cascades as important regulators of CEA-mediated 
integrin activation. The latter mechanism was evaluated in vivo in a transgenic mouse 
harboring a 187-kb human bacterial artificial chromosome (CEABAC) containing part of 
the human CEA family cluster (Chapter 3). Increased levels in the colonocyte surface 
level of aSpl and activation of the PI3-KlAKT pathway was observed, as weIl as a 
progressive (corresponding to CENCEACAM6 expression levels) increase in colonocyte 
proliferation, an increase in crypt fission, and almost a complete block on cell 
differentiation, and a marked inhibition of colonocyte anoikis/apoptosis. Finally we 
explored the specificity of the CEA signal. We observed that inhibition of anoikis by 
CEA is determined by the CEA-GPI anchor and implicates the intrinsic apoptotic 
pathway by inactivation of caspase-9. We also evaluated the reversion of this CEA-
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inhibitory effect by using inhibitors of the PI-3K and MAPK signaling cascades (Chapter 
3). 
8.-Publication status of the thesis chapters 
Chapter 2: A co-clustering model involving a5~1 integrin for the biological effects 
of GPI-anchored human Carcinoembryonic Antigen (CEA) Pilar Camacho-Leal, 
Alexander B. Zhai and Clifford P. Stanners. Journal o/Cel! Physiology. In press. 
Chapter 3: Colorectal Hyperplasia and Dysplasia due to Human Carcinoembryionic 
(CEA) and CEACAM6 expression in transgenic mice. Carlos H.F. Chan*, Pilar 
Camacho-Leal* and Clifford P. Stanners (*denotes co-first authors) Manuscript 
submitted. 
Chapter 4: Human Carcinoembryonic Antigen (CEA)-GPI anchor specifies anoikis 
inhibition by inactivation of the intrinsic death pathway Manuscript in preparation. 
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CHAPTER2 
The biological effects of GPI-anchored human Carcinoembryonic Antigen (CEA) 
are mediated by co-clustering and activation of a5J31 integrin in membrane 
microdomains 
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Abstract 
CEA functions as an intercellular adhesion molecule and is up-regulated in a wide variety 
of human cancers, inc1uding colon, breast and lung. Its over-expression inhibits cellular 
differentiation, blocks cell polarization, distorts tissue architecture, and inhibits anoikis of 
many different cell types. Here we report results concerning the molecular mechanism 
involved in these biological effects, where relatively rapid molecular changes not 
requiring alterations in gene expression were emphasized. Confocal microscopy 
experiments showed that antibody-mediated c1ustering of a deletion mutant of CEA 
(L1NCEA), normally incapable of selfbinding and c1ustering, led to the co-Iocalization of 
integrin aSp 1 with patches of L1NCEA on the cell surface. Activation of aS, as defined 
1 
by an anti-aS mAb-sensitive increase in cell adhesion to immobilized fibronectin, and an 
increased binding of soluble fibronectin to cells, was also observed. This was 
accompanied by the recruitment of Integrin-Linked Kinase (ILK) , Protein Kinase B 
(PKB/Akt), and the Mitogen-Activated Protein Kinase (MAPK) to membrane 
microdomains and the phosphorylation of Akt and MAPK. Inhibition of PI3-K and ILK, 
but not MAPK, prevented the aSp 1 integrin activation. Conversely, anti-aS antibody 
inhibited the PI3-K-mediated activation of Akt, implying the involvement of outside-in 
and inside-out signaling in integrin activation. Therefore we propose that CEA-mediated 
signaling involves c1ustering of CEA and co-c1ustering and activation of the aSpl and 
associated specifie signaling elements on the internaI surfaces of membrane 
microdomains. These changes may represent a molecular mechanism for the biological 
effects of CEA. 
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Introduction 
The Glycophosphatidyl-inositol (GPI) anchored cell surface glycoproteins CEA 
and CEACAM6 belong to the CEA subfamily within the immunoglobulin superfamily 
and are over-expressed in a variety of human carcinomas, inc1uding colon, breast and 
lung (Chevinsky, 1991; Hammarstrom, 1999). CEA family members function in vitro, at 
least, as homotypic intercellular adhesion molecules (Benchimol et al., 1989; Oikawa et 
al., 1989; Stanners, 1998). In a variety of in vivo and in vitro model systems, our 
laboratory demonstrated that de-regulated over-expression of CEA and CEACAM6 leads 
to inhibition of cellular differentiation (Eidelman et al., 1993; Screaton et al., 1997; 
Taheri et al., 2003) and disruption of cell polarization and tissue architecture (Ilantzis et 
al., 2002). Anoikis, an apoptotic process initiated by the absence of cell-ECM contacts, is 
also inhibited by CEA and CEACAM6 over-expression in multiple cell types, inc1uding 
human colorectal carcinoma cells (Ordonez et al., 2000; Soeth et al., 2001), and human 
pancreatic carcinoma cells (Duxbury et al., 2004d). 
What molecular events initiated by CEAICEACAM6 expression underlie these 
major changes in cellular state? Signaling events initiated by CEA have been difficult to 
demonstrate, perhaps due to its GPI membrane anchor and the absence of a 
transmembrane or cytoplasmic domain. Biophysical and biochemical studies have shown, 
however, that GPI-anchored proteins are often concentrated in small membrane 
microdomains in the plasma membrane (membrane rafts) (Friedrichson and Kurzchalia, 
1998; Sharma et al., 2004; Simons and Ikonen, 1997; Varma and Mayor, 1998) where 
cytoplasmic e1ements implicated in signal transduction are co-Iocalized (Brown, 1993; 
Rodgers et al., 1994; Stefanova et al., 1991). Localized signaling has been observed when 
a number of GPI-anchored proteins present in membrane rafts are c1ustered with 
antibodies or by physiologically relevant ligands (Duxbury et al., 2004b; Janes et al., 
1999; Kramer et al., 1999; Stuermer et al., 2001; Suzuki et al., 2001). 
Previous studies showed that the critical structural features of CEA necessary for 
its differentiation-blocking activity are external domains capable of mediating both 
paralle1 and anti-parallel self-binding linked to a processed carboxy terminal domain that 
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determines a specific GPI anchor (Screaton et al., 2000). The importance of self-binding 
of the extracellular domains was shown by the expression of a CEA mutant lacking a 
major portion of the N-domain (~NCEA), inc1uding the subdomains required for se1f-
binding. This mutant was completely ineffective in blocking myogenic differentiation 
but, by cross-linking with specific anti-CEA antibodies, regains this activity (Taheri et 
al., 2003). Based on these results we have proposed the following model: cell surface 
CEA-CEA parallel binding can activate signaling by c1ustering CEA molecules and 
thereby the membrane microdomains they inhabit (Screaton et al., 2000); cytoplasmic 
signaling molecules associated with these microdomains are thus c1ustered, facilitating 
their activation. 
In certain cell systems, association of GPI-linked proteins such as the urokinase-
type plasminogen activator receptor (uP AR) and CEACAM6 with cell surface integrin 
receptors is involved in the activation of intracellular signaling (Ahmed et al., 2003; 
Chaurasia et al., 2006; Ossowski and Aguirre-Ghiso, 2000; Tarui et al., 2006). Such 
signaling can lead to cell proliferation, differentiation and survival (Giancotti and 
Ruoslahti, 1999). Previous evidence supported the role of a5 pl integrin, the main 
receptor for the ECM component fibronectin, in the CEA-mediated inhibition of 
differentiation and anoikis in vitro (Ordonez et al., 2007). This work demonstrates that 
CEA/CEACAM6 over-expression on the cell surface leads to aberrant cell-ECM 
interactions through increased integrin a5pl and fibronectin binding. Blockage of the 
a5pl-fibronectin interaction using specifie mAbs against either a5pl or fibronectin 
reversed CEA/CEACAM6-mediated inhibition of cell differentiation and anoikis 
(Ordonez et al., 2007), indicating the importance of this particular integrin-ligand 
combination. 
Integrins can assume various affinity states that can be regulated by bidirectional 
signaling (Hynes, 2002; Qin et al., 2004), i.e., either by "outside-in" signaling, induced 
by extracellular factors, or "inside-out" signaling, where intracellular events involving the 
cytoplasmic domains of a and p integrin subunits lead to extracellular conformational 
changes that determine the "affinity" for ligands (Campbell and Ginsberg, 2004; 
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Ginsberg et al., 2005; Humphries et al., 2003; Shimaoka et al., 2002) and/or clustering of 
integrin receptors on the cell surface, termed "valency" changes (Carman and Springer, 
2003; Cluzel et al., 2005; Hato et al., 1998). This is essentially a positive feedback system 
that can ensure robust activation and subsequent downstream signaling. 
In the case ofCEA-mediated signaling, presented in the CUITent study, we focused 
on very early events, occurring within minutes after antibody-mediated clustering of 
CEA, on the assumption that such events are more like1y to reflect direct consequences of 
CEA action which mimic the aggregation of CEA on the surface of CEA-expressing 
tumor cells. Rapid events would mainly involve changes in phosphorylation state and 
intracellular localization. We report here that cross-linking of the adhesion-incapacitated 
~NCEA in rat L6 myoblast, LR-73 fibroblast and human Caco-2 colonic carcinoma 
transfectants induced a rapid activation of the a5p 1 integrin receptor, which we have 
operationally defined as an increase in both binding of soluble fibronectin to cells and 
cell adhesion to immobilized fibronectin, consistent with previous results. 
Our choice of certain signaling elements, amongst the plethora of elements that 
can affect cellular state, for candidates as downstream targets of a5pl activation was 
govemed by the assumption that early changes in cell surface-associated e1ements (the 
localization of CEA) will most likely be linked to the initiation of signaling activation 
determining cell state. In particular, surface-Iocalized elements that have previously been 
shown to be functionally linked with integrin a5p 1 were carefully examinated. These 
include ILK, which is a ser/thr kinase that binds to and phosphorylates the cytoplasmic 
tail of the pl integrin subunit (Hannigan et al., 1996), a modification known to cause a 
functional activation of the a5pl integrin due to increased cell surface integrin clustering 
(Wu et al., 1998). Over-expression of ILK in rat intestinal epithelial cells activates the 
a5pl integrin receptor, increases fibronectin matrix assembly (Wu et al., 1998) and 
inhibits anoikis (Attwell et al., 2000). Furthermore, forced ILK expression in C2Cl2 
mouse skeletal myoblasts leads to the inhibition of myogenic differentiation (Huang et 
al., 2000), resembling quite closely the phenotype of CENCEACAM6-expressing L6 
myoblasts. We report here that ILK moves rapidly into membrane microdomains after 
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~NCEA cross-linking and that down-regulation of ILK by specific siRNA prevents a5p 1 
activation. 
Since ILK is modulated by the phosphoinositide 3-kinase (PI3-K) (De1commenne 
et al., 1998), the PI3-KlAkt signaling cascade was also investigated. We found a rapid 
shift of Akt to membrane microdomains after cross-linking ~NCEA. Blockage of PI3-K 
using a specific inhibitor demonstrated the requirement of this signal in integrin 
activation due to CEA c1ustering. In contrast, although the mitogen-activated protein 
kinase (MAPK) pathway was also shown to be activated by ~NCEA cross-linking and, as 
with Akt, this activation was prevented by inhibition of integrin a5 activity, MAPK 
inhibition did not have any effect on the increased of cellular binding to fibronectin upon 
~NCEA cross-linking. Thus, our data supports a model whereby GPI-anchored CEA 
c1ustering leads to a5p1 integrin activation, which involves both, uni- and bi-directional 
activation ofMAPK and PI3-KlILKlAkt signaling pathways which, in turn, may mediate 
CEA inhibitory effects on cell differentiation and anoikis. 
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Materials and Methods 
Antibodies and Inhibitors 
The following antibodies were used: anti-integrin a2 monoclonal antibody (H-293), and 
anti-integrin a5 mAbs, HMa5-l, (partial blocking Ab which recognizes rat integrin a5 
subunit) and H-104 (reacts with integrin a5 of mouse, rat and human); polyclonal goat 
anti-Fibronectin Ab, C-20, polyclonal goat anti-ILK Ab, C-9, and mouse anti-NCAM 
mAb, l23C3, aIl purchased from Santa Cruz Biotechnologies. Integrin function-blocking 
human anti-integrin a5 mAb, lIAI, anti-integrin a2 mAb, PlE6, and rat anti-integrin 
a2 mAb, Ha 1129, were purchased from BD Pharmingen. Mouse anti-ILK mAb (clone 3) 
which recognizes human, rat and mouse ILK, was obtained from BD Transduction 
laboratories. Rabbit anti-Akt polyclonal antibody (detects total, phosphorylation-state 
independent Aktl, Akt2 and Akt3 proteins), anti-phospho Ser 473 Akt polyclonal Ab 
(detects endogenous levels of Aktl only when phosphorylated at Ser473 and also Akt2 
and Akt3 when phosphorylated at the corresponding residues), anti-p44/42 MAPK 
(Erkl/Erk2) (detects totallevels of endogenous p44/42 MAPK kinase), and anti-phospho-
p44/42 MAPK (Erkl/Erk2) (Thr183/Tyr185) (detects endogenous levels ofp42 and p44 
MAPK only when activated by phosphorylation at Thr183 and Tyr185 ofrat Erk2), were 
purchased from Cell Signaling. The mouse-anti CEA mAbs, J22 and D13, were 
generated in the laboratory of Dr. A. Fuks (McGill University, Montreal, PQ, Canada) 
(Zhou et al., 1993a). J22 binds to internaI domains ofCEA (Zhou et al., 1993a), while the 
epitope of Dl3 is in the N domain of CEA (Taheri et al., 2000). The pharmacological 
inhibitors PD098059 (MAPK specific inhibitor) and LY294002 (PI3-K specifie inhibitor) 
were purchased from Sigma. 
Celllines and culture conditions 
L6 rat myoblasts (Yaffe, 1968), the Caco-2 human colorectal carcinoma cell1ine (both 
obtained from ATCC, Rockville, MD) and CHO-derived LR-73 (LR) fibroblasts (Pollard 
and Stanners, 1979), were grown in monolayer cultures in DMEM (L6) or a-MEM 
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(Caco-2 and LR-73) containing 10% fetai bovine serum (FBS, Invitrogen) supplemented 
with 100 ,...,g/ml streptomycin and 100 U/ml penicillin (Invitrogen) (growth medium: 
GM), at 37°C in a humidified atmosphere with 5% C02. Cultures of subconfluent 
proliferating ceUs were used for aU experiments. 
Transfectant cells 
L6, LR-73 and Caco-2 cells were transfected by the calcium phosphate-mediated co-
precipitation method (Screaton et al., 2000; Taheri et al., 2003). Briefly, stable G-418 
resistant colonies ofL6 and LR-73 were obtained after co-transfection with the p91023B 
expression vector (Screaton et al., 2000) containing cDNA coding for the CEA deletion 
mutant ~NCEA [lacking the last 75 amine acids of the N domain (Oikawa et al., 1991)] 
and the pSV2neo plasmid as a dominant selectable marker (L6 and LR cells) (Taheri et 
al., 2003). The LR-73(~NCEA) transfectants represented a pool of such colonies selected 
by FACS for higher ceU surface expression whereas the L6(~NCEA) transfectant was a 
single clone. Double LR and L6 transfectants (~NCEA+NCAM) were obtained by co-
transfection ofboth NCAM, a GPI-anchored variant with a muscle-specific domain (Peck 
and Walsh, 1993) and ~NCEA cDNA with pSV2(neo) (LR cells); L6(~NCEA) 
transfectant cells were supertransfected with NCAM cDNA and 0.5,...,g of pBabe (puro). 
Resistant clones were pooled after selection with 400-600 ,...,g/ml neomycin (G418; 
GrnCO) or l,...,g/ml puromycin (Sigma), respectively. Pooled Caco-2(~NCEA) stable 
transfectant cells were obtained (Ilantzis and Stanners, unpublished results) using the 
PML1 Zn2+-inducible episomal expression vector containing the mouse metaIlothionein 
promoter (mMT1) and the hygromycin-B resistance gene as a selectable marker 
(Lukashev et al., 1994). Cell surface expression of ~NCEA in LR-73, L6 and Caco-2 was 
assessed by F ACS analysis; aIl ceIls were labeled with monoclonal anti-CEA antibody 
(J22), giving FACS mean values of 450, 732, and 823 respectively. LR-73 and 
L6(~NCEA+NCAM) double transfectants showed FACS mean values of 383, 530 for 
~NCEA, and 295, 160 for NCAM, respectively. 
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~NCEA cross-linking and cell pretreatment 
Cultures of ~NCEA transfectants and ~NCEA+NCAM double-transfectant cells were 
incubated for 5 minutes in serum-free medium at 37°C with 30 ~g!ml mouse anti-CEA 
mAb (J22) or mouse anti-NCAM antibody, followed by 5 minutes with secondary 
donkey anti-mouse IgG antibody (minimal cross-reaction with other species) (Jackson). 
For the soluble fibronectin cell-binding assay, cells were incubated with only the primary 
anti-CEA mAb. As controls, in all experiments, ~NCEA and double-transfectant 
(~NCEA+NCAM) cells were incubated with isotype-matched mouse IgG anti-CEA mAb 
D13, whose N domain epitope is deleted in ilNCEA, followed by secondary donkey anti-
mouse IgG. For integrin inhibition experiments, L6(ilNCEA) cells were pre-incubated 
with 5 ~g!ml of functional blocking mouse anti-integrin a5 (HMla-5) or a2 (Ha1l29) 
mAbs, for 30 min at 37° C in serum-free medium. Caco-2(~NCEA) cells were pre-treated 
with human anti-integrin a5 (lIAI) or a2 (PIE6) mAbs. 
For kinase inhibition experiments, cells were treated in serum-free medium at 37°C with 
either PD098059 (MAPK specifie inhibitor) at 30 ~M or L Y294002 (PI3-K specifie 
inhibitor) at 50 ~M for 30 min prior as well as during antibody-mediated ~NCEA cross-
linking. Control cells were treated with media containing DMSO vehicle alone (kinase 
inhibitor solvent used at 0.1 %). Cell viability following incubation with kinase inhibitors 
was evaluated using trypan blue dye exclusion, with greater than 90% viable cells. 
Confocal microscopy experiments 
On day 0.7 x 103 L6(ilNCEA) myoblast transfectants were seeded per weIl in 8-well Lab-
Tek Permanox Chamber Slide plates (Nalge Nunc INC., Naperville, IL.). After growth in 
GM for 48 hours, the ceIls were processed for visualization of membrane proteins. Cells 
were rinsed twice with PBSF (PBS+2%FBS) and labeled with 5 ~g!ml of monoclonal 
mouse antibody specifie for ~NCEA (122) together with anti-a5 (HMa5-1) or anti-a2 
(Ha1l29) integrin mAbs for 20 min at 37°C. After unbound antibody was rinsed off, 
primary antibodies were clustered with secondary antibodies coupled to fluorescent dyes: 
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rhodamine-conjugated goat anti-Armenian hamster IgG (minimal cross-reaction to 
bovine, human, mouse, rabbit and rat serum proteins) and FITC-coupled goat anti-mouse 
IgG antibodies (Jackson lmmunoResearch Laboratories, Inc.) for 20 minutes at 37°C. 
After washing with PBSF the cells were fixed by 5 minute incubation with 4% 
paraformaldehyde (PFA) at room temperature (RT). Control cells were fixed with 4% 
PF A before incubation with primary and secondary antibodies, or after primary antibody 
incubation. Negative controls were performed by incubation of cells with primary anti-
mouse or anti-hamster mAbs followed by secondary anti-hamster or anti-mouse Abs 
respectively. AIso, cross-reactivity among secondary mAbs, as weIl as staining 
specificity was assessed using appropriate controls. Images were captured using a Zeiss 
Pascal 5 microscope with a Plan-Apochromat 63xll.4 oil DIC objective. Image analysis 
was done using Zeiss LSM image browser. 
ILK gene silencing with small interfering RNA (siRNA) 
2 x 105 LR-73(~NCEA) transfectant cells were seeded in 100 mm tissue culture dishes 
and co-transfected 24 ho urs later, by calcium phosphate-mediated co-precipitation, with 
the pSilencer 2.1-U6 siRNA expression vector (Ambion) containing a human U6 RNA 
pol III promoter (Kunkel and Pederson, 1989; Myslinski et al., 2001) a puromycin 
resistance gene, and a hairpin ILK siRNA. The human ILK gene sequence specifically 
targeting the integrin binding domain (lLK-A) (5'-GACGCTCAGCAGACATGTGGA-
3') was used (Tan et al., 2004). Ruman and mouse ILK-A amino acid sequences shared 
100% sequence homology. A univers al scrambled siRNA control sequence with no 
significant homology to mouse, rat or human gene sequences provided by the Silencer 
siRNA construction kit was used as a negative control. LR-73 transfectants were isolated 
by selection with puromycin (2 Jlg/ml, Sigma). After 10-14 days, resistant clones were 
evaluated for ILK expression levels. Densitometric analysis of western blots as detailed 
before, with the ImageJ program (http://rsb.info.nih.govlijO showed that 3 out of 50 
clones tested expressed about 70%, 50% and 33% of control siRNA ILK protein levels 
(after ILK expression was normalized to p-actin expression levels). 
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Isolation of membrane raft-containing fractions 
Raft membrane microdomains were isolated by isopycnic sucrose density gradient 
centrifugation at 4°C. 30 x 106 L6(ilNCEA) cells were collected from Tl80 flasks with 
non enzyrnatic detachrnent using PBS-citrate (Screaton et al., 2000) at 37°C and then 
suspended in 1 % Brij 98-containing lysis buffer (20 mM Tris-HCl pH 8, 140 mM NaCl, 
2 mM EDTA pH 8; protease inhibitors, aprotinin and leupeptin at 10 Ilglml each, PMSF 
at 100 Ilg/ml; and phosphatase inhibitors, Na3V04 at 1 mM plus 10 mM NaF) for 30 
minutes at 4°C. The celllysates, syringed through a 27-gauge needle to ensure proper 
homogenization, were adjusted to 40% sucrose using co Id 80% sucrose buffer (10 mM 
Tris-HCl pH 8, 140 mM NaCI and 2 mM EDTA pH 8). A sucrose step gradient was 
prepared in a polyallomer tube (11 mm x 60 mm, Beckman) by successive addition of 2 
ml of the 40% sucrose celllysate, 2 ml of 35% sucrose and 1 ml of 5% sucrose all in 
sucrose buffer. The gradient was centrifuged at 45,000 rpm for 18 hours at 4°C. Fractions 
(350 III each) were sequentially harvested from the top. Sucrose concentrations were 
deterrnined by an Abbes' refractometer. Membrane fractions corresponding to the 5-35% 
sucrose interface (visually detected as a band in the density gradient) were assessed by 
dot blot for the presence of ganglioside GM1, using cholera toxin B subunit peroxidase 
conjugate (Sigma), to confirrn the proper identification of the membrane fractions. 
Cell binding of soluble fibronectin 
On day 0, L6(ilNCEA) ceUs were seeded at 104 cells/cm2 in a 96-well tissue culture 
plate. Two days later, the cells were washed with PBS + 2% FBS (PBSF), and then cross-
linked with anti-CEA J22 antibody for 5, 15,30 and 60 minutes in serurn-free DMEM in 
the presence of 10 Ilg/ml of human fibronectin (Fn) (BD Biosciences) at 37°C. As a 
control L6(ilNCEA) ceUs were simultaneously treated with isotype-matched IgG mouse 
anti-CEA D13 antibody in the presence of soluble fibronectin for the same lengths of 
time. Fn bound to ceUs was evaluated by ELISA as follows: cells were washed three 
times with PBSF, then fixed with 4% forrnaldehyde; to prevent antibody non-specific 
interactions, cells were incubated for 1 hour at room temperature with 3% BSA (Sigma) 
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in PBS (PBSB), followed by incubation for 90 minutes at room temperature with goat 
anti-fibronectin antibody C-20 at a dilution of 1:100 in PBSB; cells were then washed 
with PBSF, and incubated for 1 hour with HRP-conjugated rabbit anti-goat IgG 
secondary antibody (Jackson) at a dilution of 1 :2500 in PBSB. After rinsing the cells with 
PBSF twice, 2,2-Azino-bis(3-ethylbenzathiazoline-6-sulfonic acid) (ABTS, Sigma)-
ELISA staining was perfonned: cells were incubated with ABTS solution (0.1 M citrate-
P04, pH 4 and 3% hydrogen peroxide). Bound Fn was assessed from the absorbance 
detennined with a microplate reader at 405 nm, with a reference wavelength of 490 nm. 
Cell adhesion to extracellular matrix (ECM) components 
On day 0, L6(~NCEA), L6(~NCEA+NCAM) and Caco-2(~NCEA) transfectant cells 
were seeded at a density of 104 cells per cm2• On day 2, subconfluent cultures were 
subjected to anti-CEA antibody cross-linking (primary anti-CEA mAb J22 followed by 
donkey anti-mouse secondary Ab), detached from Petri dishes with PBS-citrate (Screaton 
et al., 2000), and added to 96-well tissue culture plates pre-coated with fibronectin (Fn), 
vitronectin (Vn), laminin (Ln), collagen 1 (C 1) or collagen IV (C IV) (CytoMatrix 
adhesion kit, CHEMICON) for 1 hour at 37°C. Staining of adherent cells to the ECM 
components was assessed according to the manufacturer's proto col. Briefly, cells 
attached to the wells were stained for 5 minutes with 0.2% crystal violet in 10% ethanol. 
Wells were then gently washed 3 times with PBS. Solubilization buffer (a 50/50 mixture 
of 0.1 M NaH2P04, pH 4.5 and 50% ethanol) was added for 5-10 minutes. The optical 
density, which increases with increased cell binding, was detennined at a wavelength of 
540 nm using a microplate reader. 
Western blot analysis 
Total cell lysates or sucrose gradient fractions were subjected to SDS-PAGE and 
transferred electrophoretically to 0.45 J.!m PDVF membranes (Millipore). Western blots 
were evaluated using antibodies specific to a5 and a2 integrins, CEA, ILK, Akt, and 
MAPK before and after anti-CEA antibody-mediated cross-linking of ~NCEA. 
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Following extensive washing, blots were developed with HRP-conjugated antibodies and 
visualized using EeL reagent according to the manufacturer's instructions (Amersham 
Life Sciences). 
Statistical analysis. 
Statistical comparison of means between groups was performed using the two-tailed 
unpaired Student t test. P<O.05 was considered significant. 
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Results 
Antibody-mediated L\NCEA clustering increases integrin aS activity 
Previous results (Ordonez et al., 2007) implicated a5~1 integrin perturbation in 
the inhibitory effects of CEA on cell differentiation and anoikis (see Introduction). An 
increase in cell adhesion to Fn and enhanced Fn matrix assembly was observed in a 
variety of celllines upon CENCEACAM6 over-expression (Ordonez et al., 2007). We 
therefore measured the kinetics of the change in the intensity of a5~1-fibronectin 
interaction after antibody-mediated cross-linking of L1NCEA in L6(L1NCEA) cells, by 
assessing the binding of purified soluble Fn to cells as weIl as the cell adhesion to 
immobilized Fn. Cross-linking of L1NCEA showed a relatively rapid increase (within 5 
minutes) ofFn binding to the cells, reaching maximum levels after 15 minutes (Fig. lA). 
The latter increase was not observed using the control mAb, D13, in which the epitope is 
missing in L1NCEA; therefore the increase in Fn binding with time was not due to slow 
saturation of cellular binding sites by the added Fn. 
A similar increase in binding of L6(L1NCEA) cells to immobilized Fn within 15 
minutes of cross-linking was observed (Fig. lB). This effect was also observed for 
L1NCEA transfectants of the CHO fibroblast LR cell line (Fig. 1 C) and the human 
colonocyte Caco-2 ceIlline (Fig. lE), indicating the generality of the effect. In order to 
demonstrate the specificity of the L1NCEA cross-linking effect, we used LR and L6 
transfectant cell lines expressing both L1NCEA and the GPI-anchored variant of the 
immunoglobulin superfamily member adhesion molecule, NCAM, which normally has 
no effect on cell adhesion to Fn (Ordonez et al., 2007). In contrast to the increase of cell 
adhesion to Fn observed upon L1NCEA cross-linking in L6(L1NCEA) and 
L6(L1NCEA+NCAM) cells (Fig. lB), NCAM cross-linking or incubation with the control 
anti-CEA mAb D13, followed by anti-mouse IgG antibody, did not show any increase in 
cell adhesion to Fn. Similar results were obtained for LR-73(L1NCEA+NCAM) cells (Fig. 
1 C). Thus the increase in binding to Fn was not due to non-specifie reorganization of cell 
surface elements due to L1NCEA cross-linking. 
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To demonstrate the involvement of the integrin a5 in this effect, both rat 
myoblast L6(l1NCEA) (Fig. ID) and human colonocyte Caco-2(l1NCEA) (Fig. lE) 
transfectants were pretreated with blocking anti-a5 or control anti-a2 mAbs, then 
assessed for binding to immobilized Fn. As shown in Fig. 1 D, E, incubation with 
integrin a5, but not a2 mAb, completely prevented the increase in cell adhesion to Fn 
after l1NCEA cross-linking. 
It has been previously described that ligand occupancy of integrin receptors can 
alter the function of other integrins present on the same cell surface (Blystone et al., 
1999; Diaz-Gonzalez et al., 1996; Ly et al., 2003). Therefore, effects of CEA clustering 
on cell binding to other ECM components were investigated. Whereas no effect of 
antibody-mediated clustering of l1NCEA in L6(l1NCEA) (Fig. IF) and LR(l1NCEA) (not 
shown) transfectants on cell binding to immobilized collagens 1 and IV (major integrin 
receptor: a2~1) was observed, there was an increase in cell binding to Vn (av~3) and Ln 
(a6~4) (Fig. IF). The effect on binding to Vn could be completely reversed by anti-a5 
mAb treatment (not shown), which is presumably due to cross-talk between a5 and av 
integrins. We have chosen to focus on the a5~1 integrin because of the complete reversaI 
of the CEA-mediated Fn binding increase (Fig. 1 D, E) and of the reversaI of inhibition of 
anoikis by anti-a5 mAb (Ordonez et al., 2007). 
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Figure 1 Activation of a5Bl integrin as a consequence of CEA clustering. 
Subconfluent cultures ofL6(L1NCEA) (A, B, D, F), L6(L1N+NCAM) (B), LR-73(L1N) (C), 
LR-73(L1N+NCAM) (C) and Caco-2(L1NCEA) (E) transfectants were cross-linked with 
mouse anti-CEA mAb antibody (122) as described in M&M, and then subjected to 
binding of soluble Fn for various times (A) or to cell adhesion to immobilized Fn (B, C, 
D, E. F), Vn, Ln, C 1 and IV (F). Control cells were treated with an isotype-matched 
mouse IgG anti-CEA mAb (D13) that binds to an epitope in the N domain ofCEA that is 
deleted in L1NCEA. The time course of soluble Fn binding to cross-linked L6(L1NCEA) 
cells shows a rapid increase, with the maximum level of binding being reached 15 
minutes after cross-linking (A). L1NCEA cross-linking increases cell adhesion of 
L6(L1NCEA) (B, D), LR(L1NCEA) (C) and Caco-2(L1NCEA) (E) cells to immobilized Fn. 
ln contrast to L1NCEA cross-linking, NCAM cross-linking in double transfectant cell 
lines L6(L1NCEA+NCAM) (B) and LR(L1NCEA+NCAM) (C) did not show any increase 
in cell binding to immobilized Fn. Pre-treatment with blocking anti integrin a5 but not 
a2 mAbs reduced the increase in cell adhesion to Fn almost to control levels upon 
L1NCEA cross-linking (D, E). Mean values, +/-SD from a representative experiment out 
of at least three independent experiments are shown (*p<.003, **p<.002). 
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~NCEA and integrin a5, but not integrin a2, co-cluster in membrane 
micro do mains 
Previous studies have demonstrated the functional role of cholesterol- and 
sphingolipid-rich membrane microdomains as platforms for cellular signaling (Brown 
and London, 2000; Simons and Ikonen, 1997). Recent studies showed that association of 
integrins with these membrane rafts positively regulates integrin activity (Baron et al., 
2003; Decker and ffrench-Constant, 2004; Del Pozo, 2004; Hogg et al., 2002; Leitinger 
and Hogg, 2002). In order to evaluate whether changes in membrane microdomain 
localization of integrin a5 could correlate with the observed dNCEA cross-linking-
mediated integrin a5 activation, isopycnic sucrose gradient centrifugation of cold Brij 98 
L6(dNCEA) cell extracts was performed. Western blot analysis of dNCEA in the sucrose 
gradient fractions showed, as expected, dNCEA localization in low density sucrose 
fractions containing membrane microdomains, as confirmed by the presence of the 
ganglioside GM1, a marker of raft-type membrane microdomains (Fig. 2A). Integrin a5, 
but not a2, was also found in the same low density fractions (Fig. 2A). Thus both 
dNCEA and a5 integrin co-existed in membrane microdomains prior to antibody-
mediated c1ustering. Western blot analysis of dNCEA and a5 integrin in the sucrose 
gradient fractions (Fig. 2A) as weIl as a5 cell surface expression levels by F ACS analysis 
(Fig. 2B) did not show differences in cell surface levels after cross-linking. From these 
results, we suggest that dNCEA and a5 integrin could exist in the same membrane 
microdomain prior to activation, which co-c1uster upon dNCEA cross-linking, leading to 
activation ofintegrin a5. 
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Figure 2 .6.NCEA and a5f31 integrin are both initially localized in membrane 
microdomains. L6(.6.NCEA) transfectant cells were lysed with cold 1 % Brij-98 and 
subjected to isopycnic centrifugation in a sucrose density step gradient before and after 
lO minutes of antibody-mediated CEA cross-linking. Twelve fractions (350 J.ll each) 
were collected from the top of the gradient. Gradient fractions were subjected to SDS-
PAGE and western blot analysis for a5 integrin and CEA; for GMl, dot blot detection 
was performed (A). Cytofluorometric analyses performed as previously described (Taheri 
et al., 2000) showed that, after .6.NCEA cross-linking, cell surface levels of integrin a5, 
remained the same (B). Three independent experiments were performed with similar 
results. 
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In support of this possibility, confocal mlcroscopy experiments were performed. 
L6(i1NCEA) transfectants were treated with either hamster anti-a5 (Fig. 3 A, B) or 
hamster anti-a2 (Fig. 3 C, D) mAbs together with mouse anti-i1NCEA mAb at 37°C for 
20 min; primary antibodies were then clustered at 37°C for another 20 min with FITC-
conjugated goat anti-mouse Ab (green dye) to visualize i1NCEA and rhodamine-
conjugated rabbit anti-hamster Ab (red dye) to visualize the integrins; cells were fixed at 
RT at the end of the Ab labeling (Fig. 3B, D). The results show that, after cross-linking 
i1NCEA, integrin a5 followed i1NCEA into the same patches (Fig. 3B). Integrin a2, on 
the other hand, showed little co-Iocalization with i1NCEA and did not acquire the 
punctate staining pattern of ~NCEA after cross-linking (Fig. 3D). When the experiment 
was performed with cells fixed either before any Ab treatment (Fig. 3 A, C) or after only 
the primary Ab treatment (data not shown), in order to reveal pre-existing co-Iocalization, 
integrin a5 showed sorne co-Iocalization with i1NCEA in very fine "particles", whereas 
integrin a2 was more diffuse and showed much less co-Iocalization. These results 
support the suggestion that co-clustering of integrin a5, but not of integrin a2, occurs as 
a result i1NCEA cross-linking, probably because of their co-habitation of the same 
membrane microdomain. 
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Figure 3 ,1NCEA cross-linking indu ces co-clustering of integrin aS but not integrin 
a2 on L6 myoblast surfaces. L6(,1NCEA) cells were labeled with primary anti-CEA 
(J22) mAb and integrin a5(HMa5-1) (A, B) or a2(Hal/29) (C, D) mAbs for 20 min at 
37°C. Primary antibodies were next c1ustered with FITC-conjugated goat-anti-mouse 
antibodies (green dye) (,1NCEA, left column) and with rhodamine-conjugated rabbit anti-
hamster antibodies (red dye) (integrins, middle column) for 20 min at 37°C and then 
fixed with 4% PF A at room temperature (B, D). Control cells where fixed prior to 
antibody labeling (A, C). Right column shows little colocalization of ,1NCEA with either 
a5 (A) or a2 (C) integrins before patching. Co-Iocalization was observed by yellow 
patches for integrin a5 (B) but not for a2 (D) after patching. These results were repeated 
in three independent experiments. 
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Involvement of ILK in a5131 Integrin Activation upon i\NCEA cross-
linking 
The identity of cytoplasmic signaling elements that are rapidly activated in 
response to i1NCEA clustering was then investigated. Since activation of ILK was 
previously shown to mimic closely the molecular and cellular consequences of up-
regulation of CEA (see Introduction), ILK was the first such element to come under 
scrutiny. ILK was found to move into low density sucrose fractions within 5 min of 
antibody-mediated cross-linking of i1NCEA in L6(i1NCEA) transfectant cells (Fig. 4A). 
The endogenous level of ILK was then reduced by stable expression of specific siRNA. 
Since ILK siRNA was poorly expressed in L6(8NCEA) cells, siRNA experiments were 
perfonned in LR(i1NCEA) transfectants. Three LR-73(8NCEA) siRNA transfectant 
clones were isolated with reduced expression of ILK by 30%, 50% and 67% of control 
levels, as shown by Westemblotting (Fig. 4B). Relative to the siRNA control, ILK 
siRNA clones prevented the increased cell adhesion to immobilized Fn after antibody-
mediated i1NCEA cross-linking which was directly related to the degree of reduction in 
ILK levels, with clone 3 at 67% reduction showing no increase in cell-Fn adhesion (Fig. 
4C). These results indicate that ILK activation may be involved in the regulation of 
inside-out integrin activation upon CEA clustering. 
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Figure 4 ILK activation is implicated in the increase of cell adhesion to immobilized 
fibronectin upon i\NCEA cross-linking. Cross-linked L6(i\NCEA) transfectants were 
lysed with co Id 1% Brij 98 and subjected to isopycnic sucrose gradient centrifugation. 
SDS-PAGE and western blot analysis were performed to detect the presence ofILK and 
GMl in membrane microdomain fractions (A). In B, three clones generated by stable 
ILK siRNA transfections in LR(i\NCEA) cells were shown to "knockdown" about 30%, 
50% and 67% of the endogenous expression of ILK (ILK expression was normalized to 
p-actin expression levels). ILK siRNA-transfected LR-73(i\NCEA) cells were removed 
from tissue culture plates by a non-enzymatic method (PBS-citrate) after i\NCEA cross-
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linking. These transfectants showed reduced cell adhesion to Fn after ~NCEA cross-
linking directly related to their degree of reduction in ILK levels (C). The results are the 
mean of +/- SD of a representative experiment out of three independent experiments 
(*p<.003). 
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Involvement of the PI3-KlAkt signaling pathway 
The PI3-K/Akt cascade is a signaling pathway frequently altered in human 
cancers (Franke et al., 2003). Activation ofPI3-K and Akt is implicated in the regulation 
of cell differentiation (Peng et al., 2003; Sayama et al., 2002), proliferation (Sayama et 
al., 2002) and apoptosis. Since ILK activation has been described to be downstream of 
PI3-K activation (Delcommenne et al., 1998), and Akt phosphorylation occurs in a PI3-
K/ILK dependent fashion (Delcommenne et al., 1998; Persad et al., 2001; Troussard et 
al., 2003), we were interested in determining whether CEA clustering induced both Akt 
activation, by Ser 473 phosphorylation, and a rapid shift ta membrane microdomain 
association. The dependence of ILK and AKT activation on PI3-K activity was also 
investigated using the specifie pharmacological PI3-K inhibitor L Y294002. Fig. 5A 
shows that Akt rapidly shifts ta membrane microdomains after ~NCEA cross-linking in 
L6(~NCEA) cells and that this localization correlates with its phosphorylation at Ser473. 
The addition of LY294002 before ~NCEA cross-linking blocked the shift of Akt (Fig. 
5A) and ILK (Fig. 5B) into low density sucrose fractions, as weIl as Akt increased 
phosphorylation in total ceIllysates (Fig. 5C). To examinate whether these changes were 
linked with the status of integrin a5, cells were pre-treated with an anti-a5 integrin 
antibody. Inhibition of integrin a5 using antibodies strongly reduced Akt phosphorylation 
(Fig. 5D). No change in Akt phosphorylation was observed, however, upon reduction of 
ILK expression in the siRNA clones of Fig. 4 (data not shown). Finally, we determinate 
whether PI3-K inhibition by L Y294002 prevented the increase of cell binding to Fn 
induced by ~NCEA cross-linking. Fig. 6 shows that in L6 and Caco-2(~NCEA) ceIls, 
pre-treatment with L Y294002 but not the MAPK phosphorylation-specific inhibitor, 
PD098059, reduced this increase and completely in the case ofL6(~NCEA). 
In summary, ILK and the PI3-K/Akt pathway appear to be involved bi-
directionally in the activation of integrin a5 initiated by antibody-mediated ~NCEA 
clustering, in that anti-a5 mAb treatment blocks the activation of Akt, and down 
regulation ofILK or PI3-K block the activation of a5. 
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Figure 5 Integrin a.5-mediated activation of AKT and ILK localization in 
membrane microdomains upon L1NCEA clustering is prevented by PI3-K inhibition 
in L6 (L1NCEA) ceUs. PI3-K inhibition prevented recruitment of Akt (A) and ILK (B) to 
membrane microdomains. Total expression levels of Akt and Akt phosphorylation on Ser 
473 (A) or ILK (B) were evaluated after L1NCEA cross-linking by western blotsof 
isopycnic sucrose gradient fractions. Decreased Akt phosphorylation was observed after 
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pre-treatment of anti-a5 integrin mAb or 50 !lM LY294002 for 30 minutes at 37°C (C). 
This experiment was repeated three times with identical results. 
The MAPK pathway is activated by ilNCEA cross-linking/integrin aS 
activation independent of PI3-K 
Integrin regulation of cell differentiation and anoikis has also implicated the 
MAPK signaling cascade (Howe et al., 2002; Sastry et al., 1999). Interactions between 
the PI3-K and the RafIMEKIErk signa1ing pathways have been reported in multiple cell 
systems (Levinthal and DeFranco, 2004; Moelling et al., 2002), as either antagonistic 
(Guan et al., 2000; Rommel et al., 1999) or agonistic (Berra et al., 1998; King et al., 
1997). In addition, the block of terminal myogenic differentiation by ILK was shown to 
be due to the p44/p42 MAP kinases inactivation (Huang et al., 2000). We therefore 
decided to look for effects on MAPK activation as a result of CEA c1ustering. Although 
Fig 6 showed that pre-treatment with PD098059, but not the PI3-K specific inhibitor, 
L Y294002, had no effect on the increase of cell binding to Fn after ilNCEA cross-
linking, we found that MAPKIErkl/2 shifted to membrane microdomain localization 
within 10 minutes of cross-linking ilNCEA in L6(ilNCEA) cells (Fig. 7A). This 
observation correlated with MAPKIErkl/2 activation, since total cell extracts showed a 
marked increase in MAPK p44/42 phosphorylation after cross-linking ilNCEA in 
L6(ilNCEA) cells, without a measurable increase in total MAPK levels in the same cell 
extracts (Fig. 7B). In addition, MAPK activation required integrin a5 activation, since 
L6(ilNCEA) cells pretreated with an anti-a5 mAb before ilNCEA cross-linking showed 
little if any increase in MAPK p44/42 phosphorylation (Fig. 7B), presumably due to the 
blockage of a5 integrin Fn binding activity (Fig. 1), thus implying a direct involvement 
of a5 integrin activation in this pathway. The latter demonstrated that unlike the PI3-K 
signal, MAPK appears to be uni-directional, since the increase in cell adhesion to Fn 
upon ilNCEA cross-linking was not prevented by MAPK inhibition, but its downstream 
activation was abolished by pre-treatment with blocking anti-a5 mAb. 
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Finally, in order toexplore possible cross-talk between the PI3-K and the MAPK 
cascades, we evaluated the effect of LY29002 in the activation ofMAPK in L6(ilNCEA) 
transfectants. PI3-K inhibition did not prevent the increase in phosphorylation of 
MAPKlErk1l2 after ilNCEA cross-linking (Fig. 7B), suggesting that MAPK signaling is 
a collateral pathway activated by CEA c1ustering independent ofPI3-K signaling. 
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Figure 6 The CEA-mediated increase in cell adhesion to fibronectin was abrogated 
by inhibition of PI3-K but not by MAPK inhibition. L6 (tiNCEA) (A) and Caco-
2(llNCEA) (B) cultures were incubated with inhibitors L Y294002 at 50 ~M and 
PD098059 at 3p~M for 30 minutes at 37°C before ANCEA cross-linking. Values shown 
are means +/- SD for a representative experiment out of three independent experiments 
(*p<.002). 
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Figure 7 Inhibition ofPI3-K by LY294002 has no effect on MAPK phosphorylation 
mediated by CEA cross-linking. L6(ilNCEA) cells were cross-linked and subjected to 
isopycnic fractionation (A) or total cell extracts were obtained from cross-
linked/pretreated L6(ilNCEA) cells with PI3-K or MAPK inhibitors. MAPK was found 
to shift to membrane raft fractions after CEA cross-linking (A). Inhibition of PI3-K with 
L Y294002 had no effect on the phosphorylation levels of MAPK (Ser 44 and Thr 42). 
The specifie inhibitor of MAPK, was used as a positive control for the inhibition of 
MAPK phosphorylation. Cells pre-treated with anti-aS integrin antibody at 37°C and 
then cross-linked for 10 minutes showed inhibition of MAPK phosphorylation (B). The 
effects of MAPK localization and activation were reproducible in at least three 
independent experiments. 
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Discussion 
CEA structural and functional analysis implicated the importance of self-binding 
extracellular domains attached to the CEA-specific GPI anchor in blocking myoblast 
differentiation (Screaton et al., 2000). It was also shown that antibody-mediated cross-
linking of a self-binding-incompetent CEA mutant, ÔNCEA, which we suggest mimics 
the CEA c1ustering due to cell surface concentration increases seen in human cancer, was 
sufficient to re-instate the CEA differentiation block (Taheri et al., 2003). This result 
afforded a method of synchronizing the molecular events initiated by the c1ustering of 
CEA and allowed the study of any early transient events not requiring changes in gene 
expression that could be involved in changing cell state. We show here that a relatively 
rapid « 5 minutes) activation ofintegrin a5~1 and accompanying changes in a group of 
signaling elements, are all set in motion by antibody-mediated cross-linking of ÔNCEA. 
Rapid re-Iocalization ofthese elements to membrane microdomains was observed, which 
implies the existence of complexes of elements that can rapidly and efficiently undergo 
interdependent changes in activation state. Co-Iocalization studies by confocal 
microscopy demonstrated that antibody-mediated c1ustering of ôNCEA resulted in co-
localization ofintegrin a5 (Fig. 3), consistent with the view that these proteins inhabit the 
same membrane microdomains, thereby recruiting and increasing the local concentration 
of attached cytoplasmic signaling elements above a threshold required for activation. 
We demonstrated that two signaling cascades, previously shown to determine cellular 
attributes which mimic those observed with CEA expression, were activated upon 
ôNCEA c1ustering: the PI3-KlILKlAkt and MAPK cascades. We showed significant 
differences in how these two molecular pathways are integrated into the scheme of 
outside-in and inside-out integrin signaling resulting in the CEA-mediated build-up of 
integrin a5 activity. Altogether these observations establish a potential molecular 
mechanism involved in the tumorigenic effects of CEA. 
The issue of integrin specificity deserves discussion. It is well known that 
integrins exhibit functional "cross talk" (Blystone et al., 1999; Diaz-Gonzalez et al., 
1996; Ly et al., 2003), in that any effect on a given integrin is usually accompanied by 
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functional changes on others, making it impossible to isolate investigation on any 
particular integrin when dealing with studies on whole cells. Indeed, our original 
observation that CEA over-expression perturbed cell-ECM interactions was followed by 
the observation of increases in cell binding to both Fn and Vn and, less reproducibly in 
different cell types, to Ln, implicating both integrins aSpl and avp3 and possibly a6p4, 
respectively. Here, we showed rapid increases in cell binding to the same three ECM 
components after cross-linking L1NCEA in L6(L1NCEA) transfectants (Fig. 1). Our 
decision to focus on aSpl-Fn interactions was predicated on previous results involving 
cells (see Introduction) and the observation that the CEA-mediated increase in binding to 
Vn (data not shown) and even to whole unfractionated ECM (Ordonez et al., 2007) could 
be completely reversed by the administration of anti-a5 mAb. Thus a5p 1 seems to 
represent a dominant controlling integrin in response to CEA c1ustering. 
Since no change in the cell surface levels of a5pl after L1NCEA cross-linking was 
observed, and both of these molecules showed prior localization in membrane 
microdomains (Fig. 2), it is possible that an initial increase in integrin affinity for Fn, 
resulting from an a5pl valency increase (Bazzoni and Hemler, 1998; van Kooyk and 
Figdor, 2000; Weitzman et al., 1997), came first, perhaps from the generation of larger 
membrane rafts (Harris and Siu, 2002). No direct binding (that withstands cold detergent 
treatment) between CEA and aSpl could be demonstrated in multiple cell systems (data 
not shown), however, indicating perhaps that the CEA and aSpl association that results 
in the putative aSp 1 valency increase is simply due to their occupation of the same 
membrane microdomains. At present, however, it is impossible to identify whether the 
initial event in this process is external, due to the ab ove mentioned valency increase, or 
internaI, such as PI3-K activation arising from integrin priming. Note that increased Fn 
binding was seen both as cell binding to immobilized Fn and binding of soluble Fn to 
immobilized cells, which distinguishes our situation from those showing only the former 
(Bazzoni and Hemler, 1998). Our present model inc1udes the formation of a "cocoon" of 
polymerized Fn around the cells, due to the more tenacious binding of Fn produced by 
the cells and the consequent failure to deposit it in the ECM (Ordonez et al., 2007), which 
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could explain the observed loss of cell polarity, disruption of tissue architecture (Ilantzis 
et al., 2002) as well as the inhibition of cell differentiation (Eidelman et al., 1993; 
Screaton et al., 1997; Taheri et al., 2003) and anoikis (Ordonez et al., 2000). 
The signaling events initiated by the c1ustering of L\NCEA inc1ude the activation 
ofPI3-K. The PI3-K family of enzymes are localized in the cytosol ofunstimulated cells, 
but in response to lipid phosphorylation, accumulate at the plasma membrane due to their 
ability to associate with newly formed phosphoinositides (Vanhaesebroeck and Alessi, 
2000). At the membrane these proteins become activated and initiate various local 
responses, inc1uding the activation of several downstream targets such as Src family 
kinases (Fincham et al., 2000), the protein serine-threonine kinase Akt (protein kinase B, 
PKB) (Vanhaesebroeck and Alessi, 2000), phosphoinositide-dependent kinase 1 (PDK1) 
(McManus et al., 2004) and ILK (Delcommenne et al., 1998). In our study we showed 
that ILK and Akt (Fig. 5) were rapidly relocated to membrane rafts after L\NCEA cross-
linking. It is interesting to note that F AK, which has been shown to be a key player in 
integrin signaling (Komberg and Juliano, 1992; Schwartz and Ginsberg, 2002) was not 
affected by CEA cross-linking (data not shown). These results implicate ILK and Akt as 
part of the CEA-associated signaling network. 
The phenotypic changes previously observed in cells over-expressmg ILK 
(Attwell et al., 2000; Huang et al., 2000; Wu et al., 1998) led to the hypothesis that ILK 
could be a component of the CEA-induced signal transduction pathway since, as for these 
previous observations, the forced expression of CEA in both mouse C2C12 and L6 
myoblasts inhibits myogenic differentiation (Screaton et al., 1997), inhibits anoikis in 
many cell types inc1uding human colonocytes and L6 myoblasts (Ordonez et al., 2000) 
and increases fibronectin matrix assembly (Ordonez et al., unpublished results). 
Consistent with previous results (Delcommenne et al., 1998; Troussard et al., 2003), we 
identified ILK and Akt as downstream targets of PI3-K, since inhibition of PI3-K 
prevented ILK localization to membrane microdomains (Fig. SB) and Akt 
phosphorylation (Fig. 5A,C). Although down-regulation of ILK expression with siRNA 
reduced the normal increase in cell adhesion to fibronectin caused by L\NCEA cross-
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linking (Fig. 4B), reflecting a requirement for ILK in the regulation of CEA-mediated 
inside-out integrin aS activation, we did not see a significant reduction of Akt 
phosphorylation in the siRNA ILK clones (data not shown). This could be due to residual 
expression levels of ILK observed in these clones, but is also consistent with results 
obtained by other groups showing that ILK is not directly responsible for Akt 
phosphorylation (Grashoff et al., 2003; Hill et al., 2002; Lynch et al., 1999; Zervas et al., 
2001). Further studies will be required to clarify this question. Our results thus support a 
model in which membrane microdomain localization of signaling elements, resulting 
from membrane raft aggregation induced by CEA clustering, may allow interaction of 
integrins with relocated and activated effector molecules such as ILK, leading to 
increased integrin-Fn binding activity and the activation of downstream signaling 
cascades, including the AktlPKB pathway. 
Another signaling pathway that has been linked to integrin signaling is the 
ERKIMAPK cascade. Various findings support a role for ERK in the regulation of the 
adhesionlcytoskeletal network, cell differentiation and apoptosis (Howe et al., 2002; 
Sastry et al., 1999). Our experiments demonstrated the activation and re1ocation of 
MAPK to membrane microdomains as a result of CEA clustering (Fig. 7 A); this 
activation was dependent on integrin activation, as pretreatment with aS integrin 
antibodies inhibited MAPK phosphorylation (Fig. 7B). However, inhibition ofPI3-K did 
not prevent MAPK activation (Fig 7B) and furthermore, a specific inhibitor ofMAPK did 
not prevent the increase of cell adhesion to Fn in response to ~NCEA cross-linking as did 
PI3-K inhibition (Fig 6). Thus it appears that MAPK activation represents a uni-
directional collateral signal regulated by outside-in integrin signaling. 
As noted in the introduction, the interaction of integrins with intracellular 
signaling elements can be bi-directional, resulting in a positive feedback loop that drives 
a rapid and robust activation of the integrin. ILK and PI3-K could be thought of as multi-
directional elements in that integrin c1ustering/activation can result in their re-localization 
and activation which, in tum, could result in further integrin activation. Our results 
implicate the PI3-K signaling cascade as an important bi-directional regulator of the 
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activation state of the aSpl integrin receptor and the MAPK cascade as a uni-directional 
consequence of aSpl activation. Of course, we have by no means characterized all the 
elements affected by CEA c1ustering, especially when secondary changes, such as the 
activation of Akt and cytoskeletal elements are included. 
In conclusion, our results suggest a model for CEA signaling in which clustering 
of CEA molecules causes membrane microdomain aggregation and subsequent activation 
of the aS integrin receptor. We show data supporting the view that the CEA GPI anchor 
plays a key role in CEA function by determining a specific subset of membrane rafts and 
their associated signaling molecules that all rapidly relocate and become activated upon 
CEA clustering. We find that signaling complexes such as the PI3-K and MAPK 
pathways are specifically activated. We propose that the MAPK and PI3-K/Akt signaling 
pathways are modulators of a CEA-mediated integrin activation mechanism that may 
contribute to aberrant cell-ECM interactions characteristic of the CEA phenotype, leading 
to inhibition of cell differentiation and anoikis, and a distortion oftissue architecture, thus 
promoting malignant pro gression. 
The findings presented in the present chapter, implicated integrin aSpl molecules as 
important signaling targets involved in the initiation of CEA-mediated signaling. In the 
next study, we extrapolate the latter results in vivo by the analysis of the effects of CEA 
and CEACAM6 expression in transgenic mice. 
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CHAPTER3 
Colorectal Hyperplasia and Dysplasia due to Human Carcinoembryionic (CEA) and 
CEACAM6 expression in transgenic mice 
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Abstract 
CEA and CEACAM6 are up-regulated in as many as 70% of all human cancers. Results 
in in vitro systems showing tumorigenic effects for these molecules suggest that this 
correlation indicates an instrumental role in tumorigenesis. The fact that they are 
normally upregulated during terminal differentiation, however, has supported the 
alternative view that they are simply indicators of differentiation status and that the in 
vitro positive results are non-physiological artifacts that do not apply in vivo. Since mice 
do not possess genes corresponding to CEA and CEACAM6, it was decided to create 
transgenic mice containing both, then to increase their copy numbers and colonocyte 
expression levels by mating to levels seen in human colorectal carcinomas. Using the in 
vitro results as a guide, molecular changes involving integrin aSp 1 and its transduced 
signaling pathway and cellular changes of purified colonocytes were monitored; tissue 
architecture was also investigated. The surface level of integrin aS and the activation of 
Akt in colonocytes were found to increase progressively with the expression levels of 
CENCEACAM6. Colonic crypts showed a progressive (with CENCEACAM6 
expression levels) increase in colonocyte proliferation towards their upper regions, an 
increase in crypt fission, a strong inhibition of colonocyte differentiation, and a marked 
inhibition of colonocyte anoikis/apoptosis. At human colorectal carcinoma leve1s of 
expression, 100% of the transgenic mice showed massively enlarged colons comprising 
continuous non-focal cytological and architectural abnormalities, including dysplastic 
and serrated adenomatous morphology. Expression of human CEA and CEACAM6 in 
mice can produce tumorigenic molecular and cellular changes in colonocytes that lead to 
massive colons displaying severe hyperplasia and dysplasia. This supports an 
instrumental role for these molecules in human cancer. 
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Introduction 
The human CEA family of cell surface intercellular adhesion molecules, a sub-
family of the Immunoglobulin Superfamily, consists of both glyco-phosphatidylinositol 
(GPI) and transmembrane (TM) anchored members (Hammarstrom et al., 1998). GPI-
anchored members, CEA and CEACAM6, show up-regulation in 50-70% of all human 
cancers, including colon, breast and lung cancers (Allard et al., 1994; Ballesta et al., 
1995; Carrasco et al., 2000; Chevinsky, 1991; Jantscheff et al., 2003; Maxwell et al., 
1993; Ryu et al., 2002; Scholzel et al., 2000a; Sugita et al., 1999). In fact, CEA represents 
a major tumor marker used widely in the management of colorectal cancer (Ballesta et 
al., 1995; Jantscheff et al., 2003; Maxwell, 1999; Shuster et al., 1980). The TM-anchored 
member, CEACAM1, on the other hand, usually shows down-regulation in cancers 
(Bamberger et al., 1998; Kammerer et al., 2004; Luo et al., 1999; Neumaier et al., 1993; 
Nollau et al., 1997; Riethdorf et al., 1997; Tanaka et al., 1997). The question arises as to 
whether or not the positive correlation between CENCEACAM6 levels and tumors 
points to an instrumental role for these molecules in cancer. This question has 
significance for the clinical interpretation of CEA and CEACAM6 levels in tumors and 
for the development of CEA-targeted therapies. Since CEA and CEACAM6 are normally 
up-regulated as differentiation proceeds during the movement of colonocytes up colonic 
crypts (Hammarstrom et al., 1998; Ilantzis et al., 1997; Jothyet al., 1993; Scholzel et al., 
2000a), many have come to believe that the increased levels of CEA and CEACAM6 in 
colonic tumors simply reflect the state of differentiation of the tumor colonocytes. 
Experiments with various model systems in vitro, including cultured human colorectal 
carcinoma colonocytes, however, have shown that if CEA andlor CEACAM6 are 
inappropriately up-regulated in cells with division potential prior to differentiation, 
differentiation is blocked (Eidelman et al., 1993; Ilantzis et al., 2002; Rojas et al., 1996), 
cell polarization and tissue architecture are disrupted (Ilantzis et al., 2002) and 
anoikis/apoptosis is inhibited (Duxbury et al., 2004d; J ay et al., 2005; Ordonez et al., 
2000; Soeth et al., 2001; Wirth et al., 2002). AlI of the above effects can contribute to 
tumorigenicity. Which of these two interpretations is correct? 
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The molecular mechanism for the observed tumorigenic effects of CEA and 
CEACAM6 could provide insight in considering this question. The structural 
requirements for CEA's differentiation-blocking ability have been shown to be self-
associating external domains linked to a CEA-specific GPI anchor (Screaton et al., 2000), 
the former to effect c1ustering and the latter to provide activation specificity following 
c1ustering (Taheri et al., 2003). CEA occupies membrane microdomains (membrane rafts 
rafts), which tend to c1uster as the CEA cell surface density increases, the latter being 
observed in many cancers (see above). CEA external domain mutants deficient in self-
binding have no effect on differentiation but become effective immediately after 
antibody-mediated cross-linking (Taheri et al., 2003). Thus, within 5 minutes after cross-
linking, integrin aS pl, which belongs to the integrin family of cell surface heterodimeric 
receptors involving cell-extracellular matrix/cell-cell interactions and cell proliferation, 
differentiation and survival (Giancotti and Ruoslahti, 1999; Hannigan et al., 2005; Hynes, 
2002), becomes activated and co-Iocalizes with CEA in larger membrane structures; rapid 
localization in low density membrane microdomains of ILK, PI-3K, AKT and MAPK 
and phosphorylation of AKT and MAPK are also observed (Camacho-Leal et al., 2007), 
presumably because all of these elements occupy the same lipid rafts as CEA. Similarly, 
antibody-mediated cross-linking of CEACAM6 activates integrin avp3 in a pancreatic 
cancer cellline (Duxbury et al., 2004a). Integrin activation and subsequent activation of 
the PI-3K1AKT and MAPK pathways have been reported by other groups to have the 
same effects observed here on differentiation and anoikis (Frisch and Screaton, 2001; 
Guo and Giancotti, 2004b; Reddig and Juliano, 2005; Stupack and Cheresh, 2002). These 
results are consistent with the instrumental model of CEA and CEACAM6 in 
tumorigenesis. 
The above results utilized various in vitro model systems involving 
CEAICEACAM6 transfectants and could therefore have given findings that do not apply 
in vivo. To address this important caveat, it was decided to construct transgenic mice 
containing human genes for CEA and CEACAM6. Mice do not possess GPI-anchored 
CEA family members, having only analogs of human TM-anchored CEACAMI 
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(Zimmermann, 1998), making this experiment appropriate. Previous transgenics 
harboring the human CEA gene only, while showing the same pattern of tissue specific 
expression as in humans (Clarke et al., 1998; Eades-Perner et al., 1994), did not show a 
predilection for developing more tumors even when crossed with tumor susceptible 
mutant min mi ce (Thompson et al., 1997). These mice, however, lacked CEACAM6 that 
is usually co-overexpressed with CEA in cancers, had transgene expression levels that 
could have been below those observed in human tumors and lacked upstream and 
downstream genomic sequences in their transgenes that could have been necessary for 
derangement of their expression, e.g., in colonocytes with division potential. 
The above deficiencies were dealt with by creating transgenic mice containing a 
187 kb insert from a bacterial artificial chromosome (BAC) that inc1uded the complete 
human genes for CEA, CEACAM6, CEACAM7 and CEACAM3 plus about 20-30 kb of 
both upstream and downstream sequences (Chan and Stanners, 2004). The expression 
patterns of these genes were almost identical to human patterns, showing normal 
expression of CEA and CEACAM6 in colorectal crypts with, unlike the CEA-only 
transgenics by Eades-Perner et al., the correct gradient, i.e., higher towards the upper 
ends of the crypts. They also showed very low colorectal cryptaI expression of 
CEACAM7 and no colorectal expression of CEACAM3 (Chan and Stanners, 2004). Two 
independent transgenic founders were obtained with 2 and 10 head-to-tail copies of the 
transgene and colonic expression levels directly proportional to their copy number (Chan 
and Stanners, 2004). Higher copy transgenics were then derived by mating the 10 copy 
founders to give 20 copy homozygotes and a further 2-fold increase in colonic 
expression. The latter expression levels were in the range observed in human colorectal 
carcinomas. We were thus poised to look for possible tumorigenic effects of CEA and 
CEACAM6 in an in vivo system that more c10sely approximated the human situation. 
These transgenic mice showed dramatic expression level-dependent tumorigenic 
effects: with sorne variation in detail, the same changes in integrin aS Pl, ILK and AKT 
as seen in the in vitro model systems were observed in purified colonocytes; furthermore, 
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the mice showed inhibition of colonocyte differentiation and anoikis, and maSSIve 
disruption of tissue architecture characteristic of dysplasia and extreme hyperplasia. 
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Materials and Methods 
Animais 
CEABAC transgenic mice (CEABAC2 and CEABAC10 lines, bearing 2 and 10 copies of 
the CEABAC transgene, respectively) were produced and maintained on the FVB strain 
background. Genotypes of mice were determined by PCR as described elsewhere (Chan 
and Stanners, 2004). CEABAC20 mice (bearing 20 copies of the CEABAC transgene) 
were produced from mating between two CEABACIO mice. Homozygosity oftransgenic 
mice was identified in splenocytes by fluorescence in situ hybridization of the CEABAC 
(see be1ow). 
Reagents and Antibodies 
Dispase was purchased from Invitrogen Life Technologies Inc. (Carlsbad, CA). Cholera 
toxin, dithiothreitol (DTT) and DNase 1 were purchased from Sigma-Aldrich Canada Ltd. 
(Oakville, Canada). Sucrose was purchased from Fisher Scientific (Pittsburg, PA). Rabbit 
polyclonal antibodies used are: anti-CEA Ab (RbaCEA) which recognizes aH human, but 
not murine, CEACAM family members; anti-integrin a5 Ab (H-104) which reacts with 
mouse and human integrina5 subunit (Santa Cruz Biotechnology Inc., Santa Cruz, CA); 
anti-integrin ~l Ab (M-I06) which detects mouse integrin ~l subunit (Santa Cruz 
Biotechnology Inc.); anti-FAK Ab which detects mouse p125FAK (Upstate Cell Signaling, 
Charlottesville, VA); anti-Akt Ab which can be used to assess the totallevel of mouse 
AkU, Akt2 and Akt3 proteins (Cell Signaling Technology Inc., Beverley, MA); anti-
Phospho-Akt (Ser473) Ab which detects mouse AkU only when phosphorylated at the 
Ser473 residue and also mouse Akt2 and Akt3 when phosphorylated at the corresponding 
residues (Cell Signaling Technology Inc.); anti-caspase-3 Ab which detects full length 
mouse caspase-3 and the large fragment of cleaved caspase-3 (Cell Signaling Technology 
Inc.); and anti-PARP (H-250) Ab which detects the C-terminus ofPARP-l and PARP-2 
(Santa Cruz Biotechnology Inc.). Mouse monoclonal antibodies used are: anti-CEA Ab 
J22 and A20, which recognize internaI domains of CEA and CEACAM6 and the N-
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tenninal domain of CEA, respectively (Zhou et al., 1993b); anti-CEA Ab T84.66, which 
recognizes only CEA (American Type Culture Collection, Manassas, VA); anti-
CEACAM6 Ab 9A6, which recognizes only CEACAM6 (Scholzel et al., 2000b); anti-
ILK Ab which recognizes mouse and human ILK (BD Biosciences); and anti-PCNA Ab 
PC10, which was purchased from DAKO Diagnostics Canada Inc. (Mississauga, 
Canada). Hamster monoclonal antibodies used are: anti-integrin a5 Ab HMa5-1, which 
recognizes mouse integrin a5 (BD Biosciences, Mississauga, Canada); and anti-integrin 
a2 Ab HMalpha2, which detects mouse integrin a2 (Chemicon International Inc., 
Temecula, CA). 
Fluorescence In Situ Hybridization and TUNEL Assay 
For fluorescence in situ hybridization (Schreiner et aL), freshly isolated splenocytes were 
treated as previously described (Spector et al., 1998); DIG-Iabeled CEA cDNA probes 
were generated using the High Prime DNA Labeling Kit (Roche Diagnostics Inc., Laval, 
Canada), and detection was perfonned using the Fluorescent Antibody Enhancer Set for 
DIG Detection (Roche Diagnostics Inc.). Tenninal deoxynucleotidyl transferase (TdT)-
mediated dUTP Nick-End-Labeling (TUNEL) assay was used to detect apoptotic cells 
according to the protocol provided by the APOAlert™ DNA Fragmentation Assay Kit 
(BD Biosciences). Fluorescent cells were visualized using a fluorescent microscope. 
Isolation of Mouse Colonie Epithelial Cells 
Colonic epithelial cells were isolated from the wild-type (WT), CEABAC2 and 
CEABAC 1 0 mice using a protocol modified from one previously described for human 
samples (Grossmann et al., 2001). Briefly, 5 to 6 intact mouse colons were flipped inside-
out, fitted over fine wooden sticks, incubated for 30 minutes in a 1.3 mM DTTIPBS 
solution at room temperature and 10 minutes in a 1.5 mM EDTAlPBS solution at 37°C, 
and then rinsed with PBS solution. Intact colonic crypts were separated from the lamina 
propria and muscular layer by vigorous shaking in PBS solution and collected by passing 
the crypts/cells suspensions through 40-j...lm nylon cell strainers (BD Biosciences). 
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Purified colonic crypts were backwashed from the cell strainers with either PBS solution 
(for flow cytometry, see below) or serum-free DMEM medium (for anoikis assay, see 
below). The integrity and purity of colonic crypts were verified under a light microscope 
before treatment with dispase (1.2 mg/ml) for 10 minutes to give colonic epithelial 
single-cell suspensions. Dispase was inactivated by adding cold EDTA to 1 mM. To 
ensure single cell suspensions were obtained, samples were examined under a light 
mIcroscope. 
Anoikis Assay for Purified Colonie Epithelial Cells 
Single cen suspensions of purified colonic epithelial cens (WT, CEABAC2 or 
CEABAC10) were divided in two halves. The first half of the suspension was kept in 
suspension in serum-free DMEM medium for 1 or 3 hours at 37°C. The extent of 
apoptosis was assessed by immunoblot analysis of caspase-3 cleavage (see below) and by 
the TUNEL assay (see above). For the TUNEL assay, the baseline number of apoptotic 
cens was determined immediately after purification using the same protocol as above 
with the second half of the suspension. For a positive control of DNA fragmentation, 
cens were treated with DNAse 1 (1 Ilg/ml) before TUNEL assay. For a negative control 
of the TUNEL assay, TdT was omitted in the TUNEL reaction. Apoptotic index was 
expressed as the percentage of apoptotic cens over the total number of cens counted. 
Counts were compared to those ofWT mice and expressed as percentage ofWT control. 
Flow Cytometrie Analysis (FACS) 
Purified colonic epithelial cens were resuspended in PBS + 2% FBS (PBSF). 5-10 x 105 
cens were incubated with primary antibodies (HMa5-1, HMalpha2, T84.66 or 9A6) for 
30 minutes on ice. cens were rinsed with PBSF and resuspended in 0.5 ml PBSF 
containing FITC-conjugated goat anti-mouse or rabbit anti-hamster secondary antibodies 
(The Jackson Laboratory, Bar Harbor, ME) for 30 minutes on ice. cens were rinsed and 
resuspended in 0.5 ml PBSF for cytofluorometric analysis using F ACScanR (Becton 
Dickinson, Bedford, MA). 
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Isolation of Lipid Raft Membrane Microdomains 
Lipid raft membrane microdomains were isolated by isopycnic sucrose density gradient 
centrifugation. Briefly, 5-10 x 106 purified colonic epithelial cells (wild-type, CEABAC2 
or CEABAClO) were incubated in lysis buffer (20 mM Tris-HCl pH 8, 140 mM NaCI, 2 
mM EDTA) with 1 % Brij 98, protease inhibitors (10 Ilglml aprotinin, 10 Ilglmlleupeptin, 
100 Ilglml PMSF and phosphatase inhibitors (1 mM NaV03, 10 mM NaF) for 30 minutes 
at 4°C. Celllysates were adjusted to 40% sucrose using ice-cold 80% sucrose buffer (10 
mM Tris-HCl pH 8, 140 mM NaCl, 2 mM EDTA pH 8). Sucrose gradients were prepared 
in Il x 60 mm polyallomer tubes (Beckman Coulter Inc., Fullerton, CA) by successive 
addition of 2 ml of celllysate containing 40% sucrose, 2 ml of 35% sucrose buffer and 
1ml of 5% sucrose buffer. Sucrose gradients were then centrifuged at 45,000 rpm using a 
swing-out rotor (Beckman Coulter Inc.) for 18 ho urs at 4°C. Multiple fractions of 350 III 
were harvested from the top of each gradient. The sucrose concentration in each fraction 
was then determined by an Abbes' refractometer. Membrane fractions corresponding to 
the 5-25% sucrose interface were tested for the presence of GM1 (only present in the 
lipid raft containing fractions) to confirm a valid membrane separation. Briefly, 5 III of 
membrane fractions were blotted onto a 0.45 Ilm PDVF membrane (Millipore Inc., 
Bedford, MA) that was then incubated with horseradish peroxidase (HRP)-conjugated 
cholera toxin for 30 minutes at room temperature. GM1-bound HRP-conjugated cholera 
toxin was then detected using ECL reagents according to the manufacturer's instructions 
(Amersham Life Science Inc., Pittsburgh, PA). 
Immunoblot analysis 
Crude colonic tissue extracts were obtained by scraping colonic mucosa away from the 
muscular underlayer, homogenizing with PBS on ice and lysing with SDS lysis buffer 
(100 mM Tris pH 8, 10% glycerol, 2% SDS). Colonic epithelial extracts were obtained 
by lysis ofpurified colonic epithelial cells (see above for isolation) in RIPA lysis buffer 
containing (20 mM Tris-HCl pH 8, 140 mM NaCI, 2 mM EDTA pH 8, 10 Ilglml 
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aprotinin, 10 )lg/mlleupeptin, 100 )lg/ml PMSF, 1 mM NaV03, 10 mM NaF). Proteins 
from crude colonie tissue extracts, purified colonie epithelial extracts or sucrose gradient 
fractions were resolved by SDS-PAGE and transferred electrophoretically to 0.45 )lm 
PDVF membranes (Millipore Inc.). Immunoblot analyses were performed using primary 
antibodies against various proteins (CEA, CEACAM6, integrin a5, integrin a2, integrin 
Pl, ILK, AKT, phosphorylated AKT, FAK, PARP, and caspase-3) and HRP-conjugated 
secondary antibodies. SignaIs were detected using ECL reagents according to the 
manufacturer's instructions (Amersham Life Science Inc.). 
Histological analysis and immunohistochemistry 
For cryosection, freshly collected tissues were fixed with 4% paraformaldehyde and 
processed as described elsewhere (Chan and Stanners, 2004). For paraffin-embedded 
sections, freshly excised tissues were fixed in Glyo-Fixx (20% ethanol, 5% glyoxal, 1 % 
propanol and 1 % methanol) for 48 hours at room temperature and processed for 
embedding in paraffin blocks for sectioning. For general histopathology, 5-)lm frozen 
sections were stained with hematoxylin (Lynch et al., 1969) or 5-)lm paraffin-embedded 
sections were stained with hematoxylin and eosin (Lynch et al., 1969). To assess colon 
differentiation, 5-)lm frozen sections were stained by the "alcian blue-periodic acid 
Schiff' method to detect mucin, followed by methyl green staining to detect nuclei (AB-
PAS-MG) (Lynch et al., 1969). For immunohistochemistry, 5-)lm frozen sections were 
probed with RbaCEA antibodies as described elsewhere (Chan and Stanners, 2004). 
Actively proliferating cells were detected using HRP-conjugated mouse monoclonal anti-
PCNA antibody. 
Differentiation and Proliferation Analyses 
For differentiation and proliferation analyses, animaIs were sacrificed at exactly postnatal 
day 21 to minimize growth variation. Percent crypt fission was scored as the percentage 
of forked dividing crypts over the total number of crypt bases for about 100 crypts. 
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Proliferation index was scored as the number of PCNA-positive nuclei divided by total 
number of nuclei in about 10 individual crypts. The level of differentiation was scored as 
the number of large goblet cells (mucin vacuole of more than 10 /-lm) over the total 
number of crypt bases for about 100 crypts. 
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Results 
Construction of CEABAC Transgenic Mice 
CEABAC2 and CEABAC10 transgenic mice are independent founders containing 
2 and 10 head-to-tail copies, respectively, of the 187 kb genomic DNA insert of a BAC 
which includes the genes for human CEA, CEACAM6, CEACAM7 and CEACAM3 
(Chan and Stanners, 2004). The tissue specific expression patterns for these genes have 
been documented previously (Chan and Stanners, 2004) and are almost identical to those 
in humans (Hammarstrom et al., 1998). CEABAC20 mice with 20 copies were obtained 
by mating CEABAClO mice, which are heterozygous for the transgene. In situ 
hybridization with a FITC-Iabeled CEA cDNA probe of cell nuclei showed a single spot 
for CEABAClO and two spots for CEABAC20 (Figure lA), which is consistent with the 
previous molecular analysis of CEABAC10 indicating head-to-tai1linkage of all copies 
into one complex (Chan and Stanners, 2004). The CEABAC20 mice could be 
immediately recognized in litters because of their significantly smaller size (Figure lB), 
which could be attributed to impaired gastrointestinal function (see below). 
Immunoblot analysis for CEA and CEACAM6 expression in the colons of 3 
month old mice is shown in Figure 1 C. As expected, WT mice show no expression of 
these CEA family members, whereas CEABAC2, CEABAC10 and CEABAC20 mice 
show increasing expression levels in proportion to their transgene copy number. 
The spatial expression pattern, both qualitatively and quantitatively, was 
important to assess, if any of these mice were to serve as models for human colorectal 
carcinogenesis. Appropriately elevated cell surface expression levels in colonocytes in 
the proliferative zone of colonic crypts would be required for this. As an approximate 
estimate, immunohistochemistry for CENCEACAM6 was performed on colonic sections 
from 3 week and 3 month old transgenic mice and compared with that of human 
colorectal carcinomas at a common stage of progression. In concordance with the 
immunoblot analysis, CEABAC2, CEABAC 1 0 and CEABAC20 mice showed increasing 
cell surface expression levels of CENCEACAM6 in the transgenic colons at 3 weeks of 
age (Figure ID). However, the high cell surface expression level of CENCEACAM6 in 
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the CEABAC20 mlce was no longer restricted to the apical surface. Moreover, 
intracellular localization of CEAICEACAM6 was more evident in the CEABAC20 mice 
(Figure ID). By 3 months of age, the expression level and pattern of CEAICEACAM6 in 
the CEABAC20 mice were compatible with those of human colorectal carcinomas 
(Figure lE). 
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Figure 1: Expression of CEA and CEACAM6 in the CEABAC mouse colon. A) 
Images of fluorescence in situ hybridization (FITC-Iabeled CEA cDNA probes and 
DAPI-stained nuc1ei) show one nuc1ear spot for CEABACI0 and two for CEABAC20. 
Original magnification: x 1000. B) Significant reduction visually of body size of 
CEABAC20 mice at 3 weeks of age. C) Immunoblots of colon protein extracts show a 
correlation between expression levels of CEA (detected with A20 mAb) and CEACAM6 
(detected with 9A6 mAb) and CEABAC transgene copy numbers in the CEABAC mice 
(CEABAC2, CEABACI0 and CEABAC20). D) Immunohistochemical staining (brown 
staining) for human CEACAM (detected with RbaCEA) in 3 week-old mouse colons 
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shows increasing cell surface expression levels of CEAICEACAM6 correlated with the 
transgene copy number. The high cell surface expression level of CEAICEACAM6 in the 
CEABAC20 mice was no longer restricted to the apical surface and significant 
intracellular localization of CEAICEACAM6 was also evident. E) hnmunohistochemical 
staining (brown staining) for human CEACAM (detected with RbaCEA) in 3 month-old 
CEABAC20 mouse colons shows levels and patterns of CEAICEACAM6 expression 
which are similar to those of human colorectal carcinomas at a similar stage of 
progression. WT denotes wild-type littermate. 
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Molecular Changes in CEABAC Colonocytes 
A case for a positive change in the activation state of integrin aSp 1 as a result of 
CEA c1ustering was made from previous in vitro studies (see Introduction). Here, using 
purified colonocytes from the transgenic mice, it was not technically possible to measure 
their binding to fibronectin, the major ligand of integrin aSpl, as an indication of its 
activation state. However, the cell surface level of integrin aS was higher in CEABAC2 
than in WT colonocytes and even higher in CEABACIO (Figure 2). This finding 
cOITelated well with the cell surface levels of CEA and CEACAM6 in the CEABAC2 and 
CEABAClO mi ce (Figure 2). CEABAC20 colonocytes presumed to have the highest 
level of integrin aS were not inc1uded in this part of the characterization because the 
extensive distortion of the crypt architecture (see below) rendered their isolation too 
difficult using the CUITent method. The expression level of integrin a2 showed no such 
increase with CEAICEACAM6 expression (Figure 2) and integrin av could not be 
detected (data not shown). These results suggest that integrin aSpl signaling could be 
increased in colonocytes from CEABAC transgenic mice and in a CEAICEACAM6 gene 
dose-dependent fashion. 
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Figure 2: Cell surface expression of CEACAM and integrins on purified 
colonocytes. FACS profiles of wild-type (WT) (shaded are a) , CEABAC2 (dotted line) 
and CEABACIO (solid line) purified colonocytes. FACS profiles of CEA detected by 
T84.66 mAb (A) and CEACAM6 detected by 9A6 mAb (B), show a higher cell surface 
expression of CEA and CEACAM6 in the CEABAC 1 0 than CEABAC2 colonocytes, 
whereas wild-type (WT) colonocytes show only a background flurorescence. F ACS 
profiles of integrin a5 detected by HMa5-1 mAb (C) show increasing cell surface 
expression levels of integrin a5 with increasing CEAICEACAM6 cell surface expression 
levels. FACS profiles ofintegrin a2 detected by HMalpha2 mAb (D) show the same cell 
surface or even less expression levels of integrins a2. Isolated colonocytes from six mice 
were used for each of five independent experiments. The results from one of these 
experiments are presented and are representative of the five. 
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In agreement with the latter supposition, a shift in subcellular localization towards 
less dense membrane complexes typical of membrane rafts for integrin aS, ILK and AKT 
and an increase in phosphorylation for AKT were observed in purified colonocytes from 
CEABAC2 and CEABAC 1 0 mice relative to WT littermate mice, as was previously seen 
for these elements in various in vitro systems (Figure 3A). No such changes were 
observed for integrin a2 subunit, integrin pl subunit or F AK (Figure 3A). However, 
since the overall detection level of integrin pl (in contrast to integrin a2 and F AK) was 
very low and no visible signal was detected in the low-density membrane fractions, the 
existence of a shift in the subcellular localization of integrin pl was questionable. In 
addition, the pl subunit is shared by many a subunits and so might not be expected to 
show large changes. Similarly, PI-3K was undetectable in this experiment (data not 
shown). These increases were understandably less dramatic than those observed in vitro 
in which the events were synchronized by cross-linking mutant CEA molecules at high 
cell surface density that lacked self-adhesive external domains (Camacho-Leal et al., 
2007). Here, antibody-mediated cross-linking of CEA and CEACAM6 in the purified 
colonocytes accentuated the shift of ILK towards less dense membrane complexes 
(Figure 3B), which is consistent with the suggestion that they arose as a consequence of 
CEAICEACAM6 clustering leading to integrin aSp 1 activation. Regardless of the verity 
of the latter interpretation, the results provide clear evidence for activation of the AKT, 
an acknowledged consequence ofintegrin activation (Giancotti and Ruoslahti, 1999; Guo 
and Giancotti, 2004a). 
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Figure 3: Subcellular localization of CEACAM and integrin signaling elements in 
purified colon oey tes. A) Immunoblots of different membrane fractions of purified 
colonocytes from derived from sucrose density gradients show a shift in subcellular 
localization from high density (H) towards low density (L) membrane complexes for 
integrin a5, ILK, total AKT and phosphorylated AKT in purified colonocytes from 
CEABAC2 and CEABACIO mice relative to wild-type (WT) littermate mice. No such 
shift was observed for integrin a2, integrin pl and F AK. B) Antibody-mediated cross-
linking of CEA and CEACAM6 with J22 mAb in the purified colonocytes accentuates 
the shift of ILK to the less dense membrane fractions shown in A. GMI is a marker for 
lipid raft-containing membrane fractions. Isolated colonocytes from six mice were used 
for these experiments. A representative experiment out of five independent experiments 
is shown. 
91 
Cellular Changes in CEABAC Colonocytes 
What are the cellular consequences in vivo of the increase in cell surface density 
of integrin a5 and the consequent downstream molecular activation events that arise from 
the presence of the CEABAC transgenes in colonocytes? A transgene copy number-
dependent increase in the colonocyte proliferation index indicated by PCNA staining was 
observed in colonic crypts from 3 week old CEABAC transgenics relative to WT 
littermates (Figure 4B). This was due to the progressive extension (with CEABAC dose) 
of the proliferative zone towards the upper parts of the crypts reaching the fulliength of 
the crypts in CEABAC20 mice (Figure 4A). This effect resulted in an overall increase in 
the length of the CEABAC20 crypts (Figures 4A and 5A). There was also a marked 
CEABAC dose-dependent increase in the incidence of crypt fission (Figure 4C), the 
process whereby new crypts are created in the colon (Mandir et al., 2005; St Clair and 
Osborne, 1985). 
Lastly, a strong CEABAC dose-dependent decrease in the differentiation of 
colonocytes, as assessed by the incidence of large goblet cells in the crypts, was observed 
in the transgenic mice (Figure 5), consistent with the pan-inhibition of cellular 
differentiation noted in various in vitro systems (Eidelman et al., 1993; Ilantzis et al., 
2002; Rojas et al., 1996). 
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Figure 4: Hyperproliferation in CEABAC mouse colonie epithelium at 3 weeks of 
age. A) Extension of the proliferative zones in colonie crypts is shown for both 
CEABACIO and CEABAC20 by PCNA staining. Lengthening of crypts, poor cryptaI 
aIignment, increase of peri-cryptaI stroma, and elongation of nuc1ei are noted in 
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CEABAC20 mice, indicating hyperplastic changes. Arrow shows an example of crypt 
fission used to calculate percent crypt fission for C. B) Proliferation indices estimated by 
PCNA staining in A show significant increases for both CEABACI0 and CEABAC20 
from WT mice (P < 0.0001) C) Percent crypt fission plotted against transgene copy-
number shows a linear curve with a correlation coefficient of 0.977; each data point is 
significantly different from the others (P < 0.0001). D) Cross sections of colons show 
increasing epithelial content with increasing CEABAC transgene copy number (i.e. 
CEAICEACAM6 expression levels). Magnification: 400x (A), 100x (D). Staining: 
hematoxylin. Error bars represent standard error. 
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Figure 5: Differentiation block in CEABAC mouse colonie epithelium at 3 weeks of 
age. A) Mucin staining of colonic crypts of WT, CEABAC2, CEABACIO, and 
CEABAC20 mice shows a progressive1y decreasing number of visible purplish-colored 
differentiated goblet cells (indicated by an arrow in the CEABAC2 colonic crypt) 
correlated with increasing CEABAC transgene copy number. Lengthening of crypts, po or 
cryptaI alignment, increase of peri-cryptaI stroma, absence of bluish cytoplasm, 
abundance of small purplish mucinous vacuoles and elongation of nuc1ei are noted in 
CEABAC20 mice, indicating hyperplastic changes. Magnification: x 400. Staining: 
AB/P ASIMG. B) Number of normai-size goblet cells per crypt plotted against transgene 
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copy-number; each data point is significantly different from the others (P < 0.0001). 
35%,67% and 85% (95% after considering the 3-fold increase in crypt length) reductions 
relative to WT mice (i.e. 0 transgene copy) are obtained for CEABAC2, CEABAC10 and 
CEABAC20 mice, respectively. Error bars represent standard error. 
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Hyperplastic and Dysplastic Changes in CEABAC Colons 
A progressive shift with CEABAC dose towards a deranged tissue architecture 
featuring more mucosal tissue and less luminal space was seen in cross sections of colons 
from 3 week old transgenic mice (Figure 4D). This effect became quite dramatic in 
CEABAC20 mice by 3 months of age, where 100% of the mi ce showed grossly enlarged 
colons with crypts up to 10 times normal length and with virtually no central lumen 
(Figure 6). These mice were considerably smaller than normal (Figure lB), had persistent 
diarrhea and rectal bleeding, and died prematurely from the first weeks of life to about 9 
months maximum; aIl animaIs died with rectal prolapse. The effects were more 
pronounced in female, especially pregnant, mice than in males. 
Histological analysis of colonic mucosa from the 3 month old CEABAC20 mice 
showed a non-focal continuous mosaic of severe hyperplasia, crypt serration and 
dysplasia (Figure 7). Dysplastic features inc1uded colonocyte stratification, displaced 
nuc1ei with prominent nuc1eoli and loss of polarization. 
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Figure 6: Massive colonic tu mors in 3 month-old CEABAC20 mice. A) Cross sections 
of colons; note the much larger size of the CEABAC20 vs wild-type (WT) colons. B) 
Dramatic increase of colon mass and absence of fecal pellets in CEABAC20 over the 
entire colon. C) Colonie crypts; note the dramatic lengthening of intensely stained crypts 
in CEABAC20. Magnification: 40x (A), 100x (C). Staining: hematoxylin (A, C). 
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Figure 7: Histopathological findings in CEABAC20 tu mors including serrated 
adenomatous and dysplastic morphology. A) Longitudinal section of nonnal colonie 
crypts showing reduced nuc1ear-to-cytoplasmic ratio, c1ear cytoplasm and absence of 
differentiated goblet cells. B) Longitudinal sections of serrated colonie crypts showing 
upper third of the elongated crypts (left panel), sawtooth like in-folding at the mid-crypt 
(middle panel) and marked branching at the crypt base (right panel). C) Cross-section of 
a hyperplastic crypt (red arrow) showing numerous small mucinous vacuoles. D) 
Longitudinal section (left panel) and cross-section (right panel) of dysplastic crypts 
showing elongated nuc1ei and nuc1ear stratification (red arrow). There is also evidence of 
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myofibroblastic (spindle cell) proliferation in the lamina propria in C and D. 
Magnification: 400x. Staining: hematoxylin and eosin. 
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A further change, characteristic of neoplasia, was the inhibition of anoikis, the apoptotic 
process that normally removes cells that are not properly anchored to the extra-cellular 
membrane and which therefore acts as a quality control mechanism for tissue architecture 
(Frisch and Ruoslahti, 1997; Frisch and Screaton, 2001; Reddig and Juliano, 2005). If the 
CENCEACAM6-mediated disruption of tissue architecture is to persist, this process 
needs to be inhibited. In fact, crypts from 3 month old CEABAC20 mice showed 
anchorless cells in their lumens that were negative for staining by TUNEL assay; such 
cells were not seen in WT crypts (Figure SA). Moreover, protein extracts from 
CEABAC20 colonic mucosa showed less P ARP cleavage than from WT mucosa (Figure 
SB) suggesting that the proportion of cells undergoing apoptosis was less in the 
CEABAC20 mice than in WT mice. In addition, colonocytes purified from isolated 
crypts of even the reduced CEABAC dose CEABAC2 and CEABAC10 mice, when 
maintained in suspension, showed a dramatic reduction in apoptosis (Figures SC and SD). 
At the molecular level, the c1eavage of caspase-3, which represents a hallmark of 
apoptosis (Cory and Adams, 2002), was also reduced in the suspended CEABAC2 and 
CEABAC10 colonocytes (Figure SE). 
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Figure 8: Inhibition of apoptosis/anoikis in CEABAC mice. A) TUNEL assays on 
formaldehyde-fixed frozen sections of wild-type (WT) and CEABAC20 colons. Cyan 
(lighter staining): apoptotic nuc1ei; blue (darker staining): non-apoptotic nuc1ei. Note the 
presence of non-apoptotic anchorless cells in the crypt lumens of CEABAC20 colons 
(yellow arrow). Magnification: 400x. Staining: DAPI. B) Immunoblots of colon protein 
extracts for P ARP show reduced c1eavage product of P ARP (~P ARP) indicating an 
overall reduction of apoptosis in CEABAC20 mouse colons. C) TUNEL assays on 
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purified colonocytes show a marked inhibition of anoikis of CEABAC colonocytes 
compared to WT colonocytes after 3 hours in single cell suspension. Negative control 
(freshly purified WT colonocytes) is completely TUNEL negative. Positive control 
(freshly purified WT colonocytes treated with DNAsel) is TUNEL positive. D) Apoptotic 
indices estimated from 3 independent experiments shown in C (total cell count of 400 
cells) (P < 0.0001 by Fisher's test). E) Immunoblots of colonocyte lysates from anoikis 
experiment for caspase-3 show a baseline cleavage of caspase-3 (~Caspase3) at time 0 
(freshly purified colonocytes) and a marked reduction of caspase-3 cleavage at time 1 hr 
(after 1 hour in single cell suspensions) for CEABAC mice, indicating inhibition of 
anoikis in the CEABAC colonocytes. 
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Discussion 
The fact that CEA and/or CEACAM6 are over-expressed in so many human 
cancers has led us and others to suggest that this effect could contribute to tumorigenesis 
(Duxbury et al., 2004d; Ilantzis et al., 2002; Johnson, 1991; Scholzel et al., 2000a; 
Stanners, 1998). However, the normally elevated expression of these molecules in 
differentiated epithelial cells presents a conundrum. Although evidence for tumorigenic 
effects of CEA and CEACAM6 has been documented in many diverse systems in vitro 
(see Introduction), the latter could be criticized for being model systems that fail to 
represent the real situation in vivo. This study, however, utilizing transgenic mice 
expressing human CEA and CEACAM6 genes with the human tissue specific pattern but 
with increasing expression levels to the point of those found in human carcinomas, 
represents perhaps the closest approximation to the human situation yet investigated. The 
results were striking in that purified colonocytes from these mice showed 
CEAICEACAM6 expression leve1-dependent molecular changes involving integrin 
activation similar to those documented in the in vitro systems; tumorigenic cellular 
changes were observed such as increased proliferation and inhibition of differentiation 
and anoikis/apoptosis; and, finally, these cellular changes were mirrored by dramatic 
changes in colonie tissue architecture featuring severe hyperplasia and dysplasia, to the 
point of rendering the entire colon a massive tumor-like structure. The resolution of the 
above conundrum is suggested to be that elevated expression of CEAICEACAM6 in 
colonocytes prior to their differentiation and loss of division potential is required for the 
manifestation of their tumorigenic effects. 
Molecular Basis of Tumorigenic Changes 
We suggest that the initial molecular events involved in these effects consist of 
clustering of membrane microdomains that specifically contain CEA and CEACAM6, 
integrin a5 /31, and a limited repertoire of cytoplasmic signaling elements, including ILK, 
PI-3K and AKT. The co-clustering causes integrin a5/31 to become activated, along with 
the PI-3K1 AKT pathway, by successive waves of inside-out and outside-in signaling 
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(Ginsberg et al., 2005; Humphries et al., 2003; Hynes, 2002) resulting in inhibition of cell 
differentiation and anoikis and stimulation of cell proliferation - the latter previously 
documented by other groups to be caused by integrin activation (Janes and Watt, 2006; 
Liu et al., 2004; Park et al., 2006; Wang et al., 2002). Much of the evidence for this 
suggested model cornes from detailed studies of the more experimentally amenable in 
vitro systems (Camacho-Leal et al., 2007; Duxbury et al., 2004a) and the fact these are 
mirrored by key changes in purified colonocytes from the CEABAC transgenics implies 
that it could apply there too. 
The question arises as to whether these effects could have been due to a random 
insertional mutation of an endogenous gene rather than to direct effects of the elevated 
expression levels of CEA and CEACAM6. The former is unlikely, however, for the 
following reasons. First, random mutation of endogenous genes by transgenesis is an 
uncommon event (Rijkers et al., 1994). Secondly, the probability of mutation of a gene 
resulting in an anticipated effect, i.e., specifically colorectal tumorigenesis, is even lower. 
Third, to our knowledge, such dramatic tumorigenic effects have never been reported in 
any knockout models. Lastly and most importantly, both independently produced 
transgenic lines (CEABAC2 and CEABACI0), which would have different sites of 
integration, showed similar tumorigenic changes directly related quantitatively to 
expression level. 
It is not c1ear from this work, however, which of the CEACAMs present in the 
CEABAC are responsible for these effects. Since, as in humans, CEACAM7 is expressed 
only at very low levels in these transgenics' colons (Chan and Stanners, 2004) and is 
under-expressed rather than over-expressed in human colorectal cancers (Hammarstrom 
et al., 1998), and CEACAM3 is not at all expressed in the colon (Chan and Stanners, 
2004; Hammarstrom et al., 1998), it seems very likely that CEA and/or CEACAM6 are 
responsible and, in fact, both of the latter genes have been shown to elicit tumorigenic 
effects in various model systems in vitro and in xenograft mouse models (Duxbury et al., 
2004d; Eidelman et al., 1993; Gangopadhyay et al., 1996; Ilantzis et al., 2002; Ilantzis et 
al., 1997; Leconte et al., 1999; Ordonez et al., 2000; Rojas et al., 1996; Soeth et al., 2001; 
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Wirth et al., 2002). It is possible that over-expression of bath CEA and CEACAM6 are 
required for these effects in vivo, which would explain the failure to see them in CEA-
only transgenics (Clarke et al., 1998; Eades-Perner et al., 1994; Thompson et al., 1997), 
although it is equally possible that the CEA colonocyte expression levels in the latter 
were too low or that the CEACAM6 expression is the key e1ement. 
With the likely assumption that the effects are due to CEA and CEACAM6, 
c1ustering of these molecules as their concentration increases by self-binding of their 
adhesive external domains (Taheri et al., 2003) is suggested to be the initial event leading 
to the changes in cellular state observed here. This suggestion is supported by previous 
work with several cell Hnes expressing a CEA mutant that is defective in self-binding. 
None of the molecular events, inc1uding integrin a5~ 1 activation, or the cellular events, 
inc1uding inhibition of differentiation were produced by this mutant, but all these events 
were promptly restored by cross-linking with specific antibodies (Camacho-Leal et al., 
2007; Taheri et al., 2003). In this study, the tumorigenic effects were strongly gene dose 
dependent, which would be expected if they depended on self-binding and c1ustering, 
which would be a positive power function (at least a square function) of cell surface 
molecular concentration. It is of interest that the CEABAC2 and CEABAC 1 0 mice which 
showed more moderate colonic changes, were nevertheless much more prone to produce 
carcinogen-induced focal colorectal tumors than WT (Chan et al., 2007). 
Evidence for the involvement of integrin a5~ 1 activation, previously shown in in 
vitro systems, was obtained in the observation of a CEABAC dose-dependent increase in 
the colonocyte surface concentration of this integrin relative to WT littermates and 
integrin a2 surface concentration. We speculate that this increase is due to an initial 
activation of integrin a5 ~ 1, as observed in vitro, followed by an increase in cell surface 
level, a positive feedback controlloop previously documented for integrins in many other 
systems (Bretscher, 1989; Bretscher, 1992; Caswell and Norman, 2006). If so, it could 
imply that the colonocyte integrin a5J31 molecules are not only increased in number but 
also in activation state, although this would obviously require direct confirmation. The 
CEABAC mouse colonocytes showed evidence for activation of the AKT pathway but, in 
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preliminary experiments, no evidence for activation of the Wnt-signaling pathway could 
be demonstrated, in that no nuc1ear accumulation of ~-catenin was seen (Chan and 
Stanners, unpublished data). 
Relevance to Human Colon Carcinogenesis 
The most striking and unexpected feature of the present results is first, the 
magnitude of the effects, which are arguably greater than those seen for any single 
oncogene or inactivated tumor suppressor gene expressed in animaIs and second, the fact 
that this tumorigenic phenotype involves the entire colon in a diffuse mosaic pattern of 
changes (Figures 6 and 7) in 100% of the CEABAC20 mice. CEA, and possibly 
CEACAM6, over-expression has been shown to be mutagenic (Chan et al., 2007; 
Screaton et al., 1997) but, if random mutations were required, the neoplastic changes 
observed would be focal, as is the case for all other published mouse models with 
tumorigenic genetic alterations. The present case may bear sorne resemblance to that of 
mucin Muc2 de1etion in mice (Velcich et al., 2002), in which relatively small non-focal 
increases in proliferation and decreases in apoptosis were observed in the entire 
gastrointestinal tract; in this case, focal carcinomas appeared later in life, presumably due 
to secondary mutations. In the CEABAC20 mice, the primary changes are so dramatic 
that any focal carcinomas would likely have little selective growth advantage and, in any 
case, the animaIs tend to die from digestive complications before such outgrowths could 
occur. Rare survivors of greater than 6 months of age, which presumably had a slower 
progression towards the dramatic phenotype that most CEABAC20 mice demonstrate, 
showed focal outgrowth from the thickened epithelia, suggesting a possibility of the 
acquisition of secondary mutations although no significant histological changes were 
observed (data not shown). Rence, this dramatic initial non-focal feature suggests that 
human CEA and/or CEACAM6 alone are sufficient to initiate a tumorigenic phenotype. 
Since human colonie tumorigenesis is in fact focal, we suggest that, unlike the situation 
here where every cell has multiple copies of CEA and CEACAM6 genes, their over-
expression itself in the adult human colon could occur by focal up-regulation in 
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expreSSIOn as observed in the carcinogen-induced colon tumors III CEABAC2 and 
CEABAClO mice (Chan et al., 2007). 
Another interesting feature of these tumors was their resemblance to mixed 
hyperplastic polyps, serrated polyps and serrated adenomas in human patients (Goldstein, 
2006b; Jass, 2004b; Jass et al., 2002), which are subtypes of pre-cancerous lesions 
(Goldstein, 2006a; Jass, 2004a) that show increased expression of CEA (Baker et al., 
2004; Jass et al., 1984). In contrast to conventional adenomas in which perturbation of 
the Wnt-signaling pathway is commonly believed as the initiating event (Giles et al., 
2003; Kinzler and Vogelstein, 1996), this serration is a consequence of alteration in cell 
proliferation and apoptosis leading to inactivation of DNA repair genes by promo ter 
methylation and secondary mutations that cause tumor progression (Jass, 2004b; Jass et 
al., 2002). For example, BRAF activating mutations and CpG island hypermythelation 
are common genetic changes found in human serrated polyps (Beach et al., 2005; Chan et 
al., 2003; Kambara et al., 2004; Wynter et al., 2004). Thus, any gene product that 
increases cell proliferation and inhibits apoptosis could initiate a series of neoplastic 
events, called the serrated pathway (Jass, 2004b; Jass et al., 2002), without the 
involvement of the Wnt-signaling pathway. Based on the proliferative and anti-apoptotic 
effects of CEA/CEACAM6 shown in the CEABAC mice, it is not surprising that the 
over-expression of CEA/CEACAM6 could be a tumor initiating event (Figures 4 and 8). 
These mice represent the first animal model for this type ofhuman colorectal neoplasia. 
However, the non-focal concomitant dysplasia observed in the CEABAC20 mice 
requires comment. The traditional view is that hyperplasia is a dead-end state that does 
not progress to dysplasia. Although the serrated pathway allows such a transition, only a 
small proportion of hyperplastic lesions transform to dysplastic serrated adenomas after 
acquiring other gene mutations, such as hMLHl or MGMT (Jass, 2004b; Jass et al., 
2002). The frequent non-focal transition to dysplasia observed in CEABAC20 mice 
suggests that over-expression of CEA and/or CEACAM6 to a critical threshold level 
alone is sufficient to transform a normal epithelium to a state of dysplasia. Further 
108 
studies, including mutational analysis of many oncogenes, tumor suppressor genes and 
DNA repair genes are required to confirm this speculation. 
Significance for Human Cancer 
If these results can be extrapolated to human colorectal cancer, in which up-regulation 
of CEA and CEACAM6 occurs as an early event in adult colonic epithelium (Ilantzis et 
al., 1997; Pretlow et al., 1994; Scholzel et al., 2000a), the magnitude of the tumorigenic 
effects observed here would imply a very significant contribution to the malignant 
phenotype. Thus, clinically, cancer treatments should aim to reduce their levels and 
should not further up-regulate them to enhance tumor targeting. Perhaps more 
importantly, strategies designed to reverse their biological effects rather than to use them 
as inert targets should be considered. In fact, reduction of their expression has been 
shown to reverse sorne tumor phenotypes (Duxbury et al., 2004e; Jay et al., 2005; Soeth 
et al., 2001; Wirth et al., 2002)(Ilantzis et al., unpublished data) and to restore sensitivity 
to chemotherapeutic agents (Duxbury et al., 2004c) (Ordonez et al., unpublished data), as 
have declustering agents (Taheri et al., 2003) (Ilantzis et al., unpublished data). Thus, 
development of agents that inhibit expression and function of these proteins could prove 
beneficial to clinical practice. 
In summary, the previous two pieces of work pointed out the involvement of integrin 
associated signaling and integrin a5p 1 molecules themselves as important effectors 
implicated in CEA-mediated tumorigenic effects. Thus, in the next study, we decided to 
investigate the nature of CEA-associated signaling by a molecular analysis of the 
inhibitory effects of CEA on anoikis. 
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CHAPTER4 
The Human Carcinoembryonic Antigen (CEA)-GPI anchor specifies anoikis 
inhibition by inactivation of the intrinsic death pathway 
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Abstract 
Ruman carcinoembryonic antigen (CEA) is a cell surface adhesion molecule member of 
the Immunoglobulin Superfamily (IgSF). Up-regulation of CEA is a common feature 
found in a variety of human cancers such as colon, breast and lung. Previous in vitro and 
in vivo results have demonstrated that CEA tumorigenic effects implicate the inhibition 
of cell differentiation and anoikis, a specific type of apoptosis triggered by the absence of 
ECM-cell contacts. In the present work, we determinate the involvement of the caspase 
cascade in the CEA-mediated inhibitory effects on anoikis and the specificity of this 
signal. Expression of CEA and a chimeric protein consisting of NCAM extracellular 
domains attached to a CEA-GPI anchor correlate with an early inactivation of caspase-9 
and activation of the PI3-KlAkt survival pathway, and at later times, inactivation of 
caspase-8. The CEA-mediated caspase inactivation as well as activation of Akt was not 
observed by expression of a CEA molecule incapable of self-binding (ÔNCEA). These 
results suggest that the intrinsic caspase pathway is involved in the inhibitory effects of 
anoikis by CEA and this signal is dependent on the presence of self-adhesive 
extracellular domains and a CEA-GPI anchor. 
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Introduction 
Cell attachment to specifie extracellular matrix (ECM) components has been 
shown to induce signal transduction cascades inside the cell that ultimately control cell 
growth, differentiation, and cell death (Giancotti and Ruoslahti, 1999). Disruption of cell-
ECM contacts triggers a specific type of apoptosis termed anoikis (Frisch and Screaton, 
2001; Reddig and Juliano, 2005; Stupack, 2005) which has been observed in various 
types of adherent cells such as intestinal (Grossmann et al., 2001), epidermal (Marconi et 
al., 2004; Tiberio et al., 2002), fibroblast (Nho et al., 2005; Tian et al., 2002) and prostate 
cells (Rennebeck et al., 2005). 
The anchorage of cells to ECM is mainly mediated by integrin receptors leading 
to a ligand-dependent activation oftwo major downstream signaling pathways implicated 
in cell survival, the RafIMAPK and the PI3-KlAkt cascades (Frisch and Ruoslahti, 1997; 
Stupack and Cheresh, 2002). As in most apoptotic pathways, anoikis protection by 
integrins has been shown to be controlled by regulation of the caspase cascade (Gilmore, 
2005), although sorne studies have demonstrated the absence of caspase activation during 
early events in the anoikis program (Wang et al., 2003). Integrin-dependent caspase 
regulation occurs via both the intrinsic and extrinsic death pathways (Frisch, 1999; 
Grossmann, 2002; Grossmann et al., 2001; Marconi et al., 2004; Miyazaki et al., 2004; 
Rytomaa et al., 2000; Rytomaa et al., 1999; Valentijn and Gilmore, 2004). Whereas the 
intrinsic pathway involves mitochondrial permeabilisation and release of cytochrome C, 
leading to apoptosome formation and a proteolytic complex formed by caspase-9, 
cytochrome C and the scaffold protein Apafl (Boatright and Salvesen, 2003), the 
extrinsic death pathway results in activation of caspase-8 and 10 (Boatright and Salvesen, 
2003). 
GPI-anchored carcinoembryonic antigen (CEA) family members, CEA and 
CEACAM6, belong to the human CEA family and are normally mainly expressed in the 
gastrointestinal tract (Hammarstrom, 1999; Stanners, 1998), but are over-expressed in 
70% of all human cancers (Nollau et al., 1997; Rosenberg et al., 1993). It has been 
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demonstrated that essentially all CEA family members, inc1uding GPI-anchored CEA and 
CEACAM6, function as homotypic intercellular adhesion molecules in vitro (Benchimol 
et al., 1989; Oikawa et al., 1989; Stanners, 1998). In contrast with the transmembrane 
member CEACAM1 (Eide1man et al., 1993; Ilantzis et al., 2002; Rojas et al., 1996; 
Taheri et a1., 2003), CEA/CEACAM6 over-expression inhibits cell differentiation and 
anoikis in vitro (Duxbury et al., 2004d; Eidelman et a1., 1993; Ordonez et al., 2000; 
Screaton et al., 2000; Soeth et al., 2001; Taheri et al., 2003) and in vivo (Chan et al., 
2007). The molecular basis of CEA inhibitory effects on differentiation were 
demonstrated by structural studies of the CEA molecule (Screaton et al., 2000; Taheri et 
al., 2003). The latter established that the CEA-specific GPI-anchor was crucial for its 
inhibitory effects (Screaton et al., 2000) as weIl as self-adhesive extracellular domains 
(Taheri et al., 2003). Subsequent findings showed that activation of the integrin a5p1 
was involved in these inhibitory effects (Ordonez et al., 2007) and that integrin activation 
via CEA results from co-c1ustering integrin molecules upon CEA c1ustering in membrane 
microdomains (Camacho-Leal et al., 2007). Associated-integrin specifie signaling 
elements, such as those involved in the PI3-K and the MAPK signaling pathways, were 
also activated upon CEA cross-linking (Camacho-Leal et al., 2007). 
In the present work we initiated a study to define the molecular mechanism by which 
CEA mediates its inhibitory effects on anoikis and the structural requirements for these 
effects. We found that, as with differentiation inhibition, self-adhesive extracellular 
domains linked to a CEA-specific GPI anchor are required for anoikis inhibition. The 
intrinsic caspase signaling pathway involving PI3-K and Akt activation was implicated in 
the blockage of anoikis by CEA. We observed that CEA prevented initially the activation 
of caspase-9 and the release to the cytoplasm of cytochrome-c and, at later times, 
inhibited the activation of caspase-8 and caspase-3. Pharmacological inhibition ofPI3-K 
but not MAPK could partially reverse the CEA-mediated inhibition of caspase activation. 
The previous results suggest that CEA induces an early inactivation of the intrinsic 
apoptotic pathway mediated by the inhibition of the PI3-KlAkt survival pathway. 
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Materials and Methods 
Antibodies and Inhibitors 
The following antibodies were purchased from Cell Signaling: polyc1onal anti-caspase-3 
Ab, which recognizes endogenous levels of human, mouse and rat full length caspase-3 
(35 kDa) and the large fragment of caspase-3 resulting from c1eavage (17 kDa); 
polyc1onal anti-caspase-9 Ab which detects endogenous protein expression levels of rat 
fulliength caspase-9 (51 kDa) and large fragments of caspase 9 (17, 38, 40 kDa); and 
rabbit anti-Akt polyc1onal antibody, which detects total, phosphorylation-state 
independent Aktl, Akt2 and Akt3 proteins and anti-phospho Ser 473 Akt polyc1onal Ab 
(detects endogenous levels of Aktl only when phosphorylated at Ser473 and also Akt2 
and Akt3 when phosphorylated at the corresponding residues). Polyc1onal anti-
cytochrome-c Ab (H-104), which detects rat cytochrome-c was obtained from Santa Cruz 
Biotechnology. The pharmacological inhibitors PD098059 (MAPK specifie inhibitor) 
and L Y29002 (PI3-K specifie inhibitor) were purchased from Sigma. 
Celllines and culture conditions 
L6 rat myoblasts (Yaffe, 1968) were grown in mono layer cultures in DMEM containing 
10% fetal bovine serum (FBS, Invitrogen) supplemented with 100 J.lg/ml streptomycin 
and 100 U/ml penicillin (Invitrogen) (growth medium: GM), at 37°C in a humidified 
atmosphere with 5% C02. Cultures with subconfluent proliferating cells were used for aIl 
experiments. In order to induce anoikis, 1.5 ml at 2XIQ5 cells/ml were cultured in 
suspension using ultra low cell attachment hydrogel plates (Coming) for the indicated 
times. 
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Cell Transfection and Infection 
Transfection procedures were carried out as previously described (Eidelman et al., 1993; 
Screaton et al., 2000). Briefly, stable L6 transfectants were obtained by the calcium 
phosphate precipitation method after co-transfection with the p9l023B expression vector 
(Screaton et al., 2000) containing full length cDNAs encoding cell adhesion proteins 
CEA, CEACAMl-4L, NCAM (GPI-linked NCAM splice variant with muscle specific 
domain), CEA deletion mutant dNCEA [lacking the last 75 amino acids of the N-domain 
(Oikawa et al., 1991)] (Taheri et al., 2003), and the N-C chimeric protein, consisting of 
the external domain of NCAM attached to the processed carboxy-terminal domain of 
CEA which determines the CEA-specific GPI anchor (Screaton et al., 2000) and 
pSV2neo plasmid as a dominant selectable marker. Resistant clones were pooled after 
selection with 400j..lglml neomycin (G4l8, GIBCO) or puromycin (Sigma) for N-C 
transfectants, except for the L6 (dNCEA) transfectant that was a single colony obtained 
by neomycin selection. 
Bcl-2 expressing L6 cells were obtained by cell retroviral vector infection as previously 
described (Screaton et al., 1997). Briefly, cells were incubated with replication-defective 
recombinant retrovirus containing pBABe (hum an bcl-2) puro (Zhu et al., 1996) or the 
vector alone in a-MEM medium plus 10% FBS supplemented with 8j..lglml polybrene for 
2 h at 37°C. Cultures were incubated overnight with GM and after 24 h they were 
subjected to puromycin selection (2j..lglml) for 7days. Resistant clones were pooled and 
cultured without selection. Bcl-2 expression was verified by western blot analysis (data 
not shown). 
Caspase activity assays 
A caspase-8, -9 and -3 colorimetric activity kit from CHEMICON was used to determine 
the activity of each one of these caspases. Briefly, after 12 or 24 ho urs of culturing L6 
cells in suspension, 2 X 106 L6 transfectant cells were resuspended in 250 j..ll of chilled 
IX celllysis buffer provided with the kit. Cells were incubated on ice for 10 min and then 
centrifuged for 5 min. Supernatant was collected (cytosolic extract) and protein 
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concentration was determined by the Bradford protein assay (Pierce). Between 50-100 Jlg 
ofprotein was incubated for 2-3 hours at 37° C with either caspase-8, -9 or -3 substrate. 
Samples were read at 405 nm in a microtiter plate reader. Background readings of the 
substrate sample alone were subtracted from the readings of experimental samples. 
Preparation of cytosolic fractions for cytochrome c 
Cytosolic fractions were obtained as previously described (Rytomaa et al., 2000). Briefly, 
attached cells or cells cultured in suspension after 8, 12 or 24 h were washed and then re-
suspended in 100JlI of mitochondrial buffer containing 70 mM Tris base, 25 M sucrose 
and 1 mM EDTA at pH7.4. An equal volume of digitonin dissolved at 0.2 mg/ml in MES 
buffer (19.8 mM EGTA, 19.8 mM EDTA, 25 M mannitol and 19.8 mM MES pH 7.4) 
was added to the cens for 5 min on ice. After centrifugation of the latter for 5 min at 900 
g for 2 min, the resulting supernatant was further centrifuged at 20,000 g for 5 min to 
obtain the cytosolic fraction. The presence of cytochrome-c on the cytosolic fractions was 
evaluated by western blot analysis. 
Terminal Deoxynucleotidyl Transferase (TdT) Nick End labeling 
(TUNEL) 
Apoptotic cells from suspension cell cultures of L6 transfectants were detected by the 
TUNEL assay according to the protocol provided by the APOAlert™ DNA 
Fragmentation Assay Kit from BD Biosciences. Apoptotic cens were visualized using a 
Nikon TE300 microscope with a Bio-Rad Radiance 2000 confocal accessory. As a 
positive control for detection of DNA fragmentation, cens were treated with DNAse 1 
before TUNEL. As a negative control, terminal transferase was omitted from the TUNEL 
reaction. The apoptotic index was calculated by scoring the percentage of apoptotic-
TUNEL positive cells with respect to the total cell count (200-300 cells). 
116 
Western blot analysis 
Total cell lysates or cytosolic fractions were subjected to SDS-P AGE and transferred 
e1ectrophoretically to 0.45 !lm PDVF membranes (Millipore, Bedford, M.A.). Western 
blotting of caspase-3, caspase-8, cytochrome-c and Akt was applied at the indicated times 
in L6 cell suspension cultures. Following extensive washing, blots were developed with 
HRP-conjugated antibodies and visualized using ECL reagent according to the 
manufacturer's instructions (Amersham Life Sciences). 
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Results 
Structural requirements for inhibition of anoikis by CEA 
The inhibitory roi es of CEA in cell differentiation (Chan et al., 2007; Eidelman et 
al., 1993; Screaton et al., 1997; Taheri et al., 2003) and anoikis (Chan et al., 2007; 
Duxbury et al., 2004d; Ordonez et al., 2000; Soeth et al., 2001) have been extensively 
documented. Structural studies indicated that the CEA-specific GPI-anchor attached to a 
selfbinding external domain was necessary and sufficient for its inhibitory effects on cell 
differentiation (Screaton et al., 2000). Expression of a chimeric protein (N-C) consisting 
of a CEA GPI-anchor fused with the self-binding external domain of Neural Cell 
Adhesion Molecule (NCAM), another immunoglobulin superfamily member which 
normally allows cell differentiation to occur, blocked this process (Screaton et al., 2000). 
Additional studies showed that self-association of CEA extracellular domains was also 
important for the inhibition of cell differentiation by CEA (Taheri et al., 2003), since 
expression of a CEA mutant lacking a major portion of CEA N-domain (~NCEA), 
ineluding the subdomains required for self-binding, failed to inhibit differentiation, 
whereas artificial elustering of ~NCEA molecules by antibody-mediated cross-linking 
restored the CEA inhibitory block (Taheri et al., 2003). 
Using the N-C chimeric protein described above (Screaton et al., 2000) and the 
CEA mutant ANCEA (Taheri et al., 2003), it was possible to determine whether, as with 
differentiation inhibition, the presence of the CEA GPI-anchor attached to a self-binding 
extracellular domain was required to confer anoikis resistance. L6 myoblasts were 
cultured in suspension for 48 h in GM, as previously described (Ordonez et al., 2000), 
and the proportion of apoptotic cells was determined by TUNEL staining (Fig. lA). As 
shown previously, CEA transfectant cells were less prone to undergo anoikis than 
parental cells (Ordonez et al., 2000). A reduced proportion of apoptotic cells was found 
in cell populations expressing Bel-2, which has been shown to have anti-apoptotic effects 
under conditions that induce anoikis (Frisch and Screaton, 2001); this transfectant was 
used as a positive control for aIl experiments. TUNEL staining in cells expressing 
~NCEA, CEACAMI or NCAM, as the parental ceIls, showed increased levels of anoikis 
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induction, whereas cells expressing the chimeric protein consisting of the CEA-GPI 
anchored fused to NCAM (N-C) self-binding extracellular domains inhibited apotosis as 
observed in cells expressing CEA itself (Fig. lB). 
Activation of cysteine protease caspase-3 is a hallmark of apoptosis, and its activation has 
been implicated as part of the anoikis cascade (Reddig and Juliano, 2005). In the absence 
of apoptotic stimuli, caspases are present in the cell as latent precursors or "procaspases"; 
for their activation, a proteolytic process of the inactive zymogen is required (Boatright 
and Salvesen, 2003). We therefore evaluated caspase-3 activation by detection of its 
c1eaved product (17 kDa) by western-blot analysis in attached L6 transfectant cells and in 
cells incubated in suspension for 12 h, 24 h (Fig. lC) and 36 h (data not shown). Western 
blot analysis detected the full length 35 kDa caspase-3 molecule in attached cells, 
whereas c1eaved 17 kDa caspase-3 product was detected in parental L6 cells as early as 
after 12 h ofanoikis induction. Cleavage was evident in many of the transfectants after 24 
h. Complete proteolysis of caspase-3 was observed at 36 h for all the celllines (data not 
shown). Densitometric analysis of the Western blots was used to determine the 
percentage of c1eaved caspase-3 fragment with respect to the total caspase levels (full-
length caspase, plus c1eaved fragment) (Fig. lC). The latter results correlated with the 
TUNEL assay data, since CEA and N-C expressing cells showed less caspase-3 c1eavage 
and presumably caspase-3 activation, in contrast to NCAM, CCI and ~NCEA 
transfectants. To confirm further these results, caspase activity by a spectophotometric 
assay was evaluated (Fig ID). Caspase-3 activity increase was also found to be partially 
prevented by the presence of proteins containing self-binding extracellular domains 
attached to the CEA GPI-anchor, but not by expression of ~NCEA, NCAM or CCI. 
These results thus show that caspase-3 activation mirrors the results obtained with the 
TUNEL assay and confirm that the presence of the CEA-GPI anchor linked to self-
adhesive extracellular domains is required for anoikis inhibition. 
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Figure 1 The CEA-GPI anchor and self-adhesive extracellular domains are 
required for CEA-mediated anoikis inhibition via inactivation of caspase-3. 
Apoptotic L6 parental and transfected cells detected by positive staining using the 
TUNEL assay from cell populations suspended for 48 h in ultra low attachment hydrogel 
plates (A). The apoptotic index was calculated by scoring the percentage of Tunel-
positive cells with respect to the total cell count (+/- SD *p<O.006) (B). Western blot 
analysis of caspase-3 c1eavage product (C) and caspase-3 activity assays (+/- SD 
*p<O.OOI)(D) from suspended L6 transfectants after 12 h (C) and 24 h (C, D) under 
detachment conditions. Three independent experiments were performed with similar 
results. 
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CEA expression prevents the release of cytochorome-c and the 
activation of caspase-9. 
Caspase-3 activity represents a late event in the apoptotic process, since activation 
of initiator caspases -2, -8, -9 and -lOis required for caspase-3 activation (Boatright and 
Salvesen, 2003). In order to determine whether caspase-9 activation was affected by 
CEA, we evaluated the activation of caspase-9 after 12 and 24h of cell incubation in 
suspension both by western blot (Fig. 2A) and activity assays (Fig. 2 B,C). Western blot 
analysis showed that CEA expression and the presence of the CEA-GPI anchor in N-C 
but not NCAM, CCI or ilNCEA expression, markedly inhibited caspase-9 activation at 
24h after anoikis induction (Fig. 2A), since the appearance of eleaved caspase-9 fragment 
(17 kDa) was partially prevented in CEA and N-C expressing L6 cells. In contrast to 
caspase-3, caspase-9 activation occurred as early as 12 h after anoikis induction (Fig 2A). 
In agreement with the latter results, a reduced caspase-9 activity was also observed at the 
same time points upon CEA and N-C expression (Fig. 2B,C). 
The release of cytochrome-c from the mitochondria into the cytosol is a hallmark 
of apoptosis induced by caspase-9 activation. Since we observed that expression of CEA 
inhibited caspase-9 activity, we decided to explore the involvement of cytochrome-c 
release as a possible part of the apoptotic mechanism inhibited by CEA. In order to 
evaluate this possibility, cytosolic fractions were obtained and cytochrome-c levels 
evaluated by western blot analysis in all transfected celllines. Fig 2D shows, as expected, 
no cytochrome-c release into the cytosol in attached cells whereas, after 12 h of anoikis 
induction, cytochrome-c was detected at markedly lower levels for bel-2, CEA or N-C 
expressing cells. Released cytochrome-c levels were shown to increase after 24 h of 
anoikis induction (Fig 2D). These results demonstrate that CEA expression inhibits the 
intrinsic death pathway by preventing cytochrome-c release and the subsequent activation 
of caspase-9. These effects correlated with the presence of the CEA GPI-anchor and self-
adhesive extracellular domains. 
123 
-N ~ 
~~~~f!i~ 
:t.j":t.~c.'i'" 
;::::; Il"'; 0 n ::::s 0 
IV 
... 
::r !:# ~ 
bcl-2 
L6 
CEA 
~CEA 
NCAM 
N-C 
CCI 
cyt:-c12h 
Rd.ativeintensity(notn1alizedtoactÎ1'l) 
Q._ •.. ~--=-... ~ ..... ~_._.~ .. _.:_ .. ~:._.~ 
bcl-2 
L6 
CEA 
ANCFA ~;;;;;;~ 
NCAM ':::::::~mErnI 
N-cli 
CCI j!mmEmEEmEEmErnI 
o 
% of cleaved caspase-3 
fragment 
~ 9 6 ~ ;S g ~ 
n 
Relative caspase actvity 
(arbitrary unil~) 
Po:=> 
o 5: ;.... ;; e !'> ~ 0 
IV 
..j;;;:. 
~ 
V) >-~ ::!: 
....... 
IV 
::r 
>-
bcl-2 
L6 
CEA 
LlNCEA 
NCAM 
N-C 
CCI 
Relative caspase actvity 
(arbitrary unils) 
t:C 
~ e ~ 
control f--~·_·_~··_···· control 1 
.-111* bcl-2 ._< * L6 
CHA 
àNCEA 
NC~i~!IiI!i\i!ii!lil!i\i!ii!lil!i\i!ii!lil!i\i!ii"'" 
* 
CCI Itm-----. 
N 
-1>-
0-
bcl-2 
L6 
CEA "'miiilmiiill-ol * 
àNCEA 
-N 
NCAM 0-
N-C 
* 
CCI 
Figure 2 CEA inhibits the intrinsic death pathway through inhibition of caspase-9 
activation and cytochrome-c release. Caspase-9 c1eavage product was detected by 
immunoblot analysis of lysates from attached cells, and from suspended cells 12 and 24 
hours after detachment (A). Caspase-9 activity was measured in suspended L6 
transfectants after 12h (+/- SE *p< 0.003) (B) and 24 hours (+/- SE *p< 0.0001) (C) of 
anoikis induction. In D, cytochrome-c levels were evaluated in cytosolic fractions from 
attached L6 transfectants and from such cells after 12 and 24 h in suspension. Means of 
three independent experiments are shown (B, C) and representative results out of three 
independent experiments are shown in (A, D). 
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Caspase-8 inactivation induced by CEA occurs later in the apoptotic 
process 
During the extrinsic death pathway, ligation of death receptors such as TNF or 
Fas on the cell surface promotes the assembly of the death-inducing signaling complex 
(DISC). This complex recruits and activates caspase-8 via the death receptor FADD. 
Sorne studies have shown that F ADD and an early activation of caspase-8 are invo1ved in 
the anoikis process (Frisch, 1999; Miyazaki et al., 2004; Rytomaa et al., 1999). In sorne 
cases, cross-talk between the intrinsic and extrinsic pathways occurs upon caspase-8 
activation, through bcl-2-like protein Bid and subsequent activation of the cytochrome-c 
(Stupack and Cheresh, 2002). We therefore decided to explore the contribution of the 
extrinsic death pathway during the CEA-mediated block of anoikis. Activity assays for 
caspase-8 were performed after 12 and 24 h of anoikis induction. In contrast to the effects 
of CEA and N-C expression observed on caspase-9 at 12 h (Fig 2B), specifie differences 
in caspase-8 activation were observed only after 24 h of suspension culture (Fig 3B). 
Caspase-8 activation was partially prevented by CEA and N-C expression whereas 
control NCAM, CC 1 and ~NCEA expression showed no such inhibition of caspase-8 
activity leve1s (Fig 3B). The latter results thus demonstrate that CEA also inhibits the 
activation of caspase-8 induced by 10ss of anchorage and that this inhibition seems to 
occur 1ate in the apoptotic process, presumably after inhibition of caspase-9 activation 
and cytochrome-c re1ease. 
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Figure 3 CEA-mediated inhibition of caspase-8 activation occurs late in the anoikis 
program. Activity assays for caspase-8 were evaluated in 12 h (+/- SE *p<O.0009) (A) 
and 24 h (+/- SE *p<O.003) (D) suspended L6 transfectant cultures. The results are the 
mean of three independent experiments. 
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Inhibition of the PI3-K cascade but not MAPK reverses the caspase-9 
inactivation induced by CEA expression 
We previously demonstrated that activation of the PI3-KlAkt and MAPK 
signaling cascades are involved in the integrin activation induced by crosslinking of 
~NCEA (Camacho-Leal et al., 2007). We therefore investigated the status of Akt and 
MAPK after inducing anoikis by suspension culture. Transfectant L6 celllysates obtained 
from attached cells and cells cultured in suspension were evaluated for Akt 
phosphorytation at ser 473 with a specific anti-phospho ser 473 Akt polyc1onal Ab by 
western blot analysis (Fig 4). As observed previously, Akt phosphorylation levels 
remained unchanged in attached cells regardless of CEA expression (Fig 4). After 12 h 
under detachment conditions, the levels of phosphorylated Akt were higher for bcl-2, 
CEA and N-C expressing cells than for parental L6 cells and for ~NCEA, NCAM and 
CCI transfectants. No effects were seen for MAPK phosphorylation (data not shown). 
These results suggest that Akt activation may be implicated in the anoikis inhibition 
mediated by CEA. 
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Figure 4 Activation of Akt correlates with CEA expression during anoikis. Total Akt 
and Akt phosphorylated on Ser 473 were evaluated by western blot analysis in L6 
transfectants in attached cells and after 12 hours of anoikis induction. This experiment 
was repeated three times with identical results. 
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Previous results generated in our laboratory implicated the PI3-KlAkt cascade as 
part of the CEA-associated signaling (Camacho-Leal et al., 2007). To test for a possible 
role of the PI3-KlAkt signaling pathway in the CEA-mediated caspase-9 and -3 
attenuation associated with anoikis inhibition, the effect of the specific inhibitor ofPI3-K, 
L Y29002, was evaluated. Cells were treated for 24 hours under suspension conditions 
with 50/-lM of L Y29002 or, as specificity control, 30/-lM of the MAPK specific inhibitor 
PD098059; cell lysates were then evaluated for caspase-9 (Fig. 5A) and caspase-3 
c1eavage (Fig. 5B) by western blot analysis using specific caspase mAbs. Densitometric 
analysis of caspase-9/-3 westernblots, giving the percentage of caspase-3/9 c1eaved 
fragment with respect to the total caspase levels, demonstrated that cell treatment with 
LY29002 could partially reverse the caspase-9/-3 inactivation induced by CEA and N-C 
expression. No effects were observed for the PD098059 inhibitor. It is interesting to note 
that the bc1-2-mediated caspase block was not prevented by inhibition of either of these 
signaling pathways. 
Thus, the latter results suggest that activation of the PI3-KlAkt pathway is 
involved in the CEA-mediated inactivation of caspase-9/-3, although the fact that the PI3-
KI Akt inhibition only partially reversed the effect of CEA, suggests that additional 
survival signaIs may be involved in the CEA-mediated anoikis inhibition. 
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L Y294002 or 30llm ofthe MAPK inhibitor, PD098059 for 24 h under detachment 
conditions. Results shown are representative ofthree independent experiments. 
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Discussion 
Although it is well documented that CENCEACAM6 expression can inhibit the 
anoikis ofhuman colorectal carcinoma cells (Ordonez et al., 2000; Soeth et al., 2001) and 
human pancreatic carcinoma cells (Duxbury et al., 2004d), an effect that it is not 
produced by the transmembrane-anchored CEA-family member CEACAM1 or the GPI-
anchored variant of the immunoglobulin superfamily member adhesion molecule, 
NCAM, (Ordonez et al., 2000), the molecular mechanism implicated in this inhibitory 
effect remains unc1ear. This study was focused on the molecular mediators associated 
with the anoikis resistance conferred by CEA expression. 
Although in sorne cases early activation of the anoikis pro gram can occur in the 
absence of caspase activation (Valentijn and Gilmore, 2004; Wang et al., 2003), the latter 
mechanism represents an important event involved in anoikis regulation (Frisch and 
Screaton, 2001; Gilmore, 2005; Stupack and Cheresh, 2002). Recently, the increase in 
anoikis susceptibility of pancreatic carcinoma cells produced by CEACAM6 siRNA gene 
silencing was shown to be associated with an increase in caspase-8 and caspase-3-
activities (Duxbury et al., 2004d). Our findings indicate that, in the case of CEA 
expression, there is also an associated caspase-mediated anoikis resistance, since we 
observed a partial inactivation of caspase-3 (Fig. 1 C) which correlated with anoikis 
inhibition by CEA (Fig lA). Although CEA expression partially induced the inactivation 
of caspase-8 (Fig 3), our data support a more prominent contribution of the instrinisc 
pathway, since we observed a CEA-mediated inhibition of cytochrome-c release from the 
mitochondria into the cytosol (Fig. 2D) and an inactivation of caspase-9 (Fig 2 A,B,C), 
whereas caspase-8 inactivation occurred later during the anoikis process (Fig 3). It is 
known that cross-talk between the intrinisc and extrinsic pathways occurs through 
c1eavage of the BH3-only protein Bid, generating the truncated form of Bid, t-Bid (Deng 
et al., 2002; Li et al., 1998; Luo et al., 1998). t-Bid then translocates to the outer 
mitochondrial membrane and promotes oligomerization of Bax or Bak to facilitate 
release of cytochrome-c and subsequent caspase-9 activation (Li et al., 1998; Luo et al., 
1998). In addition, a caspase-9-mediated caspase-8 activation has been reported in certain 
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cell systems (Cha et al., 2001; Viswanath et al., 2001). Although our results show clearly 
the involvement of both caspase pathways in the anoikis inhibition induced by CEA, 
further studies are required to establish whether caspase-8 inactivation represents an 
independent pathway to that of caspase-9, or cross-talk between these two pathways 
gives a caspase-9-dependent inhibition of caspase-8 activity. 
Previous structural studies of the CEA molecule demonstrated that the CEA-GPI 
anchor and homophilic binding of its extracellular domains were required to inhibit cell 
differentiation (Screaton et al., 2000; Taheri et al., 2003). In this work, results obtained 
with the GPI-anchored isoform ofNCAM, the N-C chimeric protein (the NCAM external 
domain attached to the CEA GPI anchor) and the ~NCEA mutant (with a deletion in the 
external domain preventing self-binding) showed that these structural requirements were 
also applicable for the CEA-mediated anoikis inhibition (Fig 1). Thus the inactivation of 
caspase-3 (Fig 1), -9 (Fig 2) and -8 (Fig 3) induced by CEA expression was also induced 
by the expression of N-C, whereas the expression of the ~NCEA mutant had no such 
effect. 
Our previous evidence supported a model for CEA signaling in which clustering 
of CEA GPI anchors in lipid rafts leads to a5 integrin clustering and activation followed 
by activation of the PB-KlAkt and MAPK signaling pathways (Camacho-Leal et al., 
2007). The role of the PB-KlAkt and MAPK cascades in cell survival mechanisms has 
been extensively documented (Frisch and Screaton, 2001). In addition, integrin activation 
has been shown to represent an important event in the regulation of the intrinsic and 
extrinsic death signaIs (Stupack and Cheresh, 2002). In this study we found that 
expression of CEA induced Akt activation during anoikis, and that this effect had the 
same structural requirements as CEA-mediated anoikis inhibition, i.e., required the 
presence of the CEA GPI-anchor and was not induced by the expression of the ~NCEA 
mutant (Fig 4). Furthermore, pharmacological inhibition of PB-K but not MAPK, could 
partially reverse the inactivation of caspase-9 and -3 induced by CEA (Fig 5), although 
this effect was not completely reversed, suggesting the involvement of other survival 
signaIs in the CEA-mediated anoikis inhibition. 
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In summary, the CUITent study provides significant insight into the molecular 
mechanism involved in the inhibitory effects of CEA on anoikis. We provide evidence 
demonstrating that the latter inhibition occurs in a caspase-dependent fashion by early 
inactivation of the intrinsic pathway, and a subsequent block of caspase-8 activity. The 
activation of the PI3-K pathway was also shown to be implicated in the CEA-mediated 
inhibitory effects. We propose that inactivation of the intrinsic death pathway is involved 
in the CEA-mediated anoikis inhibition and that, as with differentiation inhibition, this 
effect requires the CEA-GPI anchor attached to self-binding extracellular domains. 
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CHAPTER5 
General Discussion 
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Increasing knowledge regarding the role of the Carcinoembryonic Antigen (CEA) family 
members has been generated over the past years, placing these molecules as important 
regulators of various normal and pathogenic processes associated, among other functions, 
with cellular growth, differentiation and apoptosis. Specifically, over-expression of GPI-
family members CEA and CEACAM6 in multiple cell systems has inhibitory effects on 
cell differentiation and anoikis, as weIl as disruption of cell polarization and tissue 
architecture (see Chapter 1). Since CEA and CEACAM6 are over-expressed in a wide 
variety of human carcinomas (Chevinsky, 1991; Hammarstrom, 1999), it has become 
important to investigate the molecular mechanism involved in these inhibitory effects. 
Insights regarding this issue were provided by previous studies in CEA transfectants of 
hematopoietic ceIls, where antibody-mediated cross-linking of CEA lead to initiation of 
src-family kinase-dependent tyrosine phosphorylation events (Draber and Skubitz, 1998). 
More is known about the activation of CEACAM6-associated signaling. In BxPC3 
human pancreatic adenocarcinoma cells, cross-linking of CEACAM6 induces caveolin-1-
dependent Src-mediated focal adhesion kinase phosphorylation (Duxbury et al., 2004b). 
In addition, upon CEACAM6 crosslinking, a c-Src-dependent cross-talk between 
CEACAM6 and integrin avp3 occurs, leading to an increase in ECM component cell 
adhesion (Duxbury et al., 2004a; Duxbury et al., 2004b). 
In the work presented in this thesis, a molecular model for the tumorigenic effects of 
CEA has been proposed for the first time in the CEACAM field. We daim that activation 
of the integrin aSp 1 and associated signaling elements such as the PI3-K and MAPK 
cascades are involved in CEA-mediated signaling (Chapter 2). Moreover, we provide 
evidence demonstrating that this mechanism may apply in vivo, since over-expression of 
CEA and CEACAM6 genes in mice leading to a block in cell differentiation and 
anoikis/apoptosis in the transgenic colon, correlates with an increase in the colonocyte 
surface expression levels of the aSpl integrin and activation ofPKB/Akt (Chapter 3). In 
addition, based on structural studies of the CEA molecule, we dearly demonstrated that a 
specific molecular mechanism is implicated in the activation of signaling mediated by 
CEA. The presence of self-binding extracellular domains attached to a CEA-specific 
137 
GPI-anchor is required for the activation of specific signaling elements such as the PI3-
KlAkt pathway and the caspase cascade during CEA-mediated anoikis inhibition 
(Chapter 4). AlI the above aspects will be discussed in the present chapter. 
l.-Model for CEA-mediated signaling 
Integrins as molecular transducers of the CEA signal 
The first insight regarding the molecular mechanism involved III CEA-mediated 
inhibitory effects on cell differentiation and anoikis implicated the activation of the 
integrin aSp 1 (Ordonez et al., 2007). The latter study c1early showed that the inhibitory 
phenotype mediated by CEAICEACAM6 over-expression could be reversed by blocking 
integrin aSp 1 activation. It is interesting to note that, in a pancreatic cell system, another 
group demonstrated that increases in cell adhesion to the extracelIu1ar matrix components 
vitronectin and fibronectin were induced upon antibody-mediated CEACAM6 cross-
linking (Duxbury et al., 2004d), although the activation of the vitronectin receptor (avp3) 
rather than the major fibronectin receptor (aSp1) was implicated in the inhibitory effects 
of CEACAM6 on anoikis (Duxbury et al., 2004a). In Chapter 2, we also observed 
increases in cell adhesion to fibronectin, vitronectin, and to a lesser extent, laminin, upon 
L1NCEA cross-linking. Preliminary studies attempting to clarify the issue of integrin 
specificity demonstrated that, by using specific integrin aSp1 blocking antibodies, we 
could prevent the increase in cell adhesion to fibronectin as well as the increase in cell 
adhesion to vitronectin (data not shown). This result suggests possible "cross-talk" 
between aSp 1 and avp3 integrin receptors, an event that frequently occurs among 
integrin receptors (Blystone et al., 1999; Diaz-Gonzalez et al., 1996; Ly et al., 2003). 
Although the results presented in this thesis and previous results support the role of the 
aSp1 receptor as a key integrin involved in the CEA-biologica1 effects, it would be of 
special interest to explore further the nature of the aSp1-avp3 integrin cross-ta1k. 
138 
Membrane rafts as platforms of CEA-mediated signaling 
The lack of change in cell surface levels of a5f31 upon .1NCEA cross-linking, 
together with unsuccessful attempts to demonstrate direct binding between CEA and 
a5f31 molecules in several cell types and in vivo (data not shown), raised several 
questions regarding the potential molecular mechanism implicated in the observed 
integrin a5f31 activation by CEA. The above observations and structural studies of the 
CEA-molecule suggested that the most likely scenario for the initiation of CEA-mediated 
signaling could implicate c1ustering of CEA molecules on the cell surface, which may 
lead to co-c1ustering and activation of integrin molecules and intracellular signaling. How 
is this possibility sustained? 
GPI-proteins are able to initiate signaling based on their co-Iocalization with 
signaling elements in membrane rafts. Indeed, increasing evidence has been generated 
regarding the role of membrane rafts in integrin activation by GPI-anchored proteins (see 
Chapter 1). In the case of CEA we provide data supporting the view that the CEA GPI-
anchor plays a key role in CEA function by determining a specific subset of membrane 
rafts and their associated signaling molecules that all rapidly relocate and become 
activated upon CEA c1ustering (Chapter 2). Antibody-mediated cross-linking of an 
incapacitated self-binding molecule, .1NCEA, provided a plausible on-off system where 
we were able to monitor rapid integrin activation and localization to membrane rafts of 
associated integrin-signaling molecules as a result of CEA c1ustering. We provide 
evidence that the most likely mechanism whereby integrin activation occurs implicates 
the co-Iocalization of CEA and a5f31 molecules in membrane rafts in the cell surface, 
leading to their co-c1ustering and membrane raft recruitment of integrin-signaling 
elements such as ILK, Akt and MAPK. We have by no means characterized all the 
elements associated with CEA-mediated signaling; this must await a sub-proteomic 
identification and analysis of all elements that respond rapidly to .1NCEA cross-linking. 
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Delineation of CEA-mediated integrin signaling pathways 
It is weIl known that the PI3-K and MAPK signaling pathways are part of integrin-
mediated signaling having important effects on cell differentiation, apoptosis/anoikis and 
cell growth. Although these are canonical pathways activated by integrins, the work 
presented in Chapters 2 and 4, provides important evidence regarding the role of PI3-K 
and MAPK signaling pathways as part of the downstream signaling cascade activated by 
CEA. 
Important aspects of the model proposed for CEA-mediated signaling deserve special 
discussion. As mentioned in Chapter 1, integrins are known to interact bi-directionally 
with intracellular signaling elements in that extracellular ligand-induced activation of 
integrin results in activation ofintracellular elements (outside-in signaling) which can in 
turn further increase the binding avidity of the extracellular domains (inside-out 
signaling). Using the i1NCEA system we demonstrated that, whereas PI3-K influences 
the activation status of the integrin aSp 1 by both "inside-out" and "outside-in" integrin 
signaling, the MAPK pathway represents a unidirectional collateral signal regulated only 
by an "outside-in" process. Collectively, these results strongly suggest the existence of a 
bidirectional molecular connection between aSp 1 and PI3-KlAkt that may be involved in 
the regulation of colon cancer cells' differentiation and survival. For instance, we were 
able to show that pharmacological inhibition of the PI3-K but not the MAPK signal, 
could partially reverse the anoikis block induced by CEA (Chapter 4). These results open 
new questions regarding the differential role of these signaling elements in the regulation 
of cell differentiation and anoikis in the context of CEA. Experiments attempting to 
evaluate the effect of the PI3-K and MAPK inhibition on the CEA-mediated cell 
differentiation block could not be performed, mainly because the events involved in 
myogenic fusion require days to occur, and long chemical and antibody treatments are 
subject to experimental artifacts. Future experiments based on a siRNA approach for 
CEA-associated signaling elements would give better insight regarding this issue. 
Another important question raised by this work is the nature of the observed 
integrin aSp1 activation. Is this activation the result of initial valency changes of the 
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integrin receptor (integrin c1ustering), or is the initial event a change in integrin priming 
(affinity regulation)? As mentioned in Chapter 1, there is currently an important 
controversy regarding the molecular events involved in the activation of integrins 
(Bazzoni and Hemler, 1998; Carman and Springer, 2003). AIthough sorne studies support 
the first scenario (Hogg et al., 2002; Krauss and AItevogt, 1999; Leitinger et al., 2000; 
Shamri et al., 2002), others suggest that integrin activation is the resuIt of affinity 
changes of the integrin receptors (Carman and Springer, 2003; Shimaoka et al., 2002). In 
the case of CEA-mediated integrin activation, it is not possible at this point to establish 
whether conformational changes or integrin c1ustering is the prevalent mechanism of 
integrin aS f31 activation by CEA. Experimentally, it is impossible to discriminate 
between affinity and avidity-mediated adhesion changes by conventional cell-adhesion 
techniques. Future experiments, such as novel flow-cytometry-based assays for the 
detection of both integrin-mediated affinity and avidity changes at the single cell level 
(Konstandin et al., 2006), could contribute to the characterization of the mechanism 
involved in CEA-mediated integrin function. 
Molecular regulation of anoikis by CEA: cellular stress and death 
receptor cell death 
AIthough, as in most apoptotic pathways, integrin-mediated regulation of cell 
survival involves the activation of the caspase cascade (Gilmore, 2005), the contribution 
of the extrinsic and intrinsic caspase signaIs during anoikis varies with the cell type and is 
a cell and environmental context-dependent mechanism (Grossmann, 2002). In Chapter 4 
we demonstrated that CEA inhibits anoikis by inactivation of a caspase-dependent 
pathway where caspase-8 (death receptor cell death) and caspase-9 (cellular stress cell 
death) are differentially affected. We observed that the most prominent contribution to 
the inhibition of apoptosis by CEA expression is via the inactivation of the caspase-9 
(involved in the intrinsic death pathway) (Chapter 4). It is interesting to mention that, in 
agreement with these in vitro results, in the normal situation, caspase-9 but not caspase-8 
activation contributes to the initiation of anoikis in purified human intestinal epithelial 
141 
cells, although no involvement of cytochrome-c release during the anoikis pro gram is 
observed (Grossmann et al., 2001). Additional studies regarding this issue in colonocytes 
isolated from the CEABAC mouse (Chapter 3) may further characterize this mechanism 
in a more relevant system. 
The results presented in Chapter 4 c1early demonstrated that the CEA-mediated 
anoikis inhibition occurs through effects on a caspase-dependent process; however, this 
study did not address the molecular nature of these effects. Although pharmacological 
inhibition ofPI3-K, but not MAPK, partially reversed the inactivation of caspase-9 and -
3 induced by CEA expression (Chapter 4), experiments designed to evaluate effects of 
releasing the CEA-mediated block on the caspase activation by using specific blocking 
antibodies for the integrin a5p 1 were unsuccessful, probably due to the fact that antibody 
treatment under cell suspension conditions is not as efficient as under cell monolayer 
conditions. 
As in most of the cell signaling studies, the specificlty issue is always a concem: 
is the molecular pathway involved in the CEA-mediated anoikis resistance specific to 
CEA? First, we c1aimed that the caspase mechanism observed is specific to the CEA-
mediated inhibitory signal, since studies done by Duxbury et al in a pancreatic cell 
system showed that, although caspase activation is also involved in the inhibiton of 
anoikis by CEACAM6, the activation of caspase-8 was shown to play the most important 
role (Duxbury et al., 2004d). Second, as previously demonstrated for CEA inhibitory 
effects on cell differentiation, we found that the blockage of the intrinsic caspase signal 
and Akt activation required the presence of self-adhesive extracellular domains attached 
to a CEA GPI anchor. The latter reflects the specificity of the CEA-associated signal. 
Clustering of self-adhesive extracellular domains represents an important event for the 
initiation of CEA-associated signaling, leading to intracellular activation of specific 
signaling elements. The association and activation of these downstream signaling 
elements is determined by the information provided by the CEA-GPI anchor. GPI 
anchors possess different physical properties based on their sugar and lipid composition, 
which could determine differential signaling properties. Additional studies generated in 
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our laboratory showed that expression of ~NCEA, a defective self-binding molecule, 
together with a molecule capable of self-binding, N-C, both with the same GPI anchors 
but different non-interacting external domains, can occupy the same membrane micro-
domains and that ~NCEA can in fact completely inhibit N-C's CEA-like integrin-
activating and differentiation-blocking functions (Nicholson and Stanners, 2006). In 
order to generate more evidence regarding the specificity of the molecular signal 
mediated by CEA, it would be valuable to further investigate how the CEA-mediated 
signaling mechanism is occurring in the above cell system. 
2.-CEA-mediated signaling in vivo 
CEA/CEACAM6-mediated tumorigenic effects 
Transgenic mice harboring a 187 kb portion of the human CEACAM family gene locus, 
inc1uding CEA, CEACAM3, CEACAM6 and CEACAM7 genes was previously 
constructed (Chan and Stanners, 2004). The spatiotemporal expression pattern of these 
genes was found to be similar to that in humans (Chan and Stanners, 2004). Thus, in this 
thesis, we were able to investigate the prevalent mechanism whereby CEA mediates 
signaling in an in vivo model system that more c10sely resembles the human situation. 
The results presented in chapter 3 showed that, as seen in vitro and in xenograft mouse 
models (Chapter 1), CEAICEACAM6 over-expression leads to inhibition of cell 
differentiation and anoikis and disruption of tissue architecture in vivo. It is interesting to 
mention that a correlation was found between the expression levels of CEA and 
CEACAM6, i.e low to moderate in CEABAC2 and 10 and human colorectal tumor-like 
in CEABAC20, with the magnitude of the tumorigenic effects. Indeed, the higher 
expression levels in CEABAC20 mice lead to spontaneous tumor formation with 
dysplastic and serrated adenomatous morphology (Chapter 3), suggesting that the 
observed tumorigenic effects are gene dose dependent. Although more moderate colonic 
changes were observed in CEABAC2 and CEABACI0, it is important to mention that 
these mice were found to be more prone to produce carcinogen-induced focal colorectal 
tumors than WT (Chan et al., 2007). The fact that CEAICEACAM6 expression increases 
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the susceptibility to Azoxymethane (AOM)-induced colon tumor formation, supports the 
role ofCEAICEACAM6 in the development ofhuman colon tumors (Chan et al., 2007). 
CEA-associated molecular mechanism 
The findings presented in Chapter 2, established a molecular mechanism implicated in 
the CEA-mediated tumorigenic effects in vitro. Although we reported similar effects in 
the CEABAC transgenic mouse, slight differences were observed. In contrast to the in 
vitro model presented in chapter 2, it was not technically possible to evaluate the 
activation state of the aSp 1 integrin by measuring the binding of purified colonocytes 
from the transgenic mice to fibronectin. However, increases in the surface expression 
levels of the integrin aSpl from isolated CEABAC2 and CEABACIO colonocytes were 
found, expression levels that were directly proportional to the copy number. These latter 
results suggest that surface expression increases of aSpl would have the same effect as 
the activation implicated in the in vitro studies and it could possibly involve the 
activation of membrane trafficking pathways mediating the aSpl recycling to the cell 
surface. As reported in several studies, this mechanism is involved in the maintenance of 
surface integrin function which contributes to cell processes such as cell migration and 
tumor cell invasiveness (Caswell and Norman, 2006). Additional studies directed towards 
this hypothesis could clarify whether or not this particular mechanism is involved. 
Moreover, to further evaluate the role of the integrin aSpl in the CEAICEACAM6 
tumorigenic effects, it would be valuable to cross the CEABAC mice with the p 1-
conditional knockout mice (Raghavan et al., 2000). If integrin aSp 1 is fully responsible 
for the CEAICEACAM6-mediated tumorigenic phenotype, we would expect a reduction 
of these effects by crossing the pl and the CEABAC mice. It is also possible that based 
on the observed effects of CEACAM6 in the activation of the integrin avp3 (Duxbury et 
al., 2004a), crossing these mice may result in a moderate reduction in tumorgenicity due 
to functional compensation by the presence of avp3 integrin. 
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Regarding the changes in other signaling elements previously found to be affected 
in vitro such as ILK and AKT (Chapter 2), analysis of sucrose gradient membrane 
fractions from isolated CEABAC2 and CEABAC 1 0 colonocytes showed increases in the 
localization of ILK and to a lesser extent AKT to membrane rafts, increases that also 
correlated with the copy number. At this point, is important to mention that the prevalent 
correlation between the magnitude of the tumorigenic and molecular changes seen in the 
CEABAC mice with the copy number, support the findings presented in Chapter 2 and 
previous findings (Taheri et al., 2003). These studies demonstrated that c1ustering of 
CEA molecules represents an important molecular event involved in the initiation of 
CEA-mediated tumorigenic effects. Key experiments such as treatment with monovalent 
dec1ustering agents that can interfere with CEAICEACAM6 interactions would strength 
the latter contention. 
Histopathological analysis of CEABAC20 colonic mucosa found similarities to 
mixed hyperplastic polyps, serrated polyps and serrated adenomas in human patients, 
implicating the serrated pathway in the non-focal concomitant dysplasia observed in the 
CEABAC20 mice (Chapter 3). These findings, in a molecular context, have important 
implications. In contrast to conventional adenomas, initiation of morphological changes 
such as epithelial serration do not require perturbation of the Wnt-signaling pathway 
(Jass, 2004, Jass 2002). Rather, tumor progression results from the alteration of cellular 
proliferation and apoptosis, leading to the inactivation of DNA repair genes and the 
acquisition of other mutations such as hMLHI or MGMT. Based on the latter 
observations, together with preliminary results suggesting no involvement of the Wnt-
signaling pathway in the CEABAC20 mice (data not shown), it is possible that over-
expression of CEAICEACAM6 may represent a previously unsuspected crucial event 
implicated in the initiation of many human cancers. Additional studies such as mutational 
analysis of tumor suppressor genes, oncogenes and DNA repair genes would be required 
to support further this possibility. 
As mentioned in section 1, in contrast with our observations regarding the role of 
a5pl integrin in CEA-mediated tumorigenic effects, other .studies on the CEACAM6 
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molecule have shown that, in a pancreatic cell system, over-expression of CEACAM6 
affects the function of the av~3 integrin (Duxbury et al., 2004a). In fact, both CEA and 
CEACAM6 (but not CEACAMl) expression was shown previously to inhibit the retinoic 
acid-induced neurogenic differentiation of mouse embryonic carcinoma cells by 
perturbing av~3 integrin (Mallette and Stanners, unpublished). Due to the presence of 
both CEA and CEACAM6 in the CEABAC transgenic mice, we would expect functional 
effects on both integrins; however, we did not find changes in av~3 cell surface 
expression levels in CEABAC mouse colonocytes (data not shown). It is not known 
whether this represents a technical problem or the dominance of a5 ~ 1 in situations where 
both integrins can potentially be affected. 
3.-CEA molecular therapy. Possible clinical therapies based on CEA-
mediated signaling. 
At present, an increasing number of therapeutic strategies in diverse pathologies 
have considered the cell microenvironment as an important source of novel treatment 
targets. Although, as mentioned previously (chapter 1), CUITent c1inical trials are testing 
anti-integrin antibodies, short integrin peptidomimetics (Tucker, 2002; Tucker, 2006) and 
integrin-associated molecules (Adjei and Rowinsky, 2003; Bianco et al., 2006) for the 
development of new anti-cancer therapies. This has not been an easy task, either because 
of the poor selectivity of certain inhibitors, or most importantly, because of the difficulty 
of determining the activation state of integrins in tumors. 
The mechanistic understanding of CEA-mediated signaling provided by this 
thesis suggests that modulation of ECM/integrin interactions by targeting the 
extracellular domain of integrins, in order to alter their binding functions and their 
associated downstream signaling, could be used as the basis for new cancer treatments of 
tumors over-expressing CEA and/or CEACAM6. The CEABAC mouse model provides a 
more applicable mode! of human cancer which may potentially increase the significance 
of the in vitro cytotoxicity studies. Lastly, based on the importance of CEA clustering as 
an important event required for the initiation of CEA-mediated signaling, the 
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development of dec1ustering agents may represent an alternative nove1 anti-cancer 
therapy. This strategy has been pursued recently with promising results in a mouse 
system utilizing human colon carcinoma cells (Ilantzis et al, manuscript in preparation). 
4.- Final conclusion 
The studies presented in this thesis establish for the first time a model for the molecular 
mechanism involved in the tumorigenic effects mediated by CEA (Fig. 1). It was shown 
that activation of the a5j31 integrin represents an important event for the initiation of 
signaling mediated by CEA, and is the result of membrane raft aggregation induced by 
CEA c1ustering, leading to the re-Iocalization and activation of effector molecules such as 
PI3-K, and MAPK. Studies done in transgenic mice harboring part of the human 
CEACAM family gene locus, which established CEAICEACAM6 over-expression as an 
important event leading to turnor formation and progression in vivo, demonstrated that 
integrin activation was also the operative mechanism for CEAICEACAM6 tumorigenic 
effects in vivo. Importandy, it was also found that the activation of integrin-associated 
signaling cascades, such as the PI3-KlAkt pathway, is implicated in the block of anoikis 
byCEA. 
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Figure 1 Model for the effects of CEA clustering. Antibody-mediated cross-linking, 
which mimics natural c1ustering on the cell surface due to self-binding of the extemal 
domains of CEA, c1usters CEA-containing membrane rafts. These are cohabited by a5j31 
integrin molecules, which therefore co-c1uster, resulting in a valency-mediated increase 
in affinity for their major ligand, fibronectin. A consequent ligand-induced activation 
(outside-in signaling: downward arrow) induces intracellular signaling by recruitment 
and concentration at the underside of membrane rafts of signaling elements such as PI3-
K, ILK, Akt and MAPK. PI3-K activation in particular may reinforce integrin avidity by 
integrin priming (inside-out signaling: upward arrow) through integrin-associated 
proteins such as ILK. The overall effect of this change in state is an interlinked net of 
inside and outside elements with a robust integrin activation, resulting in a tenacious 
binding and subsequent polymerization of fibronectin, forming a "cocoon" around the 
cells. The cocoon could lead to a loss of cell polarity, a disruption of tissue architecture 
due to a loss of cell "tissue address", and an inhibition of anoikis, due to the maintenance 
of cell-ECM interaction. 
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